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Abstract 
An RT-PCR assay was developed to amplify and sequence the full S1 gene of classical and variant infectious 
bronchitis virus (IBVs) enriched in allantoic fluid (AF) or the same AF inoculated onto Flinders Technology 
Association (FTA) cards. Seven IBV strains (M41, D274, 793B, IS/885/00, IS/1494/06, Q1 and QX) were 
grown in SPF eggs and RNA was extracted from AF. Full S1 gene amplification was achieved by using two 
primers and products were sequenced using primers; A, SX3, 1050+ and 1380+ to achieve full S1 gene 
coverage. Following serial dilutions of AF, it was found that detection limits of the partial assay were higher 
than those of the full S1 gene. Partial S1 sequences exhibited higher than average nucleotide similarity 
percentages (79%; 352bp) compared to full S1 sequences (77%; 1,756bp), suggesting that the full S1 protocol 
has greater strain differentiation efficiency. For IBV detection from AF inoculated FTA cards, four serotypes 
were incubated and stored for up to 21 days at three temperatures; 4°C, room temperature (24°C) and 40°C. 
RNA extracted and tested with partial and full S1 protocols. Through partial sequencing, all IBVs were 
successfully detected at all sampling points and storage temperatures. In contrast, for full S1 sequencing, was 
not able to amplify the gene beyond 14 days of storage or when stored at 40°C. Full S1 sequencing appears to 
be suited for detection of IBVs enriched in AF, and has limited application for samples directly embedded onto 
FTA cards.  
 
Following Q1-like infection of specific pathogen free (SPF) or two different breeds of broiler chicks, the live 
body weight of all three types of chicks were significantly reduced. Also, respiratory clinical signs were found 
in all types of chick. For the infected SPF chicks, all swabs were RT-PCR positive, with the IBV viral load 
peaking in the trachea and kidneys at 9 dpi, whereas the proventriculus peaked later at 14 dpi. Significant up-
regulation in the expression of several genes (IFNα, TLR3, MDA5, LITAF, IL-1β and IL-6) were seen in the 
trachea and kidneys at 3, 7 and 9 dpi. In the broiler chicks, the immunopathogenesis of Q1 was cross-compared 
between fast and slow growing broiler birds. For the fast-growing line (Line-A), swabs from the infected group 
were RT-PCR positive at all sampling days, whereas the slow growing line (Line-B) were positive until 14 dpi. 
At 7-9 dpi, higher viral loads were found in the trachea, proventriculus and kidney of fast growers compared 
to slow growers. Mean IBV ELISA antibody titres in the Line-B were higher than Line-A. Tracheal innate 
immune response showed IFN-α up-regulation only in Line-A but IFN-β was up- regulated in both lines. For 
TLR3, an up-regulation was seen in Line-A up to 7 dpi, and for all sampling days in Line-B. MDA5 was up-
regulated in Line-A and down-regulated in Line-B at 1 dpi. In the kidneys, for Line-A birds, IFN-α and IFN-β 
were up-regulated at 1 and 1-3 dpi respectively. There was up-regulation in TLR3 in Line-B throughout the 
study period but not for Line-A. MDA5 was up-regulated in both lines at 7 and 9 dpi. It appears that the 
immunopathogenesis of IBV Q1 infection in slow growing (Line-B) chicks was milder in terms of the 
proinflammatory cytokines levels when compared to the fast growers (Line-A), which could be associated with 
the genetic differences between these breeds. 
 
In an attempt to establish an in vitro infectious model to cross-compare the virulence of IBV live vaccines, 
eight vaccines and three virulent strains of IBVs were assessed in tracheal organ cultures (TOCs). At 24 and 
72 hours post infection (hpi), TOC media and tracheal rings were collected and used for RT-PCR, qRT-PCR, 
measurement of innate immune responses and examination of total apoptotic cells. Differences in virulence 
were noted between the strains as certain vaccine strains resulted in cilia destruction comparable with the 
virulent strain. Average cilia motility readings showed that Mass1 and VirMass reached complete ciliostasis at 
96 and 72 hpi respectively, whereas, in the 793B and QX groups complete ciliostasis was reached for all strains 
by 120 hpi. The qRT-PCR analysis revealed decreased viral presence in the media at 24 and 72 hpi. Differences 
were found between the total apoptotic cell counts in the tracheal rings among virulent and vaccine strains. 
Down-regulation in mRNA expression of IFN-α at 24 and 72 hpi occurred in all virulent and vaccine infected 
TOCs. At 24 hpi, there was up-regulation in IFN-β which was down regulated by 72 hpi in virulent infected 
TOCs. At 24 and 72 hpi, there was up-regulation in the mRNA expression of TLR3 in all vaccine and variant 
strains. An up-regulation of MDA5 was seen at 24 hpi in Mass serotype strains, vir793B, 793B1 and QX 
strains. This study demonstrates successful use of the in vitro TOC model for distinguishing differences in 
virulence and replication rates among the vaccine IBV strains. 
 
Four of the vaccine strains used above were included in an in vivo experiment to validate previous data using 
a chicken host model. Following inoculation of different vaccine strains in SPF chicks, the 
immunopathogenesis was evaluated. IBV vaccines (Mass1, Mass2, 793B1 and 793B3) were administered by 
the oculo-nasal route and chicks were monitored daily for clinical signs. At 1, 3, 5, 7, 9 and 14 dpi, OP and CL 
swabs were collected for virus detection, and blood was collected for antibody assay. Necropsy was carried out 
on 1, 3, 5, 7, 9 and 14 dpi, with gross lesions observed and tracheal tissues collected for qRT-PCR, 
immunohistochemistry (CD4+ and CD8+), histopathology and host innate immune gene expressions. 
Respiratory signs started from 3 dpi. Viral load was lower in the 793B3 group at 5-7 dpi, compared to other 
groups. Higher expression of IFN-β was seen at 3 dpi in 793B groups, whereas793B1 showed a lower 
expression of TLR3 at 5-7 dpi compared to other groups. Down-regulation of IL-6 was seen at 7-9 dpi in all 
inoculated groups except for Mass2. There was higher up-regulation of MYD88 in the tracheal tissue in all 
inoculated groups. There was higher up-regulation of IFN-γ at 7-9 dpi in Mass1 and Mass2 compared to the 
control and 793B1 and 793B3. From lachrymal fluid, tracheal washes and tracheal tissue there was higher up-
regulation in IgG expression in the all inoculated groups at 9-14 dpi. In Mass2 and 793B3, there was higher 
up-regulation of IgA in the tracheal tissue at 7-9 dpi. The 793B1 inoculated groups demonstrated higher cell 
mediated immune responses, represented by higher CD8β gene expression in the period of 5-9 dpi, and higher 
cell counts of CD4+ and CD8+ at 14 dpi. Results demonstrated that the in vivo were generally comparable to 
in vitro findings. This demonstrates that large number of IBV live vaccines could be screened for virulence and 
early immune responses using TOCs, instead of birds. 
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1.1 Introduction 
Infectious bronchitis (IB) is an avian viral disease; it is an important acute disease, and it is 
associated with respiratory disorder in domestic chickens caused by infectious bronchitis 
virus (IBV), a highly transmissible coronavirus belonging to the family Coronaviridae. IBV 
was first isolated in 1936, with the first commercial vaccine against the Massachusetts 
serotype following in 1950 to help reduce economic losses. In 1956, the first available report 
was published confirming that IBV has several serotypes (Raggi and Bankowski 1956). 
Since the initial discovery, there have been many reports concerning the disease and its 
prophylaxis, but it remains one of the most important poultry diseases in the world, with the 
virus mutating into new serotypes and strains requiring the development of new empirical 
vaccines (Dolz et al., 2008).  
Schalk and Hawin (Schalk and Hawin 1937) defined an apparently new breathing disease 
among chicks in the U.S. state of North Dakota in 1931. Since that time, IB has been 
recognised in broiler, layer and breeder chickens internationally, and more than 50 serotypes 
or variants have been discovered (Cavanagh and Gelb 2008; Jackwood 2012; Jackwood and 
de Wit 2013). The highly contagious nature of IBV and emergence of numerous serotypes 
have complicated IB control with vaccination (Jackwood and de Wit 2013). The arrival of 
novel IBV strain variants presents an ongoing problem for the poultry industry (Hofstad 
1984), as these variants may circulate and persist among both vaccinated and non-vaccinated 
flocks (Cavanagh and Gelb 2008).  
IBV is a single-strand RNA virus of approximately 27.6 kb in size (Boursnell et al., 1987). 
IBV S glycoprotein purposes include attachment to the host cell and neutralisation of 
antibodies (Abs) yet it initiates host protective immunity, such determinations induce 
conformational changes in the spike (Ignjatovic and Galli 1994; Johnson et al., 2003; Zelus 
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et al., 2003). Such changes leading to virus-cell fusion and release of the nucleocapsid into 
the cytoplasm (Risco et al., 1996). The total number of amino acid (AA) that forming the S 
protein (comprising the N-terminal half) is 1162 AA. The first subunit of S glycoprotein is 
S1 (contains the receptor binding domain (RBD) of the S protein), which comprise of 535 
amino acids (90-kDa), and the second part is S2 (contains transmembrane domains and the 
C-terminal cytoplasmic tail) is comprise of a 627 AA (84-kDa) (Koch et al., 1990). One 
portion of the S2 subunit (ectodomain region) contains two heptad repeat regions and  fusion 
peptide (Luo and Weiss 1998) which are involved in oligomerisation of the S protein(de 
Groot et al., 1987) and is required for entry into susceptible cells (Tripet et al., 2004). The 
spike interacts with the M protein on pre-Golgi membranes forming multimeric complexes 
(Opstelten et al., 1995) and is incorporated into forming virions (de Haan et al., 1999).  
IBVs have an affinity for respiratory or gastrointestinal epithelium, and cause relatively mild 
clinical signs in adults but with more severe symptoms occurring in young birds (Cavanagh 
2007). The virus replicates in the cytoplasm of host cells, where the RNA works directly as 
messenger RNA (mRNA) for the RNA polymerase (Hiscox et al., 2001). The S1 subunit 
binds to host cell receptors, which are responsible for stimulating neutralising Abs 
(Cavanagh and Davis 1986); in addition, the S1 subunit is important for cell tropism (Casais 
et al., 2003). The more variable S1 section is the most significant for this induction (Casais 
et al., 2003; Winter et al., 2008). The virus is assembled and buds into the endoplasmic 
reticulum; subsequently, it is released through exocytosis. After exocytosis, virions remain 
attached to the cellular membrane (Murphy et al., 1999; Hodgson et al., 2006). 
The economic importance of IBV was first observed by Delaplane and Stuart in 1939, who 
identified IB as a common respiratory disease in semi-mature and older chickens and could 
result in significant losses in egg production (Delaplane and Stuart 1939). These losses are 
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well documented which result from infection alone or further to secondary infection with 
another pathogen such as Escherichia coli. Such losses are from mortalities, medication, 
delayed growth, infertility and eggshell deformities. Eventually, condemnation of a large 
number of carcasses could be the result of IBV infection reported in the slaughterhouse(Jones 
2010). Due its adverse effects on poultry production and also its negative role on economic 
trade, because of the potential for viral spread, the World Organisation for Animal Health 
(OIE) has defined IBV as an internationally important disease of high concern (Bagust 
2013). 
Recent advancements in molecular identification and sequencing techniques have allowed 
for new strains and variants to be identified (Wit et al., 2011; Jackwood 2012). According 
to international diagnostic laboratory, IBV genotyping is important for controlling infection 
through selection of the most appropriate vaccine.  
It is important to use appropriate diagnostic methods to differentiate IBV from other upper 
respiratory pathogens, such as avian influenza and Newcastle disease. Although viral 
isolation is considered the gold standard for IBV diagnosis, it is time consuming, laborious 
and requires several passages in embryonated chicks (Gelb and Jackwood 1998). The 
detection of IBV can be confirmed from infected chicken tissue by immunohistochemistry 
(IHC) (Chen et al., 1996) or in situ hybridisation (Collisson et al., 1990). Recently, reverse 
transcription polymerase chain reaction (RT-PCR) has proven to be a useful and rapid 
technique for IBV diagnosis and it has allowed for strain genotyping through sequencing 
(De Wit 2000). Moreover, viral dissemination can be detected and quantified in the infected 
tissues using real-time polymerase chain reaction (Real-Time PCR), also known as 
quantitative polymerase chain reaction (qPCR), during the period of infection, even if virus 
isolation has not been successful (Roh et al., 2014). 
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In the 1950s, basic methods were used for IBV isolation and identification, including serum 
neutralisation testing in embryonated eggs (Fabricant and Levine 1951). After inoculation, 
usually at 9 days of embryonic life, viral isolation in the embryonated eggs typically resulted 
in curled and stunted embryos. These signs become more prominent after 7 days post-
inoculation, illustrating the presence of IBV infection. However, this process, which used 
field samples, required serial passages in embryonated eggs; thus, the results could be 
misinterpreted, as the findings were relatively subjective and false-positive results may have 
occurred. Although this technique was still being used in recent work (Cook et al., 2012), 
this classical method is time consuming, expensive and requires a significant number of 
inoculated chick embryos. To increase the sensitivity of RT-PCR, specialists are now using 
in vitro systems to amplify the virus. Several additional procedures have now been adopted 
to identify or differentiate IBV, such as restriction fragment length polymorphism (RFLP) 
(Abreu et al., 2006), hybridisation (Nagano et al., 1993) and sequencing (Krapez et al., 
2011). 
For molecular detection, samples of swabs and tissues, or imbedded onto Flinders 
technology association (FTA) cards are processed for conventional RT-PCR (Moscoso et 
al., 2005; Cook et al., 2012). However, the use of RT-PCR alone does not discriminate as to 
whether there is viable or non-viable virus in the chicken at the time of sampling. This feature 
is crucial when analysing PCR results in connection with the disease situation in the field. 
In addition, RT-PCR does not provide live viruses that can be used for challenge studies or 
to produce new vaccines (Cook et al., 2012).  
Some IBVs are established, others have recently emerged and still others appear for a short 
period and then disappear from that area, often reappearing in a different region. Despite 
differences in IBVs’ identity, infection with these viruses causes similar signs at two sites of 
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infection, taking respiratory and urogenital forms. Different diagnostic approaches for IBV 
have been reviewed in previous work (De Wit 2000; Ignjatovic and Sapats 2000; Ganapathy 
2009; Villarreal 2010; Bande et al., 2016). This section presents a review of recent literature 
on some aspects of IBV, including the available diagnostic assays, which focus on clinical 
and laboratory diagnosis, pathogenesis and immunity.  
1.2 The Virus  
The aetiological agent of IB is a Gammacoronavirus, a positive sense single strand RNA 
virus, genus Coronaviridae, order Nidovirales. The viral particle is constituted by an outer 
envelope with glycoprotein projections. The N protein is a phosphorylated, highly basic 
structural protein that forms a helical nucleocapsid when bound to the coronavirus RNA 
genome within the virus particles. The genomic material of the virus is made up of at least 
10 open reading frames (ORFs) and genes characterized by the following organization: 
5’UTR-1a-1abS-3a-3b-E-M-5a-5b-N-3’UTR (Figure 1.1). The genome encodes four 
structural proteins, spike glycoprotein (S), small membrane protein (E), integral membrane 
protein (M) and nucleocapsid protein (N), and a set of accessory proteins (Cavanagh 2007). 
The replicase gene is forms a two-thirds of the genome, which is expressed through two 
polypeptides, pp1a and pp1ab.  These are cleaved by two types of virus-encoded proteinases 
resulting in the formation of 15 non-structural proteins. Members of the Coronaviridae 
family have a common feature of differences in the number, location along the genome and 
amino acid composition of accessory proteins (Liu et al., 2014). Recently, with the increases 
of coronaviruses and accessory proteins reverse genetics systems (RGS) have been proved 
to be generally dispensable for replication in vitro (Casais et al., 2005). Besides that, further 
in vivo infection researches have shown that coronavirus accessory proteins are involved in 
virus–host interactions (Shen et al., 2003; Haijema et al., 2004). Such studies were not 
imaginable until latterly, because RGS was only based on a non-pathogenic IBV Beaudette 
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strain, which is a highly cell-adapted strain that is unable to replicate in vivo (Casais et al., 
2005). 
 
 
Figure 1.1. IBV genome structure and subgenomic mRNAs. Gene 1 is comprised of ORFs 
1a and 1b, which are located proximal to the 5’ untranslated region (UTR) and the leader 
sequence. These encode proteins associated with RNA replication and transcription. The S, 
E, M and N genes are located proximal to the 3’ UTR and encode the proteins found in virus 
particles. Interspersed between these structural protein genes are accessory genes encoding 
non-structural proteins 3a, 3b, 5a and 5b, which are not essential for replication(Bickerton 
2010). 
 
1.3 IBV variants distributions  
It is well known that IBV vaccines have poor cross protection between serotypes, which 
emphasises the importance of identification and surveillance (Jackwood 2012). IBV variants 
can appear due to recombination and mutation events in the S1 gene and may occasionally 
be due to the introduction of virus from other regions (Jones 2010). Factors that play a 
significant role in spreading of IBV variants are not fully known, however the trade of 
poultry products and wild bird migration may have contributed to this dissemination (de Wit 
et al., 2011). 
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Variants have been detected around the world such as; USA (Jackwood et al., 2010), Latin 
America (Villarreal et al., 2010), Europe (Worthington et al., 2008), Africa ,(Bouqdaoui et 
al., 2005), Asia (Lee et al., 2008), Australia (McFarlane and Verma 2008) and in the Middle 
East (Mahmood et al., 2011). Unlike Arkansas strain of IBV which appears to present only 
in the USA, 793B and QX strains were widely distributed in many continents (de Wit et al., 
2011). 
On the other hand, D1466 strain has been found in some Western Europe countries but it has 
not reported from outside Western Europe (Jane K. A. Cook et al., 1999). It seems to be that 
control programme and geographical isolation have helped in a part of preventing the IBV 
variants from entering other neighbouring countries (Jackwood 2012). 
1.4 Transmission 
The transmission of IBV happens between an infected flock to another clean one. These 
flocks could also be a risk to the neighbouring area or further field via migratory birds 
(Erbeck and McMurray 1998; Hughes et al., 2009; Promkuntod 2016). The virus is 
transmitted both directly and indirectly, usually by aerosols created by the discharge from 
upper respiratory tissues or faeces passed by infected chickens. Moreover, the contaminated 
items and utensils from staff could be an important way for the spread of infection from one 
farm to another (Jackwood and de Wit 2013). Recent data also indicates that the virus has 
the ability for venereal transmission in 54-week old hens (Gallardo et al., 2011). 
1.5 Host and breed susceptibility 
The primary natural hosts are usually domestic fowl (Gallus gallus) and pheasants 
(Phasianus spp.) (Cavanagh et al., 2002); several IBV-like coronaviruses have been detected 
in domestic and non-domestic avian species, including peafowl, wildfowl, penguins, turkeys, 
waders pheasants, pigeons, quail, and Amazon parrots (Dea and Tijssen 1989; Circella et al., 
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2007; Hughes et al., 2009; Wu et al., 2016). Antigenic similarity between avian IBV (AIBV) 
and turkey coronavirus (TCoV) has been reported (Guy 2000).  
Different ages and breeds have been shown to be infected by IBVs, but greater severity is 
evident in young chicks compared with the adults. In the same way, resistance is connected 
to age, and it rises with increasing age (Crinion and Hofstad 1972a). Some breeds have also 
been shown to be more resistant. It was a focus of early experiments to demonstrate that 
resistance to IBV M41, in line C white leghorn chickens, is greater than line 151, although 
the shedding rate is almost identical (Otsuki et al., 1990; Bumstead 1998). This may be due 
to the inherited differences in major histocompatibility complex (MHC), such as can be 
found among three standard chicken haplotypes (Bacon et al., 2004). Moreover, the 
outcomes indicated that the genetics of B defined haplotypes may be exploited to produce 
chicks resistant to respiratory pathogens or with more efficient immune responses (Banat et 
al., 2013). This feature was tested when different breeds exhibited a different mortality rate 
when IBV inoculation was given alone or in combination with E.coli (Cook et al., 1986). 
Hence, it seems that IBV resistance is closely related to the breed. This point needs to be 
taken up in research highlighting the immune mechanisms specific to different types of 
chickens so it would help to select a breed with inherited resistance in endemic areas to 
decrease the economic losses from novel IBV strains. 
One gap of knowledge in the literature of what remains unknown is how different chicken 
lines respond in IBV in vivo infection. Among this response is the pathogenesis and innate 
immune responses to not only virulent strains but also to vaccines and connected this with, 
the local, humoral, and cellular responses. The previous point has been covered in other 
pathogens but not IBV, amongst types of broilers chicken that are either fast or slow growing 
breeds. Hence, further studies could find some aspect which relate to field strain resistance 
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and so decrease losses in IBV infection not only by reducing mortalities but also by retaining 
body weight during infection. 
Many studies have reported the variation in severity of IBV infection depending on different 
genetic lines of chickens. In comparative studies of two types of chickens (white leghorn 
line C and white leghorn line 151) infected with IBV, the genetic differences are produce 
clear variation in their clinical signs, virus load in tissue and pathological lesions in tracheal 
epithelial tissue. The results showed that line 151 chickens had more severe respiratory signs 
than did line C chickens, although similar amounts of the virus were recovered from the 
tracheas (Otsuki et al., 1990; Nakamura et al., 1991). Similarly, different mortality rates have 
been seen among various types of chickens following a challenge of either IBV alone or in 
combination with E. coli (Smith et al., 1985; Bumstead et al., 1989). Purchase et al., (1966) 
reported that inoculated embryonic chick mortality was different among many types of white 
leghorn chickens with unmeasured MDAs. 
1.6 IBV entrance and receptors 
It has been proven that IBV infects the kidney, trachea and reproductive tract via the 
interaction of the S1 glycoprotein IBV receptor-binding domain (RBD; present in M41 
amino acids 19–69) with receptors on the cell surfaces, namely those of α-2,3-sialic acid 
(Winter et al., 2006; Shahwan et al., 2013). The RBD in the S1 spike plays a central role in 
host cell–virus attachment (Babcock et al., 2004; Promkuntod et al., 2014). For this reason, 
changes in the S1 glycoprotein tend to control the virulence and tissue tropism of the IBV 
strain (Casais et al., 2003; Thiel 2007). In attenuated Beaudette-IBV, another type of receptor 
beyond sialic acid receptors has been claimed to potentially accommodate the strain’s vast 
host range in cooperation with a putative heparan sulphate (HS) binding site (Madu et al., 
2007). 
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The IBV tissue tropism differences of some strains or variants are still unclear; for example, 
in the most recent study, the results revealed differences in the susceptibility to infection in 
oviduct cell culture with the QX but not the nephropathogenic B1648 strain (Mork et al., 
2014). Although the attachment was sialic acid dependent, it seems that the variety of the 
two strains’ infection competences in the oviduct is not related to the sugar attachment 
feature of IBV spike proteins. Moreover, it has been shown in S1 proteins that IBV strains 
bound with the same effectiveness to oviduct epithelial cells (Mork et al., 2014). Changes in 
the tissue tropism could be linked to the replicase gene, such as in IBV isolate 
CK/CH/LGX/130530, and thereby change the viral pathogenesis (Han et al., 2016). 
After the virus is attached, structural changes happening in the S1 glycoprotein mediate the 
membrane fusion activity of the S2 carboxylic acid terminal of the spike glycoprotein 
(Cavanagh 2007). Then, the virus enter the cell and frees its nucleocapsid in the cytoplasm 
of infected cells (Chu et al., 2006). The virus replicates in the cytoplasm, causing budding 
formation and is released.  
1.7 Pathogenesis  
The respiratory system is the main site infected by IBV. After a short viraemia of 18–36 
hours, the virus spreads to different tissues. There are several field isolates and some variants 
which affect the chickens’ digestive, renal and reproductive systems. The pathogenicity scale 
varies, corresponding to the system involved and virus strain (Cavanagh 2007; 
Wickramasinghe et al., 2014). This diversity is assumed to be due to the amino acid 
differences in the primary viral attachment S1 domain of the spike protein (Wickramasinghe 
et al., 2014). Numerous factors have been associated with the clinical consequences in 
chickens subjected to an infection, such as the age and sex of the birds; type of immune 
status (including maternally derived Abs [MDAs], immunosuppressive agents and flock 
vaccine-take status) and virus strain; and environmental conditions, such as cold stress, 
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climate, dust, ammonia and co-infections (Jackwood and de Wit 2013). The body systems 
that are more affected by some strains than others need to be considered in future research, 
and it is possible that a variant will emerge that infects some tissues that never been a target 
in the known classical or variant IBVs. 
Typically, the virus produces lesions after replicating in many mucosal cell membranes, 
including those of the respiratory tract (trachea, Harderian gland, nasal turbinates, air sacs 
and lungs), reproductive organs (testes, oviduct) and kidneys. The virus also has the potential 
to proliferate in various cells of the alimentary tract, where it is frequently associated with 
mild lesions (Raj and Jones 1997b), and it can produce macro- and micro-changes in the 
small intestine that may be associated with alteration in the S1 structure or mutation (Hauck 
et al., 2016). 
The tropism of some IBVs to infect the kidney more than the tracheal tissues has been the 
focus of some studies, clarifying the mechanisms of the virus at the infected site and assisting 
in developing better avoidance strategies to control infection (Cook et al., 2012; Reddy et 
al., 2015). In the kidney, a unique mechanism probably found, which results in kidney 
tropism (Reddy et al., 2016). 
The severity of lesions in the respiratory tract caused by IBVs is variable; it is influenced by 
viral virulence, bird age at infection (Jones 1974), genetic susceptibility of the chicken line 
(Joiner et al., 2007) and maternal or active immunity of the chicken (Awad et al., 2016). 
Moreover, the severity of IBV infection is also affected by increased susceptibility to 
primary or secondary respiratory pathogens leading to increased damage from these co-
infections. These increased damage from duel viral-bacterial infections have been shown for 
agents like E. coli (Matthijs et al., 2005; Matthijs et al., 2009), Mycoplasma imitans, 
Mycoplasma gallisepticum (Ganapathy and Bradbury 1999) and Mycoplasma synoviae 
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(Landman and Feberwee 2004). Bacterial or viral complications associated with IBV 
infection are a wide resource for investigation, and further trials could answer many 
questions in the context of dual infection with this contagious disease. 
Extensive primary viral infection lesions will be exacerbated by secondary bacterial 
infections, especially in broilers, causing a higher mortality, decreased growth, increased 
feed conversion ratio, antibiotics consumption and carcass condemnation rates. Evidently, 
an effective vaccination plan against IBV will help these birds in avoiding clinical IBV 
disease, and consequently, secondary airsacculitis from E. coli infection (Matthijs et al., 
2005).  
Although some IBV strains are considered nephropathogenic, causing lesions in the kidney 
under field or experimental conditions (Terregino et al., 2008; Ganapathy et al., 2012), other 
strains cause slight or no lesions under the same conditions, leading to the same question 
about variations in tissue tropism of IBV strains (Khataby et al., 2016).The proventriculus 
is another tissue targeted during infection by some IBV variants, such as QX and Q1, leading 
to proventriculitis in infected birds (Yudong et al., 1998; Yu et al., 2001; Ganapathy et al., 
2012). However, despite the isolation of this variant from the previous organ, there is no 
evidence of local proliferation by IBV strains. Moreover, the death percentages were greater 
than those previously reported during IBV single infection. It seems that these cases were 
either complicated by another pathogen / factor, which led to elevated mortality. Further 
experiments are needed to validate proliferation of IBV in the proventriculus after 
confirmation of the virus’s presence in this tissue during embryonic infection by M41 
(Abdel-Moneim et al., 2009). In addition, IBV has been isolated from the pancreas of 
brown/red broilers chickens at 2 weeks of age (Hauck et al., 2016).  
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1.8 Diagnosis  
The diagnosis of IBV infection is divided between either clinical or laboratory cases and also 
either during field infection or under experimental conditions. Each test is related to one 
another; but, some of them, are directly connected together (Figure 1.2). The routinely 
diagnostic methods in the majority of countries would be the isolation, viral neutralization 
and detection of anti IBV antibody by Antigen-detecting enzyme-linked immunosorbent 
assay. However, the genomic detection by RT-PCR is not available in some portions around 
the world, and within the countries not all laboratories have this diagnostic method. 
Consideration should be given to the diagnostic capability of laboratories involved and to 
the purpose of the positive IBV identification. 
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Figure 1.2: Illustration of the process of clinical and laboratory diagnosis of infectious 
bronchitis virus from suspected clinical samples or during experimental infections. 
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1.8.1 Clinical signs 
IBV has the potential to infect chickens at all ages. In single infections, IBV has a relatively 
short incubation period in flocks, with reports of 18–48 hours in some broiler chicks 
(between 2 and 6 weeks of age) (Ignjatovic and Sapats 2000). After 3–5 days post-infection 
the virus titre reaches the highest point; then, it rapidly decreases, since the virus primarily 
grows in the upper respiratory tract, subsequently spreading to other, non-respiratory tissues 
(Jones and Ambali 1987; Lucio and Fabricant 1990). The signs vary according to the chicken 
breed (Jackwood and de Wit 2013) and the severity of infection depends on factors such as 
viral virulence and the bird’s age (Ganapathy 2009). Typical clinical signs include tracheal 
râles, coughing, sneezing and gasping and difficulty breathing, with or without a nasal 
discharge. In uncomplicated cases, these clinical signs last for only 5–7 days and disappear 
in 10–14 days (Raj and Jones 1997b). Other signs include a lack of food intake and whitish 
diarrhoea, watery eyes, swollen sinuses and apparent body weight retardation; the birds may 
be huddled under heat sources (Jackwood and de Wit 2013).  
Secondary infections from other bacterial and viral pathogens, such as E. coli, often follow 
the primary infection, and they can intensify the respiratory signs (Nakamura et al., 1992). 
In some cases, secondary co-infections with Mycoolasma synoviae can result in egg 
abnormalities (Feberwee et al., 2009). If chronic respiratory disease develops, it may last for 
several weeks, with mortality ranging between 5% and 25% (Fabricant and Levine 1962). 
Factors that may affect the severity of respiratory clinical signs include the environmental 
conditions, breed of chicken, type of housing system, vaccine programme, strain of IBVs 
and other co-infections (Jackwood and de Wit 2013). For nephropathogenic strains, factors 
that may increase the mortality rates include a cold environment, a high protein diet and the 
breed of chicken (Bhattacharjee et al., 1994). Normally, wet litter occurs due to increased 
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water intake (Irvine et al., 2010). Occasionally, after the start of infection, mortality occurs 
within 4–5 days; the risk of mortality subsides by day 12 (Cumming 1963). 
IBV infected layers can have decreased egg production, decreased egg quality (Cavanagh 
and Naqi 2003) or a loss of shell pigment (Butcher et al., 2011). Some eggs can also have 
soft, misshapen or rough shells; watery albumin and overall decreased hatchability 
(Cumming 1969; Ganapathy 2009). In layers, further to the clinical respiratory signs, 
reduced egg production can range up to 70% (Box et al., 1980; Box and Ellis 1985). 
Production levels can also be influenced by factors such as the IBV strain serotype, host 
immunity and the level of egg production during infection (van Eck 1983). False layers are 
the result of infection of 2-week-old females, due to the resulting damage to the oviduct 
(Worthington et al., 2008; Ganapathy 2009; J. J. de Wit et al., 2011). 
1.8.2 Pathology 
The lesions in the field are often different from those seen under experimental condition. In 
specific pathogen-free (SPF) chicks, which are frequently used to study IBV pathogenesis 
due to being not have maternal derive antibody and very sensitive to the virus exposure. Such 
chicks are come from parent flocks which are free from a considerable common and 
important of pathogens, and at our laboratory, were tested free from aMPV, IBV, NDV, 
H9N2, ILT, IBDV and mycoplasmas’. The clinical signs of lesions in the trachea, the 
kidneys and oviduct are the main findings. In severe cases, the virus spreads from the trachea 
and causes significant exudation and necrosis in the air sacs (Cavanagh and Naqi 2003). 
Secondary bacterial infections are sometimes cofactors in more severe disease in the field; 
however, the viral serotype may also play a role in the disease outcome (Cavanagh and Naqi 
2003; Dwars et al., 2009). 
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Infected chickens may show signs of dehydration, oedema, tracheal congestion, pulmonary 
congestion, caseation and tracheal plugs (Smith et al., 1985). Air sacs are foamy, especially 
during the acute infection and then they become cloudy and sometimes contain a yellow 
caseous exudate (Ziegler et al., 2002). Many publications have reported that IBV infections 
in young female chickens can lead to cystic oviducts (Crinion and Hofstad 1972b; Chew et 
al., 1997; Benyeda et al., 2009). In addition, infection during chick development may 
decrease the weight and length of the oviduct, potentially accompanied by a decreased ovary 
size (Sevoian and Levine 1957). At early ages, infected females can form a visible, 
undeveloped oviduct structure, with a blind sac projecting forward from the cloaca (Jones 
and Jordan 1972). Some infected hens have excessive amounts of exudate in the oviduct 
(Ganapathy 2009; Awad et al., 2016), and cystic oviducts were found in two female chicks 
when IS/885/00 was tested in an immunopathogenesis study (Ganapathy 2009; Awad et al., 
2016). 
The nephropathogenic IBV strains, commonly infect the kidneys, consequently causing 
increased water intake and diarrhoea , in addition to mortality, such as in the case of nrTW I 
strain (Xu et al., 2016). Nephropathogenic IBV can produce distended kidneys, enlarged 
ureters and deposition of urates (Cumming 1963; Ganapathy 2009). In roosters, a main 
finding is epidydimal lithiasis and a corresponding reduction in fertility was found , both in 
those that had been vaccinated (Jackson et al., 2006) and those naturally infected with IBV 
(Villarreal et al., 2007). The signs and severity of these pathological changes in the oviduct 
and decrease in egg quality and production may vary based on the IBV strains and age of the 
hen (Cavanagh and Naqi 2003). In uncomplicated infection, the lungs seemed largely 
unaffected in some experimental studies (Grgic et al., 2008; Boroomand et al., 2012). 
Further, some IBV variants, such as QX, could be the cause of proventriculitis (Ganapathy 
et al., 2012). 
      Chapter One                                                                  Introduction & literature review                                      
                                                                                         
                                                
                                                          
19 
 
Gough and his colleagues reported that birds infected with the IBV 793B strain displayed 
deep pectoral myopathy as a specific gross lesion (Gough et al., 1992). Similarly, this strain 
was isolated from broiler parent flocks suffering from bilateral myopathy, muscle paleness 
and swelling, with sometimes prominent fascial haemorrhage in both deep and superficial 
pectoral muscles ( Raj and Jones 1996). Another type of lesion could be seen under infection 
with the Q1 strain, represented by an increased thickness to the proventricular mucosa and 
the presence of a milky fluid when squeezed, where the whole proventriculus appeared 
swollen and enlarged (Yu et al., 2001). However, another IBV variant has been isolated in 
cases of proventriculitis (Ganapathy et al., 2012). Characterisation of proventriculitis is 
important for our increased understanding of IBV’s pathogenicity as it has not received much 
critical attention. Probably, studying IBV Q1 in either SPF or broilers chicks will help clarify 
this issue and fill in a knowledge gap in this area. 
1.8.3 Histopathological and clinical signs in infected chicks 
In the trachea, the development of lesions has been divided into three stages, as follows: the 
degenerative, hyperplastic and recovery stages (Nakamura et al., 1991). Histological 
changes in early infection include mucosal oedema, de-ciliation and rounded or sloughed 
epithelial cells (Chen and Itakura 1996). Lymphocyte and heterophil infiltration can be seen 
within 18 hours of infection. During the regeneration period (approx. 48 hours) after 
infection, the lamina propria may be infiltrated with lymphoid cells. After 7 days, the 
establishment of germinal centres can be seen (Siller and Cumming 1974). 
In the air sacs, important findings, on the first day of infection are oedema, desquamation of 
epithelial cells and fibrinous exudates (King and Cavanagh 1991). After this, heterophil 
infiltration and fibroblast proliferation will increase. Eventually, cuboidal epithelial cell 
regeneration occurs in the recovery period (Siller and Cumming 1974), which starts at 4–6 
days and is completed by 10–20 days (Chen et al., 1996). 
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In the lungs, lesions comprise epithelial cell desquamation and purulent exudation in the 
early phase, within 4 days (Ignjatovic and Sapats 2000). A recent study reported histological 
lesions at 3 days post-infection, with small areas of pneumonia observed in the lungs of IBV-
inoculated groups. In addition, pulmonary lesions were limited to the primary bronchi 
commonly being diffuse peribronchial infiltrates of lymphocytes and a few heterophils 
(Mahdavi et al., 2007).  
In the oviduct, the epithelial cells can undergo decreased cilial height, along with glandular 
dilatation and infiltration of lymphocytes (Ignjatovic and Sapats 2000), fibroblasts and 
plasma cells in the lamina propria (Crinion 1972). Although there is some information in the 
literature regarding infection of the oviduct and testis, the effects of this infection may need 
to be researched more extensively in the future, with more detailed descriptions and 
evaluation of this infection’s outcomes. A well-known virulent IBV genotype that has been 
accompanied by cystic oviduct is QX (Benyeda et al., 2009; J. J. de Wit et al., 2011), which 
also leads to kidney infection and increased mortality, respiratory signs and complete 
tracheal ciliostasis (J. J. de Wit et al., 2011). 
In the kidney, the conventional histological changes are displayed as interstitial nephritis 
(Siller 1981). In the case of acute infections, granular degeneration, vacuolation, 
desquamation of the tubular epithelium and excessive heterophile infiltration are observed 
(Riddle 1987). Lesions in the medullary tubules are typically prominent (Siller 1981). 
Necrotic foci may be found during the regeneration stage, and the inflammatory cells shift 
to plasma cells and lymphocytes in the course of recovery. IBV can cause urolithiasis, 
showing distended ureters being filled with urates, accompanied by atrophy of the kidneys, 
and urate calculi, that are usually found in the ureters (Siller and Cumming 1974). 
      Chapter One                                                                  Introduction & literature review                                      
                                                                                         
                                                
                                                          
21 
 
In the chronic stage, interstitial nephritis is seen in the cortex and medulla, accompanied by 
plasma cell and lymphocyte infiltration (Chen and Itakura 1997). Infiltrating plasma cells 
have a distended cytoplasm and stain deeply with the periodic acid–Schiff (PAS) stain due 
to the Russell bodies’ immunoglobulin contents (Siller and Cumming 1974). 
In the intestinal tract, nonspecific lesions have been reported in the colon (Ambali and Jones 
1990). Such lesions include desquamation of the cells of villi tips, congestion and focal 
infiltration of lymphocytes, macrophages and heterophils. However, one trial attempted to 
test several IBV strains after passage through the intestinal tract using developed in vivo and 
in vitro schemes to reduce not only their presence, but also their effects on the upper 
respiratory tract. The results revealed that tested strains were causing no lesions in the 
intestinal tract (Alvarado 2004). Conversely, in a more recent study, the researchers detected 
IBV-like coronavirus in the intestine and other parts of the digestive system; the lesions were 
distended and pale, and their content was wet (Mohammed et al., 2012). Histopathological 
changes showed cellular infiltration in the lamina propria, blunting of the villi, changes in 
the crypts and cyst formation. Coronavirus particles were confirmed by negative stain 
electron microscopy. Transmission electron microscopy of the intestine confirmed 
coronavirus in the cytoplasm of enterocytes. Moreover, IBV antigens were identified in 
intestinal epithelial cells, in addition to cells in the pancreas and proventriculus, via 
immunohistochemistry (IHC) (Hauck et al., 2016). 
1.9 Factors affecting the IB diagnosis  
1.9.1 Sampling time after infection 
Usually, in the case of pathogenic IBVs, the first site for virus replication is the trachea; this 
is followed by viraemia, and then the virus is transmitted to other organs (Raj and Jones 
1997b). It has been reported that the optimal time for virus isolation is 3–5 days after 
infection, due to the presence of high virus concentrations (Jackwood and de Wit 2013). 
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However, the virus cannot be detected by isolation after two weeks because the titre drops 
below the detection level (De Wit 2000). 
1.9.2 Sampling for IBV detection   
Typically, an acute infection in unvaccinated birds will produce a greater amount of IBV in 
the trachea for viral detection (De Wit 2000). In comparison, in vaccinated layers or breeders 
with chronic infection, for example, a lesser amount of IBV is present in the trachea (De Wit 
2000). For RT-PCR, the trachea and kidney are more suitable organs for the detection of 
acute infection. In contrast, the caecal tonsil and kidneys are better suited for the detection 
of a chronic infection (De Wit 2000; Villarreal et al., 2010). In some cases, virus isolation is 
not always considered as the preferred procedure; therefore, using RT-PCR is preferable for 
IBV identification. Cloacal or tracheal swabs can be directly processed by RT-PCR for a 
rapid diagnosis (Cavanagh et al., 1999). 
1.9.3 Sample quality 
To maintain the virus’ viability, clinical tissue samples should be stored immediately at 4°C 
or frozen at –20°C (especially for isolation). Alternatively, a 50% glycerine solution should 
be used to keep the samples active for several days (De Wit 2000; Villarreal et al., 2010). If 
samples (e.g. organs or swabs) are to be stored for a long period, then –80°C is optimal 
(Ganapathy 2009). Swabs from potentially infected birds should be pooled in sterile media 
accompanied with antibiotic and anti-fungal compounds (McMartin 1993).  
Recently, there has been an increase in sampling by using FTA® sampling cards (Whatman). 
Birds’ swabs or tissue impression smears are applied directly to the FTA card and then dried 
in air. These cards are made of a cotton-based cellulose paper impregnated with chemicals 
that bind and stabilize nucleic acids and inactivate proteins. After clinical samples are 
applied onto FTA cards, their reagents have been shown to inactivate many pathogens and 
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to lyse most cell types. RNA viruses are  reported to be relatively stable and FTA cards have 
been used for the detection of many avian pathogens such as such as Newcastle disease virus, 
infectious bursal disease, avian Metapneumovirus, Avian influenza and IBV (Moscoso et 
al., 2005; Purvis et al., 2006; Awad et al., 2012; Keeler et al., 2012). However, the stability 
on storage and recovery time of viral RNA demonstrated differences when FTA cards were 
used for rabies virus detection (Sakai et al., 2015). 
1.9.4 Host immunity during infection 
It has been shown that any impairment to the immune system, such as infection with 
infectious bursal disease (IBD) at an early age, can lead to a lack of immunity, and 
consequently, increase the potential for a severe IBV infection (Giambrone et al., 1977; 
Winterfield et al., 1978; Toro et al., 2006). The level of immunity and incubation time 
against IBV affects the time to detection after a challenge (Rosenberger and Gelb 1978). One 
study reported that using cyclosporine as a T-cell suppressor had no effect on virus titre or 
the detection of the M41 strain by the monoclonal Ab (MAb) method following challenge 
(Raj and Jones 1997b). 
1.10 Virus isolation  
Now days PCR makes isolation less necessary for identification. In many laboratories, 
isolation is applied by passages of clinical samples in tracheal organ cultures (TOCs), 
chicken kidney cell cultures (Otsuki et al., 1979b) or embryonated chick eggs (Darbyshire 
1978; Ganapathy 2009). Classically, a field strain will induce visible embryonic changes, 
consisting of stunted and curled embryos with feather dystrophy (clubbing) and urate 
deposits in the mesonephros in the second to fourth passage. It should be stated that the 
isolation of IBV takes a relatively long time and is more expensive compared with RT-PCR. 
Currently, PCR, immunofluorescence assay (IFA) and ELISA are used for detection. As a 
result, the isolation performed in combination with other tests can be used to maintain the 
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sensitivity and save time (De Wit 2000). Hence, alternative techniques, such as IFA, 
immunoperoxidase assay (IPA), antigenic ELISA and RT-PCR, could be successful for 
antigen or nucleic acid detection, rather than detection of infectious particles. Furthermore, 
in a mixed infection, virus isolation (VI) can be hampered by the presence of other viruses 
(De Wit 2000). 
1.10.1 Samples for virus isolation 
If samples are to be collected from large suspect flocks, material should be screened from 
both healthy and infected birds (Jackwood and de Wit 2013). IBV can be isolated from a 
number of tissues, including the trachea (Naik et al., 2005), lung and kidney (Wang et al., 
1997), cloacal swabs (Lucio and Fabricant 1990) and caecal tonsils (Franca et al., 2011). 
The virus isolation success rate is higher in the early stage of infection (Cook 1984). The 
reproductive organs in layers can be used for up to 28 days post infection but are more 
unreliable (Cook 1984). It has been reported that, to confirm IBV infection using antigen 
detection methods, initial isolation may be achieved in biological systems like embryonated 
chicks, cell cultures and TOCs. Although IBV does not create specific lesions in any of these 
systems, they are still useful in laboratories (McMartin 1993) for propagation of the virus. 
IBV isolation in SPF eggs should take place at 9–10 days of age (Montassier et al., 2008). 
In TOCs, the inoculation should be from SPF chicks at 19–20 days (Jones and Hennion 
2008). Cultures are only considered negative when allantoic fluid (AF) is collected after third 
passages (Gelb and Jackwood 2008). Confirmation of an IBV positive culture should ideally 
be achieved by VN, haemagglutination (HI), immunofluorescence, IHC, electron 
microscopy or RT-PCR. TOCs are considered the most sensitive approach for serotyping by 
using VN and virus isolation, especially if egg adaptation from continuous passages is 
unwanted (Cook et al., 1976b;  Gelb and Jackwood 1998). 
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1.10.2 Isolation in embryonated eggs 
The clinical signs resulting from IBV infection in embryonated chicks are typical for a viral 
pathogen and include haemorrhages, embryo dwarfing, curling and death. The signs can 
differ depending on the serotype and sample origin, and the severity increases with an 
increasing number of egg passages, such as with serotypes Massachusetts 41, Beaudette and 
Connecticut (Johnson and Newman 1971; Villarreal et al., 2010). It has been shown that the 
virus reaches its maximum amount after 1–2 days in AF (Darbyshire et al., 1975). 
Viral culture in embryonated chick eggs is considered to be the gold standard for isolating 
IBV from field samples (Cook et al., 1976b). The precise changes from the field strain during 
the first passage are probably minor. In contrast, by increasing the number of continuous 
passages, the dwarfing and embryo mortality increase (Clarke et al., 1972). One main 
disadvantage of this method is that at least three passages may be required for recognising 
lesions, which prolongs the period to diagnosis (Ashraf M Awad et al., 2014). Furthermore, 
the IBV may be unviable due to improper storage conditions before egg inoculation. 
Moreover, dual infections from multiple IBV strains may also hamper replication (Villarreal 
et al., 2010). Positive virus isolation by this method for non-egg-adapted field strains can 
take longer than that for egg-adapted strains.  
1.10.3 Virus isolation using cell cultures 
Cook et al., (1976a) reported that the first attempt at IBV isolation from infected material in 
a conventional monolayer cell culture failed. Interestingly, a recent study showed that IBV 
strains H120, M41, Gray and H52 could be propagated in HeLa cells, with different 
cytopathic effects (CPEs) (Chen et al., 2007). To obtain optimal viral replication and CPE, 
IBV should be cell-culture adapted (Gillette 1973). Kidney cell cultures from both chicks 
and chickens are extremely sensitive to cell adapted IBV strains (Lukert 1966; Otsuki et al., 
1979a). 
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1.10.4 Virus isolation using chicken organ culture 
In one report, Cook (1984) demonstrated that TOCs represent a highly successful method 
for the serotyping, isolation and titration of IBVs, since field strains are not necessarily 
adapted for growing and inducing nonspecific ciliostasis. TOCs are ideally checked every 
24 hours for 4-5 days using inverted optical microscopy to measure ciliary activity, as virus 
multiplication causes a reduction in the tracheal ring viability (Epiphanio et al., 2002). Due 
to lower sensitivities, cultures from other tissues are not recommended ( Raj and Jones 1996; 
Bhattacharjee and Jones 1997). 
Although TOCs are considered an efficient approach for virus propagation, they are not 
considered sensitive to field strains that have no tropism or affinity for the respiratory tract. 
As a result, potential false negative results can arise. In addition, ciliostasis can be induced 
by other infectious pathogens; therefore, detection of IBV by alternate methods is also 
required (Villarreal et al., 2010). 
1.11 Antigen detection (or IBV identification) 
Identification of IBV using antigen detection is usually conducted by egg passage, as field 
samples need to adapt to chick embryos. This approach is time consuming and requires a 
massive quantity of the virus. Nevertheless, IBV can be detected from infected field samples 
directly using IHC, immunofluorescence or immunoperoxidase through IBV-specific MAbs 
or polyclonal sera (Gelb and Jackwood 2008). AF and tracheal mucus can be used through 
an agar gel-precipitating (AGP) test,  is considered as highly sensitive (Gelb and Jackwood 
2008). Antisera are collected from birds infected with IBV or injected with viral proteins, 
and as a result, Abs against these antigens, such as the virus matrix protein or nucleoprotein, 
may be present in the collected sera. Biological differences in vivo can hamper 
standardisation and technical performance, therefore, MAbs are used to supply definitely 
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reproducible products, as they react with IBV antigens with one or more epitopes (Koch et 
al., 1986).  
The main problem with using MAbs to detect IBV antigens results from mutations in the 
nucleotide sequence (and subsequently, the amino acid sequence) in the epitopes with which 
the MAbs no longer react. Then according to the MAb used, the viral strain is not IB or not 
from the same IBV serotype as the Mab is targeted towards (Cavanagh and Davis 1988; 
Cavanagh et al., 1988; Wainright et al., 1989). This issue can be avoided by using MAbs 
specifically targeting conserved regions of the virus or by using multi-MAbs (a mixture of 
MAbs) (De Wit 2000). In this case, the risk is reduced that one alteration or absence of an 
epitope could lead to a false-negative result in an antiserum-based assay, since multiple MAb 
epitopes are targeted alongside novel ones (De Wit 2000). 
1.11.1 The agar gel precipitating test 
The AGP test can be used in the initial stages of infection, although it is considered 
insensitive for IBV detection, especially when other precipitating antisera tests exist. In 
addition, AGP can be used for IBV confirmation in inoculated eggs; this method has a greater 
sensitivity compared with using sera (Gelb et al., 1981). The AGP test can be used in the 
initial stages of infection, although it is considered insensitive for IBV detection, especially 
when other precipitating antisera tests exist. The AGP test is done as follows: The tracheal 
exudate is gathered and resuspended with 0.2 ml of phosphate-buffered saline (PBS); it is 
used as the antigen in middle of AGP. Six marginal wells are present; four are filled with 
reference antisera, and the others are used as negative and positive wells. A minimum of two 
reference antisera producing precipitating lines is required for the sample to be considered 
positive for IBV, since there is a low degree of cross-reaction of IBV isolates (Lohr 1981). 
In addition, AGP can be used for IBV confirmation in inoculated eggs; this method has a 
greater sensitivity compared with using sera (Gelb et al., 1981). 
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1.11.2 Immunofluorescence antibody tests 
Clarke et al., (1972) used a specific fluorescein stain for allantoic cells from eggs inoculated 
with IBV. The results showed that this test decreased the time and cost, while showing a 
higher sensitivity compared with the viral isolation method, which caused dwarfing of chick 
embryos (Clarke et al., 1972), as well as allowing the detection of IBV from TOCs and cell 
cultures (De Wit et al., 1995). In addition, immunofluorescence antibody (IFA) testing may 
be used as group specific when using polyclonal IBV serum or group- specific MAbs (Yagyu 
and Ohta 1990; De Wit et al., 1995). De Wit et al., (1995) reported that IFA is sometimes 
used as a type specific assay using specific MAbs. It has been proven that direct 
immunofluorescence staining of TOCs can detect an IBV infection (Bhattacharjee et al., 
1994), but the sensitivity of IFA can differ. For example, tissue was taken from chickens in 
an experiment on SPF chicks, and the results showed the lung to be positive by virus isolation 
(VI)   and also the kidney and trachea for about 2 weeks, whilst  IFA identified IBV antigen 
at 1–7 days in the lung and trachea and for 3–11 days in the kidney (Jones and Jordan 1972). 
So the sensitivity can be low when used on infected field tissue, and this is potentially lower 
than VI (De Wit 2000). Many researchers have reported the difficulty in reading the 
fluorescein due to non-specific reactions (Yagyu and Ohta 1990; De Wit et al., 1995). This 
issue is more significant in field samples than with samples from experimental birds, as 
additional factors like E. coli infection, ammonia and dust can lead to epithelial damage (De 
Wit 2000). IBV can also be detected by using IFA from TOCs (Bhattacharjee et al., 1994), 
embryonated eggs (Pensaert and Lambrechts 1994) and cell cultures (Wainright et al., 1989). 
Two methods can be used to increase the specificity of IFA, namely decreasing the time of 
storage at low temperatures between sampling and fixation (Braune and Gentry 1965) and 
using MAbs rather than hyper-immune anti-IBV serum (Yagyu and Ohta 1990; De Wit et 
al., 1995). Although VI is more sensitive than IFA overall, especially at the end of infection 
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(in some research, the detection end point has lasted for 14 days) (Ambali and Jones 1990), 
there is also the potential for IFA to have a higher sensitivity than VI does (Hawkes et al., 
1983; De Wit et al., 1995). It is necessary for the virus to be infectious and viable when VI 
is targeted; however, this is not the case with IFA, since it only needs viral proteins or an in 
vitro probability of some viral replication (Hawkes et al., 1983; Yagyu and Ohta 1990). In 
addition, when mixed IBV infections are present, there is a variation in the quantity and 
speed of viral multiplication between the strains that can lead to hampered proliferation for 
either one or both. Therefore, a virus with limited antigen production may be undetected 
with this approach (Droual and Woolcock 1994; Cavanagh et al., 1999). 
1.11.3 Immunoperoxidase assay (IPA) 
Like IFA, IPA is a staining technique for Abs. After fixation (e.g. with acetone (Naqi 1990)) 
and embedding of the tissue section or organs, a substrate and chromogen are added. An 
anti-IBV-specific peroxidase-labelled conjugate connects with the IBV and dyes the antigen 
sample for detection.  
Compared with IFA, IPA has the advantages of evaluating antigen-connected cells in 
addition to general tissue morphology. Assessment of the slides can be achieved with light 
microscopy, and the slides can be stored for prolonged periods. These features differ from 
IFA, where staining can fade if the samples are not kept frozen and away from light exposure 
(De Wit 2000). However, IPA requires a few days to carry out, and it is sensitive to 
background staining (De Wit 2000). Removing of endogenous peroxidase is preferable 
during the IPA procedure (De Wit 2000). A previous study detected IBV from 
chorioallantoic membranes (CAMs) in inoculated eggs using IPA within 15 hours post-
infection, with a detection limit of 106.2 EID50 (50% egg infective dose)(Naqi 1990). Recent 
study results have revealed that IPA had 83% and 84% sensitivity and specificity, 
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respectively, in contrast to RT-PCR which was positive 31%, when IBV 793B was detected 
from different tissues (Shamsaddini-Bafti et al., 2014). 
1.11.4 Electron microscopy 
Berry et al., (1964) reported that IBV has a distinct morphological structure which bear 
projections on their surfaces in negatively stained preparations, and virus characterisation 
can be carried out according to these features. However, although morphological differences 
among different IBV strains have been reported (Harkness and Bracewell 1974)such as 
pleomorphism in the virion shape, absence or presence of a corona and differences in 
projection shape, a high level of experience is required to interpret IBV particles observed 
in this manner.  
1.11.5 Antigenic ELISA 
Antigenic ELISAs are used to detect IBV using IBV-MAb bound specific micro-titre plates 
(De Wit 2000). Many studies have reported that antigenic ELISAs represent an accurate and 
precise method for IBV detection compared to AF (Boots et al., 1992; Naqi et al., 1993; 
Ignjatovic and Ashton 1996) and the detection limitation is around 106 EID50 (Yagyu and 
Ohta 1987; Nagano et al., 1990), 103 plaque-forming units (PFU) or 100–1000 median 
ciliostasis doses (CD50) (Ignjatovic and Ashton 1996). In one report, the author suggested 
that this quantity of virus is essential for the detection of IBV, further highlighting the 
relative insensitivity of the test (De Wit 2000). 
1.12 Indirect diagnosis 
Several indirect assays are employed to detect specific Abs against IBV, including the VN 
test (Witter 1962), HI test, agar gel immunodiffusion test (Dawson and Gough 1971) and 
ELISA (Mockett and Darbyshire 1981), which are considered mainly for detection the Ab 
initiated after IB infection or vaccination. In this way, an Ab that arises after the infection or 
vaccination will be detected and measured; these Abs are consider specific for IBV. In this 
      Chapter One                                                                  Introduction & literature review                                      
                                                                                         
                                                
                                                          
31 
 
technique, two samples should be collected, one at the start of infection, and the other after 
4 weeks (Villarreal et al., 2010). 
De Wit (2000) described several factors that are considered important which can interfere 
with specific Ab detection, such as the time of infection, age of the birds, immunity at the 
time of infection, maternal Ab level, vaccination status and number of samples.  
1.12.1 Virus neutralisation (VN) 
VN is considered serotype specific and exhibits high specificity; detection occurs when the 
Ab interacts with S1 protein epitopes and prevent cell adhesion (Gelb and Killian 1987; de 
Wit et al., 1997). It can be carried out in cell cultures, TOCs or chick embryos for Ab 
detection (De Wit 2000). Hesselink (1991) reported two approaches to VN testing, alpha and 
beta. In the alpha method, diluted viruses are used in different concentrations with a fixed 
serum concentration. For beta testing, various serum concentrations are used with a fixed 
volume of the virus.  VN is a serotype-specific tool for identifying the primary and secondary 
phases of the immune responses, and the results reflect that the test Ab shows good 
serotyping precision in vitro. This is because IBV-neutralising Ab is found to the S1 protein 
(Karaca et al., 1992; Ignjatovic and Galli 1994). But it has been shown that there is a strong 
correlation between the total inoculum volume and specificity, as neutralisation is far higher 
from a single inoculation (Marquardt et al., 1981; Gelb and Killian 1987).  
Ladman et al., (2006) showed that VN tests using Archetti and Horsfall’s (Archetti and 
Horsfall 1950) method could be employed to calculate the antigenic association values 
among strains using chick embryos. Moreover, Dolz et al., (2006) stated that the VN results 
showed a slight antigenic correlation (less than 35%) among some IBV reference strains, 
such as M41 and IT02. 
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1.12.2 The haemagglutination inhibition test (HI) 
Like in the VN test, the HI test identifies Abs to the IBV S1 spike glycoprotein, and the test 
requires 7–14 days from when the samples are taken to confirm Ab detection (de Wit et al., 
1997). For this, the IBV test sample needs to be treated with neuraminidase to agglutinate 
chicken red blood cells. The HI test is strain and serotype specific, especially after the first 
inoculation (De Wit 2000). A titre of below 32 is considered negative.  
1.12.3 ELISA 
ELISA testing is an essential, classical serological method for Ab diagnosis; the assay 
provides evidence of infection or vaccination, depending on the time of sampling and 
seroconversion. An earlier study developed and used a MAb-blocking ELISA; this was 
compared with a conventional, indirect ELISA. In this experiment, chickens were inoculated 
with three strains, namely Connecticut, Massachusetts and Arkansas(Karaca and Naqi 1993). 
The results showed good correlation between VN and ELISA.  
1.12.4 IBV genomic detection  
Many trials have been reported that are being used for detection of a part of the IBV genome 
(Cavanagh et al., 1999) or the entire genomic RNA (Xue et al., 2012) using different primers. 
The routine procedure involves three steps. The first step is proliferation of the virus from 
clinical samples in vitro using TOCs or embryonated eggs. In the next step, RT-PCR is 
employed to translate the genome and to proliferate the cDNA numerous times using 
polymerase. Ultimately, one of the following approaches is used: sequencing (Cavanagh et 
al., 1986), RFLP (Kwon et al.. 1993) or hybridisation (Jackwood et al., 1992). Typically, the 
S1 gene is the most significant part to be detected via the specific primers, which are 
designed from the hypervariable region in the S1 gene. These primers are considered specific 
for different IBV strains, such as Conn, JMK, Delaware, Mass, Ark, California C/633/85 
(Keeler et al., 1998), 793B, D1466 and D274 (Cavanagh et al., 1999). However, universal 
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primers that have been tested before, which also correlate to the S1 gene, are being employed 
in many IBV serotypes (Worthington et al., 2008). In contrast, the results when using RT-
PCR with clinical samples and tissues directly are often insufficiently sensitive (De Wit 
2000). Therefore, TOCs and chick embryo are usually used for the proliferation of IBV 
before RT-PCR (De Wit, 2000), or in some cases, they may be utilised directly from infected 
birds (Roberts and Chousalkar 2008). Some factors have been mentioned as affecting the 
RT-PCR reaction which include the amount of ions in the sample (e.g. Mn 2+) and the use 
of a control to check for cross-contamination (Jackwood et al., 1997). An important factor 
is using specific primers to detect IBV strains by RT-PCR (Zwaagstra et al., 1992).  
There are many types of RT-PCR, including universal (Worthington et al., 2008) and unique 
types, which are used to differentiate vaccine strains from variants, such as the Massachusetts 
vaccine and Brazilian field genotypes of AIBV (Fraga et al., 2016). Further types of RT-
PCR are duplex RT-PCR (Saba Shirvan and Mardani 2014) and GeXP-multiplex PCR assay, 
which was utilised to differentiate nine avian pathogens at the same time (Xie et al., 2014).  
At the same time, qRT-PCR has also been used in the detection of IBV (Marandino et al., 
2016), or qRT-PCR data with the use of universal and type-specific primers (Roh et al., 
2014). Moreover, real-time detection is employed, as in the SYBR Green I real-time RT-
PCR (Fellahi et al., 2016) and Taq Man probe methods (Callison et al., 2006), which are 
considered more sensitive than conventional RT-PCR. Using the PCR products from RT-
PCR, with sequencing and phylogenetic analysis exploration of the evolution of novel 
emergent IBV genotype or strain is possible.  
More recently, there has been successful high-resolution melt (HRM) curve analysis of PCR 
products, which was found to be sensitive and rapid in detecting variants and able to 
differentiate between field and vaccine IBVs (Hewson et al., 2010). At present, the efficiency 
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of next-generation sequencing (NGS) has been established, analysing the full-length genome 
sequence in a short time frame (Reddy et al., 2015). Using one approach will be preferable 
over another, depending on the assay’s cost, purpose and sensitivity and specificity.  
1.13 Strain classification  
To date, there is no consensus on a classification system for IBV strains. The favoured 
classification system correlates with the aims of either vaccination or epidemiological 
surveillance, as well as cost, experience and the availability of the technique (De Wit 2000). 
To establish a proper protection scheme to control IBV, typing of field strains is necessary. 
It is well known that IBV is classically characterised by forming new serotypes and 
genotypes, since there is either a high mutation rate or during recombination of amino acids 
(Cavanagh et al., 1992; Jia et al., 1995). Serotypes or genotypes result from an alteration in 
the amino acid level in S1 gene (De Wit 2000). The detailed classification of IBV was 
reviewed by de Wit (2000), who found that IBV strains are classified by functional and non-
functional groups. The first group includes strains classified by the biological activity of the 
virus, leading to specific pathotypes, protectotypes and serotypes. In contrast, the non-
functional group includes strains related to the viral genome. The pathotype is defined by 
the criteria of tissue tropism and major lesions, which are demonstrated by an IBV strain in 
natural hosts (Cavanagh 2005). However, major issues occur with classifying IBV strains 
based on the different manifestations of virulence due to frequent strain mutation and the 
lack of test standardisation (De Wit 2000). 
Serotypes are categorised according to VN after IBV isolation in embryonated eggs, TOCs 
or cell culture. In contrast, protectotypes depend on cross-immunisation study for typing. 
Moreover, genotyping is achieved by genetic characterisation using RT-PCR and RFLP for 
cleavage site analysis and sequencing (Callison et al., 2006). 
      Chapter One                                                                  Introduction & literature review                                      
                                                                                         
                                                
                                                          
35 
 
 1.13.1 Serotyping  
Traditionally, the HI test (King and Hopkins 1984) and VN in TOCs (Darbyshire et al., 
1979), chick embryos (Dawson and Gough 1971) and cell cultures (Hopkins 1974) are used 
for serotyping. In this typing system, two strains (e.g. a and b) may be considered to belong 
to the same serotype if two-way heterologous neutralisation titres (antiserum A with virus 
B) varies less than 20-fold from homologous titres (virus B with antiserum B, virus A with 
antiserum A) in both directions (Hesselink 1991). However, not all IBV strains 
spontaneously haemagglutinate red blood cells, and they ought to be treated with 
neuraminidase for HI (Ruano et al., 2000). 
The researchers used fluorescent foci for serotyping (Csermelyi et al., 1988). Furthermore, 
ELISA and MAbs have also been used for serotyping and distinguishing IBV strains 
(Ignjatovic and McWaters 1991). Nevertheless, this method has some drawbacks, such as 
poor availability of MAbs and it is essential to produce new MAbs with each new variant 
(Karaca et al., 1992). Serotyping becomes impractical, since more and more new IBV strains 
are being detected, and these must be distinguished from those already present to carry out 
a neutralisation test. Furthermore, the antibody must be prepared in SPF chickens. 
1.13. 2 Genotyping 
Genotyping is done using specific or universal primers, with differentiation carried out by 
nucleotide sequence analysis. A drawback of this classification method is that the detection 
may be restricted by the primers used. Although universal oligonucleotides are adequate for 
the detection of most known IBV strains, emerging variants or some strains in a mixed 
sample may be missed (Ganapathy 2009). In this type of classification, strains are typed 
according to their genetic characterisation (usually from a part of the genome). In other 
words, IBV strains may be typed according to the genetic characterisation of the S1 subunit, 
especially the S1 hypervariable region (Cavanagh 2005). Genotyping is not the preferred 
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approach for independent use in classification. Therefore, a basic approach, such as the VN 
or HI serotyping, may be supported by in vivo experiments for IBV classification 
accompanied by genotyping (De Wit 2000). 
Field strains that were classified by the VN or HI serotyping method have been replaced by 
genotyping (Jackwood and de Wit 2013). This is considered the most common method (Lee 
and Jackwood 2000). Briefly, RT-PCR is carried out, followed by either sequencing or RFLP 
through determination of the enzyme cleavage site (Lin et al., 1991). It has been reported 
that genomic data are objective and supply important evidence to be used in epidemiological 
research (de Wit et al., 2011). However, many researchers have demonstrated conflicting 
results between serotyping and genotyping (Capua et al., 1999). To summarise, De Wit and 
colleagues (2011) stated “genotyping is an excellent tool for epidemiological studies, and is 
a convenient, practical tool for typing that can be used best as a means of screening to select 
potentially relevant strains. In situations where there is suspicion in the field that the 
genotype of recent isolates does not provide accurate information about the actual antigenic 
nature of these IBV isolates, then conventional testing (serotyping) and especially in vivo 
protection studies are required’’(Wit et al., 2011). 
Recently, there has been growing interest in complete S1 sequencing, with reports from 
Thailand, Sweden and India (amongst others) aiming to further understand the molecular 
characterisation of IBV (Pohuang et al., 2011; Abro et al., 2012; Kamble et al., 2014). In 
addition, it was suggested, during the 8th international symposium on avian corona-
pneumoviruses and complicating pathogens (2014), that the full S1 gene should be 
sequenced to determine the genotype of IBV isolates. Recent work in Italy, has outlined the 
benefits of sequencing the full S1 gene and classified IBV strains into a number of distinct 
lineages based on the data (Valastro et al., 2016). An earlier study aimed to obtain full S1 
sequences by using two primers to amplify and sequence around 1,700 base pairs (bp) from 
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the S1 gene, after purifying and digesting with restriction enzymes (Kwon et al., 1993). 
Recently, the same primers were used in a second study (Abdel-Moneim et al., 2006), while 
a separate investigation looked into the differences in sequencing the entire S1 and partial N 
gene for grouping IBV genotypes (Huang et al., 2004). 
1.13.3 Protectotyping 
Classification in the protectotype category involves decreasing the number of serotypes to 
protectotypes, which are important in vaccine programmes in the field. Protectotyping is 
beneficial and applicable; if two strains have cross-protection, this means they belong to the 
same protectotype (De Wit 2000). Few strains, such as M41, can be considered protectotypes 
which provide cross-protection against other strains. Serotypes that belong to the same 
protectotype have a common epitope responsible for cross-immunity. Strains that are not 
linked serologically may still protect each other, such as the H120 and T strain, which 
originated from Australia (Darbyshire 1985). 
To determine the protectotype, a cross-immunisation challenge study may be more 
beneficial; moreover, it may tend to reduce the number of protectotypes compared with 
serotypes, since the immune responses will be missing (McMartin 1993). However, this type 
of research is expensive, cumbersome, and requires a large amount of birds, effort and 
technical equipment for isolation. The researchers found an alternative way to apply cross-
immunisation testing using TOCs or ovary organ cultures from vaccinated hens; this was 
followed by using in vitro heterologous or homologous inoculation strains to evaluate the 
cross-immunity (Raj and Jones 1996). 
1.14 Immunity  
Collectively, the natural, local and cellular and humoral immune systems play an essential 
role in the control of IBV infection. The Harderian glands (HGs), considered the main eye-
associated lymphoid tissues draining secretions in the respiratory tract, and the conjunctiva 
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of the lower eyelid (CALT), are involved in the local immunity in the eye. HG secretions 
(secretory immunoglobulins [sIgs]) protect the upper respiratory tract (RT) (Gurjar et al., 
2013). All the local immunoglobulins (IgM, IgA and IgY [IgG] in the lachrymal fluid are 
produced by the HGs, which provide local protection in the upper RT via the 
immunoglobulins. After IBV attenuated vaccine application, proper correlates of protection 
have been proposed, represented by IgG and IgA levels in tears (Okino et al., 2013). 
Recently, it has been reported that simultaneous application with Ma5 and 4/91 vaccine 
strains induces high levels of immunoglobulins (IgA and IgY) in the URT washings and high 
level of CD8+ T cells in the HGs (Śmiałek et al., 2016; Zhang et al., 2017). The levels of 
the different immunoglobulins (IgY, IgA and IgM) were reported to be different in the 
chicken line (Nakamura et al., 1991).  
In the trachea, the ciliated epithelium has cells that produce mucous goblet cells. Lymphoid 
follicles and scattered lymphoid cells consisting of antigen-presenting cells (APCs), CD4+ 
and CD8+ cells are found in the lamina propria. Hyperplasia of the alveolar mucous glands 
and goblet cells is considered the first step in triggering the innate immunity after IBV 
infection (Nakamura et al., 1991). In addition, after vaccination, extensive lymphocyte 
infiltration and large numbers of B and T cells and plasma cells have been reported, as the 
trachea is extremely reactive to IBV (Matthijs et al., 2009). 
The innate immune system consists of different cell types, including natural killer (NK) cells, 
macrophages, granulocytes and dendritic cells (DCs) and proteins (antimicrobial peptides, 
complement). Ultimately, T and B cells, which are considered adaptive immune system cells, 
may be stimulated by APCs to help in countering infection and supporting recovery (R. 
Chhabra et al., 2015a). APCs, including macrophages and DCs, play a central role as 
regulators of the adaptive immune responses by interacting with T cells (CD4+ and CD8+) 
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and B cells, whereas NK cells elicit antiviral reactions by killing the virus-infected cells 
(Figure 1.3). 
Pathogens that cross the physical barriers encounter macrophages, which are the main 
defence line in the infected tissue, and they are massively distributed in that tissue. With 
DCs, they produce cytokines and chemokines, which trigger the local inflammatory phases 
(Hawkes et al., 1983). These inflammatory responses in the early stage of IBV infection in 
the respiratory tract and/or other organs are induced by the high influx of proinflammatory 
cytokines, which are involved in the activation of innate immune responses by recruiting 
mononuclear leukocytes and polymorphs to the primary site of viral infection. The 
overexpression of these cytokines may be associated with tissue destruction (Kameka et al., 
2014). 
The recognition of IBV always results in the activation of innate cells, such as macrophages, 
heterophils and DCs, by Toll-like receptors (TLRs); following this, the downstream 
immunomodulatory cascade is initiated. Conserved structures in the infectious agents are 
rapidly recognised by these cells through pattern recognition receptors (PRRs). In chickens, 
there are three crucial PRRs, TLRs, retinoic acid-inducible gene (RIG-I) - regulatory induce 
gene -like receptors (RLRs), and NOD-like receptors NLRs (R. Chhabra et al., 2015a). 
Recently, in-depth studies have been performed on PRRs and the immunological parameters 
that accompany their expression (Okino et al., 2013; Kint et al., 2015). Researchers have 
found that TLR3 induces interferon-I (IFNF-I; α, β) production through double-stranded 
RNA viral sensing (Kint et al., 2015). Then, the produced IFNs actively stimulate adjacent 
cells to express high antiviral proteins, stimulating NK and macrophage cells to elicit 
antiviral responses. 
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When antigen-specific immunity is triggered, a type II IFN (IFN-γ) is produced by DCs, 
NKT, NK cells, CD8+ effector cytotoxic T lymphocytes and Th1 CD4+ T cells. Type II IFN 
increases the expression of major histocompatibility complex (MHC) class I molecules in 
healthy cells, and antigen presentation on macrophages promotes the NK cell activity and 
leukocyte adhesion and binding required for migration. It has been asserted that cytotoxic T 
cells (CT), which are expressed in the cellular mediated immune response (CMI), are 
essential for limiting an IBV infection during the early stage. The MHC controls the CTL 
action, and it is associated with CD4+ and CD8+ cells (Joiner et al., 2007). After that, the 
humoral immunity starts through B cells, which are stimulated by T-dependent antigens 
(help from Th cells). APCs with class II MHC proteins process and present antigen to CD4+ 
T cells (helper cells). Helper T cell become activated. Activated T cell secreted cytokines 
that in turn activate B cells. B cell differentiates into effector and memory (plasma) cells and 
produce antibodies (Figure 1.3). 
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Figure 1.3. Model of innate immune recognition of virus in chickens. The plasma membrane 
receptor of TLR3 recognize PAMPs. Viral recognition relies on intracellular vesicles of 
PRR, whose ligands are dsRNA derived from viruses or virus-infected cells(TLR3), ssRNA 
derived from RNA viruses (TLR7), short 5′ppp dsRNA (RIG-I), and long dsRNA (MDA5). 
TLR3, TLR7 localize mainly in the ER in the steady state and traffic to the endosome, where 
they engage with their ligands. The recognition triggers the downstream signal transduction 
to activate NF-κв or IRF3/7, finally induces interferon and inflammatory cytokine 
production. Model of T cell differential and the cellular and humoral immune responses after 
activation of MHC pathways and the subsequent immunomodulatory responses (green 
colour indicated the target genes or cells involve in this study). 
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1.15 Study aims  
To improve diagnosis of IBV, in particular through use of molecular techniques. In addition, 
to enhance our understanding on the molecular pathogenesis including early immune 
responses following infection of virulent or vaccine IBV strains in in vivo and in vitro 
infection models. These aims were achieved through the following specific objectives:- 
 To design and evaluate a universal RT-PCR for amplification and sequencing the full 
S1 for six strains (M41, D274, 793B, IS/885/00, IS/1494/06, and Q1) stored onto 
FTA cards at 4 oC, 24 oC, and 40 oC (Chapter 3). 
 To investigate the pathogenicity and host innate immune responses of variant IBV 
Q1 in SPF chicks (Chapter 4). 
 To compare the pathogenicity and early host innate immune responses to variant IBV 
Q1 in two broiler lines, Line-A and Line-B, with differing growth rates (Chapter 5). 
 To establish an in vitro model for assessment IBV vaccine strains in tracheal organ 
cultures, which will support 3Rs (replacement, refinement and reduction) 
requirements (Chapter 6). 
 To validate the chapter 6 results in vivo, to compare the pathobiology and host 
immune responses following administration of single live vaccines in day-old SPF 
chicks (Chapter7).
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2.1 SPF eggs for in vivo and in vitro experiments 
All SPF embryonated chicken eggs that were used in tracheal organ culture (TOC) 
preparation, virus titration, propagation and virus isolation in all chapters were obtained from 
a commercial source1. Eggs were incubated at 37°C with 55% humidity. The eggs originated 
from a parental flock free from chicken pathogens, including IBV.  
2.2 Tracheal organ culture (TOC) 
All TOCs were prepared from embryonated SPF (White leghorn) eggs at 18-19 day post 
incubation. All stages of preparation were under sterile conditions. First, the eggs were wiped 
with 70% alcohol, viable chicks were humanly euthanized and the tracheas were removed 
using sterile forceps and scissors. After removing any attached tissues, the trachea were 
placed in pre-warmed TOC culture medium (Appendix І).  
A tissue chopper2 was used to obtain 0.6 mm-thick rings from the removed tracheas. A single 
ring was placed into a sterile tube3 containing 600µl of pre-warmed TOC media. Tubes were 
incubated in a rotating incubator4 (8 revolutions per minute’s (rpm)) at 37°C. Ciliary activity 
was checked after 24 hours by an inverted microscope under low power (100 x 
magnification). Only rings with 100% ciliary activity were included for in vitro work. 
                                                 
 
 
1 Novartis, Liverpool, UK 
2, Campden Instruments LTD, Loughborough, Leics. England 
3 Thermo Scientific, Warrington, UK  
4 Lab Thermal Equipment, Greenfield, NR OLDHAM 
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2.3 Specific pathogen free (SPF) and broiler chicks for in vivo studies 
Embryonated SPF eggs (White leghorn) were incubated at 37°C (Figure 2.1A). After 
checking for fertility on day 18, eggs were moved to a static hatching tray for hatching by 
day 21(Figure 2.1B). Day-old broilers Ross 308(Line-A) and Hubbard JA57 (Line-B) 
chicks were purchased from a nearby commercial hatchery5. Chicks were kept in an 
isolation unit (University of Liverpool) throughout all in vivo experiments and reared on 
deep litter with water and feed (free of antibiotics) were provided ad-libitum. All 
experimental procedures were undertaken following approval by the University of Liverpool 
ethical review committee and according to UK legislation on the use of animals for 
experiments. 
 
 
                                                 
 
 
5 Frodsham Hatchery, Frodsham, UK 
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Figure 2.1. The process of hatching from SPF embryonated chicken eggs.(A) Eggs were 
incubated at 37 °C for 21 days at 55% humidity. (B) One day old hatched chicks for 
experiments. 
2.4 Chick welfare and management  
All work was conducted in accordance with UK legislation governing experimental animals 
and was approved by the University of Liverpool ethical review process. All animals were 
checked twice (minimum) daily to ensure their health and welfare. All chicks were housed 
securely with ventilation and temperature adjusted according to age. Chicks were reared on 
wood shaving litter with food and water supplied ad libitum (Figure 2.2 A). Both feed and 
water was free of preventive or therapeutic medications or herbal products. Individual groups 
were kept in separate isolation rooms to prevent cross-contamination. Personal protection 
equipment (PPE) was used at all times during postmortem valuation and tissue collection, 
including disposable facemasks, gowns, and gloves (Figure 2.2 B). 
A
A 
B 
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Figure 2.2. Chicks management and birds necropsy.  
(A) Chicks at day one old rearing in deep litter and chicks were given ad libitum access to 
food and water. (B) Appropriate personal protection equipment (PPE) at necropsy. 
 
 
2.5 Virulent infectious bronchitis virus propagation  
Allantoic fluid containing infectious bronchitis viruses was checked for contamination of 
other avian viruses such as Newcastle Disease virus, avian metapneumovirus, avian 
influenza, infectious laryngotracheitis virus, infectious bursal disease virus and adenoviruses 
by PCR, and bacteria such as Escherichia coli and Mycoplasma spp by culture prior to use 
(Awad 2014). All IBV-rich allantoic fluid was aliquoted and stored at -70 °C after being 
titrated in TOCs according to the Reed-Muench method (Reed and Muench 1938). 
2.6 Vaccine virus propagation 
All commercial vaccines were reconstituted in 1mL of TOC media (Sterile distilled water, 
900mL; 10x MEM+ EBSS + L glutamine 100mL; 7.5% NaHCO3 20mL; Penicillin 
/Streptomycin 4mL), except for QX2 (Chapter 6 and 7), which was reconstituted in 3 ml. 
For each vaccine, 0.1 mL of reconstituted vaccine was separately inoculated in the allantoic 
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cavity of 10 SPF eggs and incubated for 48h at 37°C. Eggs were monitored daily by candling 
and non-specific dead eggs (within the first 24 hours) were discarded. After 48 hours, eggs 
were kept at 4oC for 24 hours, and allantoic fluid was collected from each egg. Collected 
allantoic fluid was centrifuged, pooled, aliquoted and stored at -70°C until used. 
Representative aliquots were titrated in ECE or TOC before used in either in vivo or in vitro 
experiments.  
2.7 Swabs and blood sampling  
For in vivo experiments (chapters 4, 5, and 7), oropharyngeal and cloacal swabs were 
collected along with blood samples. Swabs were subjected for RT-PCR to detect IBV and 
were investigated for genetic differences compared to the inoculum used. Blood was 
collected in 1.5ml Eppendorf tubes and left overnight in a slanted position to separate serum. 
2.7.1 Swab samples  
Dry swabs6 were used to sample the cloaca and oropharyngeal cavity. After sampling, swabs 
from each group were pooled and dipped into 1.5 ml of TOC media. The media underwent 
2x freeze-thawing and stored at -70oC until required for RNA extraction. 
2.7.2 Serum  
Blood was collected from the brachial wing vein using a sterile needle, and placed in labelled 
bijou tubes without coagulant. In order to obtain serum separation, tubes were kept at a 45o 
angle. Samples were centrifuged, sera collected and stored at -20 oC until needed. 
                                                 
 
 
6 Medical Wire and Equipment (MWE), Corsham, UK 
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2.8 Clinical and pathological assessments  
2.8.1 Clinical signs  
Clinical signs were recorded daily according to a previously published scoring system (Grgic 
et al., 2008), using the following criteria: 0 = no signs; 1 = mild signs; and 2 = moderate 
signs. 3 = severe. Mild gasping, coughing, râles or depression were considered as mild signs, 
moderate signs considered as depression, along with gasping or ruffled feathers, moderate 
signs considered as depression, along with gasping or ruffled feathers whereas severe 
gasping, coughing, sneezing or depression, or both, accompanied by ruffled feathers were 
recorded as severe signs (Grgic et al., 2008). If the chicks exceeding the severity limit were 
removed from the experiment in accordance with the project license.  
2.8.2 Pathological changes  
For Chapter 4 and 5, the trachea, kidney and proventriculus were observed following culling 
and dissection, with gross lesions recorded as described below. (Mahgoub et al., 2010) 
(Table 2.1). 
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Table 2.1 Scoring system used for gross lesion assesment following IBV infection 
 
Tissue Lesions Score 
Trachea No lesion 0 
 Congestion 1  
Mucoid exudate 2  
Caseous plug or airsacculitis, perihepatitis and 
pericarditis 
3 
Kidney No lesion 0 
 Swelling and pale 1  
Swelling with visible urate 2  
Large swelling, pale with tubules and ureters distended 
with urates 
3 
 
2.9 Tissue samples for isolation and RT- PCR  
All sampled tissues were collected using sterile instruments. Tissues for quantitative real 
time reverse transcription polymerase chain reaction (qRT-PCR) were collected in RNA 
later7 to preserve the integrity of tissue RNA. For virus isolation, the sampled tissues were 
ground aseptically using a sterile pestle and mortar with sterile sand and TOC media 
(Appendix І). Samples were stored at -70 oC until required. Samples were subjected to RNA 
extraction and RT-PCR to detect the partial S1 gene.  
2.10 Virus isolation in embryonated SPF eggs 
Isolation and propagation from previously ground tissues was achieved in fertile SPF eggs 
at 9-10 days old. After candling eggs to ensure viability, 200µl of ground tissue supernatant 
                                                 
 
 
7 Qiagen, Manchester, Uk 
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was injected into the allantoic cavity aseptically and incubated at 37 oC. Eggs were monitored 
daily and dead embryos within 24 h were removed. During the first and second passages the 
allantoic fluid (AF) was collected after 48 hours. For the third passage, allantoic fluid was 
collected after 5 dpi (Figure 2.3). A positive IBV isolation was confirmed by RT- PCR and 
were sent for commercial sequencing using the forward primer SX3+ (Source BioScience 
Ltd, Nottingham, UK). 
  
 
Figure 2.3. Inoculated eggs at 5 dpi. (+) Dwarfism, curling, haemorrhages the characteristic 
effects caused by IBV in chicken embryonated eggs, (-) negative control 
2.11 Histology  
Histological changes were scored as follows: 0 = no change, 1= mild, 2 = moderate, 3 = 
severe (Chen and Itakura 1996; Chhabra 2016), Trachea and kidney samples were processed 
for histological examination after fixing in 10% buffered formalin (Appendix І) then 
embedded in paraffin and sectioned at 5 μm thickness. Slides were stained with 
+ - 
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Haematoxylin and Eosin (H&E) (Chhabra 2016). Proventriculus samples embedded in 
Optimal cutting temperature compound (OCT) were cut at 5 μm sections using a pre-cooled 
cryostat and mounted on glass slides. Slides were washed with 95% ethanol three times and 
then washed with tap water. The Haematoxylin stain was then applied for 30 seconds 
followed by another wash with 95% ethanol. Eosin stain was then applied followed by a final 
wash with 95% ethanol and 100% ethanol (Appendix І). Slides were then washed in xylene 
and a coverslip was added. Samples were examined by a pathologist at the University of 
Liverpool. 
2.12 RNA extraction from swabs and allantoic fluid for RT-PCR 
For RNA extraction, the phenol chloroform method was used as previously described (Ball 
et al., 2016c). A volume of 300 μl of TOC media from swabs or AF was treated with 300 μl 
of solution D (Appendix І), and frozen at -20°C overnight. This was then mixed with 50 μl 
sodium acetate and 650 μl phenol chloroform 5:1. Tubes were mixed and then centrifuged 
at 13,000 g for 5 minutes. The top layer was removed and mixed with 500 μl isopropanol 
and then precipitated overnight at -20°C. Following this, the sample was centrifuged at 
13,000 g for 15 minutes. The supernatant was removed and the precipitate was carefully 
washed twice with 100% ethanol and then left to air dry. The precipitate was re-suspended 
in 30 μl of re-suspension water (containing 2.5 µl of Rnasin, 5 µl of DTT and 92.5 µl water) 
and left to stand at 4oC for at least 15 minutes. Samples were then vortexed for 10 seconds 
before proceeding for RT-PCR (Chomczynski and Sacchi 2006).  
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2.13 RNA extraction from FTA cards and TOC 
FTA cards discs or circles were cut down using sterile scissors and forceps. Then, these discs 
were placed in tubes contain 1000 ml TE8 buffer (Chapter 3). After, vortexing and incubating 
at room temperature for 10 mins 100 μl was taken for extraction. From TOC 140 μl of 
supernatant was taken and processed for extraction as described below. 
Viral RNA was extracted using the QIAamp viral RNA Mini Kit (Qiagen) (Appendix І) 
according to the manufacturer’s instructions. In brief, 140 μl of each sample was added to a 
1.5 ml Eppendorf tube9 containing 560 μl of buffer AVL lysis buffer (containing 
reconstituted carrier RNA) and vortexed for 15 s. Samples were then incubated at room 
temperature for 10 minutes and pulse centrifuged. A volume of 560µl of 100% ethanol was 
added to each tube, vortexed and pulse centrifuged. Then 630 μl was removed from each 
tube, placed in a spin column/collection tube and centrifuged at 8000 rpm for 1 minute, flow 
through was discarded and this step was repeated with remaining sample. The spin column 
was placed in a clean collection tube along with 500 μl of buffer AW1.The previous step 
was repeated with using AW2 buffer. Spin columns were centrifuged at 13000 rpm for 3 min 
and the flow through was discarded. Centrifugation was repeated at 13000 for 1 minute. 
Finally, 60 μl of Sigma water was used to elute the RNA from the column and stored at -20 
°C (F. Awad et al., 2014).  
                                                 
 
 
8 Thermo Fisher Scientific, Warrington, North West England, England 
9 Elkay Laboratory Products UK (Ltd), Basingstoke, Hampshire, UK 
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2.14 Total RNA extraction from tissues collected on RNA® later 
Total RNA extraction was carried out using the RNeasy Mini Plus kit 10for tissue samples 
(Appendix І). Samples (30mg) were cut into small pieces using sterile scissors and mixed 
with 600 μl of RLT buffer plus mercaptoethanol (10µl Mercaptoethanol to each 1 ml RLT 
buffer) and a stainless steel bead (5 mm). Tissues were homogenised using a Tissue Lyser11 
and lysate was centrifuged at 13000 rpm for 3 min. The solution (550 μl) was transferred to 
a spin gDNA eliminator spin column. Then, samples were centrifuged for 30 sec at 
10,000rpm, flow through was saved in the collection tubes. To a 550 μl of the supernatant 
similar volume of 550 μl of 70% ethanol was added. From the previous mixture a 700 µl 
including any precipitate was placed in a RNeasy spin column. Washing and elution was 
performed according to the manufacturer’s instructions using RW1, and RPE buffer in two 
stages. A volume of 30 μl RNase-free water was used to elute the RNA from the column. A 
NanoDrop1000 spectrophotometer was used to quantify the extracted RNA. The extracted 
RNA was stored at -70oC until used for quantitative reverse transcription PCR (qRT-PCR) 
analysis and preparation of cDNA for host gene and cytokine mRNA expression. 
2.15 IBV RT-PCR of the partial S1 gene 
 
The IBV RT-PCR was conducted as previously described (Worthington et al., 2008) that 
targets a 393bp portion of the S1 gene (Appendix І). 
                                                 
 
 
10 Qiagen, Manchester, UK 
11  Storm Bullet Blender 
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2.15.1 Reverse transcriptase  
The RT reaction mix comprised of (x5 Buffer, DTT , dNTP’s, Rnase inhibitor, Superscript 
II RT12, water and SX2- primer ) (Table 2.2) (Appendix І ). Five µl was added into a 0.2 ml 
pre labelled Eppendorf tube for each sample, along with 0.5 µl of extracted RNA. The tubes 
were then placed in a thermocycler13 and run under the following conditions: 42oC for 1 
hour, 72oC for 10 minutes and then held indefinitely at 8 oC.  
2.15.2 Nested PCR 1 
A master mix or Supermix containing (DNA polymerase, salts, magnesium, and dNTPs) 
(Appendix І) was added to the product of reverse transcriptase as follows; 0.5 µl from SX1+ 
and SX2- respectively (Table 2.2) with 19 ml from Supermix14. Samples were run under the 
following conditions: 94oC for 15 seconds followed by 35 cycles of 94oC for 10 seconds, 
50oC for 20 seconds, and 72oC for 40 seconds and then held indefinitely at 8oC. 
2.15.3 Nested PCR 2 
The master mix was prepared as follows; 24µl from Supermix mixed with 0.5µl- oligo SX3+ 
and 0.5µl oligo SX4-(Appendix І). After vortexing, a total volume of 24.5µl was placed into 
200 µl clip top eppendorf tube (Appendix І).Then, a volume 0.5µl of PCR 1 product was 
added. Samples were placed in a thermocycler under the following conditions: 94oC for 15 
                                                 
 
 
12 Invitrogen 
13 13 GeneAmp PCR system 9700, Applied Biosystems, Warrington, North West England, England 
14 Thermo Fisher Scientific, Warrington, North West England, England 
      Chapter Two                                                                        Materials and methods 
                                                                                        
                                                
                                                          
56 
 
seconds for 1 cycle and 35 cycles at 94oC for 10 seconds, 50oC for 20 seconds and finally 
72oC for 40 seconds. Finally, samples were held at 8oC. 
Table 2.2. Primers that were used in the partial S1 PCR (PCR1 and PCR2) 
Oligonucleotide* Sequence(5’ 3’) Position**  
SX1+a CACCTAGAGGTTTGTTAGCATG 677-698  
SX1+b CACCTAGAGGTTTGCTTGCATG 
 
 
SX2-a TCCACCTCTATAAACACCTTTAC 1148 -1168  
SX2-b TCCACCTCTATAAACACCCTTAC   
SX3+ a TAATACTGGCTAATTTTTCAGATGG 705 - 725  
SX3+b TAATACTGGTAATTTTTCAGATGG   
SX4- AATACAGATTGCTTACAACCACC 1075-1097  
*Following primers SX1, SX2, and SX3 are a combination of two oligonucleotides (a and 
b).  
**Positions of these primers are based on M41 S1 gene. 
 
2.15.4 Agarose gel electrophoresis 
A 1.5 % w/v (0.7g in 35 ml of 1x TBE buffer) agarose gel was prepared by dissolving agarose 
in 1x TBE buffer (Tris-borate-EDTA) by heating in a microwave (Appendix I). After 
cooling, a 2 µl nucleic acid solution (RedsafeTM)15 was used to stain the agarose. The agarose 
was then poured into a mould (12cm x 9cm) Hybaid Electro-4 gel tank16 consist of 20 wells. 
A gel comb was used to make wells within the gel during the casting period. After 15-20 m 
set period, the wells in the agarose gel were loaded with 10 µl of product from PCR 2 mixed 
with 4 µl of loading buffer (Appendix І). A 100 bp ladder (molecular marker)17 was also 
                                                 
 
 
15Intron Biotechnology, Inc,  Sangdaewon-Dong, Korea 
16 Hybaid Ltd, Middlesex, UK 
17 Amersham Pharmacia Biotech, Buckinghamshire, UK 
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included to compare the amplicon size. The gel ran at 75V for 50 min in 1x Tris-borate-
EDTA (TBE) buffer (Appendix І), and visualised using an ultra violet transilluminator18. To 
determine the size of the PCR fragments, amplicons were compared to the DNA ladder. 
2.15.5 Purification for sequencing  
Purification of the nested PCR product was carried out using 0.99 μl shrimp alkaline 
phosphatase (SAP)19 mixed with 0.15 μl Exonuclease 1 (EXO)20. The sample was incubated 
for 30 minutes at 37 °C and then for 10 minutes at 80 °C to remove unwanted substance. 
Samples were sent for bi-directional sequencing at an external laboratory using forward and 
reverse primers (Source Bioscience Ltd, Nottingham, UK).  
2.16 Nucleotide comparison of partial S1 gene sequences 
Using ChromasPROv1.7.3 the sequences were first cleaned and analysed 
(http://technelysium.com.au/).Isolate identification was confirmed after a BLAST (National 
Centre of Biotechnology Information) search was carried out against the full database. 
Sequences were then aligned in MEGA6 (Tamura et al., 2013), using Clustal W (Thompson 
et al., 1994). Local BLAST was carried out against the original inoculated viral sequence. A 
single nucleotide polymorphism (SNP) is a variation of a single nucleotide that occurs at a 
specific position. All SNPs, insertions and deletions were identified using MEGA6. 
                                                 
 
 
18 UVitec Ce Mo32977 transiliminuim UVITEC celt 
19 Qiagen, Manchester, UK 
20 Affymetrix, Thermo Fisher Scientific, Warrington, North West England, England 
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2.17 cDNA synthesis  
From the total RNA extraction, the SuperScript III First-strand synthesis system21 was used 
to prepare first strand cDNA (Appendix І). The reaction mixture was prepared from random 
primers, diethyl-pyro carbonate (DEPC) treated water and dNTP mix22, and 1 μg was added 
from the RNA sample. The sample was incubated for 5 minutes at 65oC then chilled on ice 
for 1 minute. Following incubation, a volume of 7 μl of cDNA synthesis mix (First strand 
buffer, DTT, RNase out inhibitor and Superscript III RT) was added to each primer /RNA 
mix. Samples were centrifuged at 5,000 rpm for 10 s, followed by incubation at 25oC for 10 
min, then 50oC for 50 min, and the reaction was terminated at 85oC for 5 min. At the end of 
the reaction, tubes were kept on ice.  
2.18 Quantitative reverse transcription PCR (qRT-PCR) for quantification of viral 
RNA  
The IBV 3’ untranslated region (UTR) gene-specific primer and probe sequences were used 
to quantify the viral RNA as previously described (Jones et al., 2011). This protocol uses 
the IBVRT1 forward primer CTATCGCCAGGGAAATGTC, and the IBVRT2 reverse 
primer GCGTCCTAGTGCTGTACCC, along with the IBVRT3 TaqMan® probe FAM-
CCTGGAAACGAACGGTAGACCCT-TAMRA. The qRT-PCR Roter® gene probe, Real-
Time PCR kit23 (qPCR) (one-step) was utilized according to manufacturer’s instructions 
using 40 ng of total RNA per reaction. 
                                                 
 
 
21 Invitrogen, Life Technologies, Inchinnan,  Renfrewshire Scotland 
22 Invitrogen, Life Technologies, Inchinnan, Renfrewshire Scotland 
23 Qiagen, Manchester, UK 
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Cycling conditions were 10 min at 50°C and 5 min at 95°C, 40 cycles of 5 s at 95°C, 10 s 
at 60°C annealing temperature and followed by a final step of 10 s at 72°C. The Rotor-
Gene
® 
Q thermocycler software was used to measure the threshold cycle (Ct) after 
amplification plots were recorded and analyzed. The relative equivalent units (REU) of 
viral RNA was identified after the Ct data was converted as previously described (Londt et 
al., 2013) by standard curve generated via 10-fold dilutions of extracted RNA from infected 
allantoic fluid of 10
6 
EID50 of M41. 
2.19 Quantitative reverse transcription PCR (qRT-PCR) for host gene expression 
analysis  
The prepared cDNA above was subjected to qRT-PCR to evaluate host gene expression by 
calculating the relative expression in triplicate. The LightCycler® 48024 was used to quantify 
the selected genes with LightCycler 480 SYBR green primers which were supplied by 
Eurofins Genomics25 (Table 2.3), and Master Mix 126. Each sample included 10 μl of master 
mix, 1.8 μl each of forward and reverse primers (each at 300nM) of the selected gene, and 
1.4 μl of nuclease free water (Appendix І). The cDNA was diluted at a ratio of 1:50 in a final 
volume of 5 μl. The diluted cDNA was added to 15 μl of the prepared master mix for a total 
volume of 20 μl. The cycling conditions were 10 min at 95°C, 45 cycles of 10 s at 95°C, 10 
s at 60°C annealing temperature and 10 s at 72°C, followed by a final step of melting curve 
analysis to ensure the specificity of the SYBR green PCR. Data obtained from the qRT-PCR 
                                                 
 
 
24 Roche, Welwyn Garden City, UK 
25 Edersberg, Germany 
26 Roche, Welwyn Garden City, UK 
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was normalised by a relative standard curve method to 18S ribosomal RNA (18SrRNA) 
expression (Kuchipudi et al., 2012; Chhabra et al., 2016), which were presented as fold 
changes in gene expression of mock vs virus infected samples.  
 
Table 2.3. Primer abbreviations, full names and sequences used for analyzing pro-
inflammatory cytokines and host genes profiles (Kuchipudi et al., 2012).  
 Target Primer sequences:  
Reference  18S rRNA* (F) TGTGCCGCTAGAGGTGAAATT 
  (R) TGGCAAATGCTTTCGCTTT 
Viral recognition MDA5 (F) AGGAGGACGACCACGATCTCT 
  (R) CCACCTGTCTGGTCTGCATGT 
 LITAF (F) CCCTTCTGAGGCATTTGGAA 
  (R) CAGCCTGCAAATTTTGTCTTCTT 
 TLR3 (F) GCAATTTCTCCTTCACCTTTTCA 
  (R) CTTTATGTTTGCTATGTTGTTATTGCT 
Type I Interferons IFN-α (F) CTTCCTCCAAGACAACGATTACAG 
  (R) AGGAACCAGGCACGAGCTT 
 IFN-β (F) TCCAACACCTCTTCAACATGCT 
  (R) TGGCGTGTGCGGTCAAT 
Inflammation IL-1β (F) TGCTGGTTTCCATCTCGTATGT 
  (R) CCCAGAGCGGCTATTCCA 
 IL-6 (F) CACGATCCGGCAGATGGT 
  (R) TGGGCGGCCGAGTCT 
**18S rRNA =ribosomal RNA, MDA5 = Melanoma differentiation-associated protein 5, 
LITAF=Lipopolysaccharide-induced tumor necrosis factor (TNF)-α factor), TLR3=Toll like 
receptor 3, IFNα =Interferon alpha, IFNβ =Interferon beta, IL-1β =Interleukin 1 beta, IL-6 
=Interleukin 6. 
 
 
 
 
2.20 Enzyme linked immunosorbent assay (ELISA) 
Serum samples were analysed using a commercial IBV ELISA kit (IDEXX, Westbrook, 
Maine, USA) according to manufacturer’s instructions. Sera were diluted in a ratio of 1:500 
with diluent and added to coated antigen plates. Plates were incubated for 30 minutes at 25 
oC then washed 3-5 times with 350 ml of sterile distilled water. Following this, 100 ml 
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conjugate was added then incubated for a further 30 minutes. The wash step was repeated, 
substrate was added and further incubated away from direct light. Finally, 100ml of stop 
solution was added to each well. Plates were read using a micro plate reader Multiskan™ 
FC Microplate Photometer27 at 650nm to determine the sample absorbance. Samples with a 
sample/positive ratio volume greater than 0.2 were considered as positive, the calculation of 
the titre was achieved by using the formula Log10+1.09(log S/P) +3.36. 
2.21 Immunohistochemistry 
2.21.1 Cryostat (tissue section) 
Approximately 1-2 cm (longitudinal) was taken from each proventriculus and placed in cryo 
embedding compound optimal cutting temperature (OCT)28. The sample was immediately 
frozen in -190 oC liquid nitrogen and kept at -80 oC until required for processing. Sample 
blocks were sectioned by a pre-cooled cryostat29 covered with a glass slide and placed in the 
dark overnight. Fixation was carried out with pre-cooled -20 oC acetone for 10 minutes. 
Finally, samples were dried at room temperature (RT) for around 10 minutes and stored at -
70oC until staining. 
                                                 
 
 
27 Thermo Fisher Scientific, Warrington, North West England, England UK  
28 Solmedia laboratory,  Shrewsbury, UK 
29 LEICA CM 1900, Germany 
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2.21.2 Immunohistochemistry staining (IHC) 
Monoclonal antibodies against 30IBV nucleocapsid protein were used to confirm the 
presence of IBV antigen in the proventriculuar tissue. Staining was carried out as previously 
described (Rautenschlein et al., 2011).  
Fixed sections of proventriculus were further treated as follows. To prevent solutions running 
off the slides a ImmEdge Hydrophobic Barrier PAP Pen31 was used to draw a barrier around 
the sections and the sections were washed in Tris Buffered Saline (TBS) (Appendix І) for 5 
mins. Endogenous peroxidase activity was blocked using 100 μl of Dako REAL32 for 10 min 
at room temperature before the primary antibody (monoclonal antibody against N-protein33) 
was applied at a dilution of 1:1000 in TBS. Slides were incubated in the primary antibody 
overnight in a humidified chamber to prevent the slides drying out. For antibody detection 
3x drops of Dako ENVISON+ horseradish peroxidase (HRP) (α mouse) was applied to the 
slides for 30 min at room temperatures before washing 3x2min in TBS. To produce the 
insoluble dark brown DAB-HRP substrate DAB (3, 3 -diaminobenzidine) (Impact DAP)34 
was applied to the sections for 3-5 mins (according to manufacturer’s instructions) followed 
by 2x 5min washes in TBS and distilled water respectively. Slides were counterstained in 
haematoxylin for 1 minute and "blued" in running tap water for 5 mins. Finally, slides were 
                                                 
 
 
30 Southern Biotech, Birmingham, AL, USA 
31 Vector Laboratories, Burlingame, UK 
32 Dako, Glostrup,  Denmark A/S 
33 Prionics, Lelystad, the Netherlands 
34 Impress kit, vector lab, BURLINGAME, CA, USA 
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dehydrated (1x 96% ethanol 1min, 2x 100% ethanol 3mins) before clearing in xylene and 
cover slipping with DPX. 
2.22 Statistical analysis  
All the statistical analysis was done using GraphPad Prism version 6. Data was analysed 
according to data type (Figure 2.5; obtained from (Lopes et al., 2014). Parametric data was 
analysed using the one-way analysis of variance (ANOVA), followed by the post-hoc least 
significant difference (LSD) multiple comparison test for more than two groups, and 
Student’s t test if there were two groups. For the trachea and kidney lesion scores and viral 
load, the significant differences between the groups were analysed by Kruskal-Wallis test 
followed by Dunn’s mean test. Differences between groups were considered significant at 
P<0.05. The Kruskal-Wallis test is considered an acceptable alternative to ANOVA. 
 
Figure 2.5. Flow chart to indicate the appropriate statistical test according to the data 
distribution
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Chapter 3: Evaluation of the full S1 gene sequencing of classical 
and variant infectious bronchitis viruses extracted from 
allantoic fluid and FTA cards 
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Abstract  
Sequence variability in the S1 gene determines the genotype of infectious bronchitis virus 
(IBV) strains. An RT-PCR was developed to amplify and sequence the full S1 gene of 
classical and variant IBVs enriched in allantoic fluid (AF) or the same AF inoculated onto 
FTA cards. Seven IBV strains (M41, D274, 793B, IS/885/00, IS/1494/06, Q1 and QX) were 
grown in SPF eggs and RNA was extracted from AF. Full S1 gene amplification was 
achieved by using two primers and products were sequenced using Primers; A, SX3, 1050+ 
and 1380+ to achieve full S1 gene coverage. Following serial dilutions of AF, it was found 
that detection limits of the partial assay were higher than those of the full S1 gene. Partial S1 
sequences exhibited higher than average nucleotide similarity percentages (79%; 352bp) 
compared to full S1 sequences (77%; 1,756bp), suggesting that the full S1 protocol has 
greater strain differentiation accuracy. For IBV detection from AF inoculated FTA cards, 
four serotypes were incubated up to 21 days at three temperatures; 4oC, room temperature 
(24oC) and 40oC. RNA was extracted and tested with partial and full S1 protocols. Through 
partial sequencing, all IBVs were successfully detected at all sampling points and storage 
temperatures. In contrast, for full S1 sequencing, was not able to amplify the gene beyond 
14 days of storage or when stored at 40oC. Full S1 sequencing appears to be suited for 
detection of IBVs enriched in AF, and has limited application for samples directly embedded 
onto FTA cards.  
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3.1 Introduction 
Infectious bronchitis (IB) is an acute viral disease caused by infectious bronchitis viruses 
(IBVs), that mainly infect the respiratory system in broiler and layer chicken flocks 
(Cavanagh 2005). Infection causes economic losses due to high mortality, poor body weight 
gain (Ignjatovic and Sapats 2000), a decrease in egg production (reaching up to 70%) and 
reduction in egg quality (increased eggshell pigment) in layers (Box and Ellis 1985; Muneer 
et al., 2000). In some cases, infection can cause further complications, including cystic 
oviducts (Benyeda et al., 2009; Ganapathy et al., 2012) and false layer syndrome (Crinion 
and Hofstad 1972a). Certain IBVs, including several Australian strains, have been associated 
with renal complications such as nephritis (Cavanagh 2005; Mahmood et al., 2011) and 
digestive complications, such as proventriculitis (Ganapathy et al., 2012; Toffan et al., 
2013). 
The relationship between antigenic differences among IBV strains has been previously 
investigated (Raj and Jones 1997b; Jackwood and de Wit 2013), and others have reported 
that partial S1 sequences have a stronger correlation with protective relatedness between 
strains, rather than antigenic relatedness (Ladman et al., 2006). In addition, variations in the 
nucleotide sequence of S1 may lead to alterations in the virus categorisation, such as receptor 
binding abilities(Jackwood and de Wit 2013). 
More than 25 serotypes have been recognized to date, often differing by up to 50% at the 
amino acid level (Adzhar et al., 1997; Gelb Jr et al., 2005). Only a minor amino acid 
sequence alteration, at the very least a 5% change (25-30 amino acids) in the S1 subunit, is 
required to affect the protection status conferred by vaccinations of the same serotype 
(Cavanagh 2003). As a result, there is low cross protection among vaccine serotypes (Kuo 
et al., 2010).  
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In recent years, sequence analysis has become a common method to identify strain types, 
typically being carried out on specific nucleotide regions of the S gene (Cavanagh 2003) or 
the N gene (Williams et al., 1992). Previous studies have focused on analysing different base 
pair portions of the S1 gene (between 228 to 380bp) (Wang and Tsai 1996; Al-Shekaili et 
al., 2014), leading to difficulties when comparing genotype analysis between studies.  
For many years, the Massachusetts (Mass) serotype was the only recognized serotype (via 
virus neutralisation), originally isolated in Massachusetts in the 1930s. Jungherr and 
colleagues reported a Connecticut IBV type in 1956, which was not cross protective to nor 
cross neutralised by the Mass IBV strain (Jungherr et al., 1956). In 1984, researchers in the 
Doorn institute first isolated the Dutch strain D207 from Mass vaccinated flocks (Davelaar 
et al., 1984). The 793B serotype was identified in the 1990s (Parsons et al., 1992), with 
sequence data distinct from Dutch and Mass (Cavanagh 2005). The QX genotype was first 
described in 1996 in China, and was associated with severe nephritis, proventriculitis, 
tracheitis, decreased egg production and false layer syndrome ( Jones 2010;  De Wit et al., 
2011). Later, another variant, known as Q1, was detected from layer flocks showing 
respiratory signs, which can also cause proventriculitis (Yu et al., 2001). While certain 
genotypes like 793B and Mass have a global distribution (Cook et al., 1996), others are 
considered to have regional importance, such as IS/885/00 (Meir et al., 2004), IS/1494/06 
(GenBank accesion number EU780077), Arkansas (Ark) (JJ De Wit et al., 2011) and the 
California variants (Moore et al., 1998).  
FTA cards have been used for a number of IBV studies looking to detect the virus from 
clinical or laboratory samples (Moscoso et al., 2005; Ganapathy et al., 2015). While the 
cards are useful for transporting genomic material worldwide, the quality and quantity of 
RNA eluted varies depending on the initial amount of IBV RNA, storage duration and 
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temperature and the extraction methodology. Previous work has outlined that for IBV, a 
partial S1 amplification and sequencing from FTA card extraction is successful down to a 
viral concentration of 100.2 EID50/ml (Awad et al., 2012). However, the feasibility of full S1 
gene sequencing has not been examined. For IBVs extracted from FTA cards, it has been 
reported that storage duration and temperature can influence the molecular detection of 
several IBV strains(Moscoso et al., 2005). 
The aim of this study was to develop and evaluate a RT-PCR assay to amplify and sequence 
the full S1 gene of seven IBV genotypes grown in allantoic fluid. The sensitivity of the 
scheme was investigated using RNA extracted from allantoic fluid, both directly and after 
inoculation onto FTA cards. The effects of storage temperatures on detectability of the 
viruses were also assessed. 
3.2 Materials and methods 
3.2.1 Virus strains  
The following virulent IBV strains were used in this study: M41, QX, D274, IS/1494/06, 
IS/885/00, Q1 and 793B (Ganapathy et al., 2012; Chhabra et al., 2015b) (Table 3.1). Viruses 
were passaged in embryonated SPF chicken eggs (Chapter 2.1). 
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Table3.1. Shows the IBV strains that used in this study, passage number and country of 
isolation   
IBV 
strains Passage Reference number/year 
Country or  
accession number 
 
Reference 
M41 Sixth 1997 UK 
(Raj and Jones, 
1997) 
D274 Fourth ---- UK Ball et al., 2016) 
793B Fourth 793B, KG12/11 France 
(Ganapathy, un 
published) 
Q1 First 37089/2013 Italy Toffan et al., 2013 
QX Fourth QX – KG3P UK 
(Ganapathy et al., 
2012) 
IS/885/00 Fourth 12VIR/6109-12 CK/Eg/BSU-2/2011/ Egypt  
(Abdel-Moneim et 
al., 2012) 
IS/1494/06 Fourth 12VIR/6110-133 EU780077/ Egypt EU780077 
 
 
 3.2.2 Strain titration in tracheal organ cultures (TOCs): 
All the strains used in this study were passaged in embryonated specific-pathogen free (SPF) 
chicken eggs and titrated in tracheal organ cultures ( TOCs) to obtain the ciliostatic dose per 
ml (CD50/ml) (CD50) (Chapter 2.2) (Cook et al., 1976b). The initial titres for the viruses are 
given in the bracket; 793B (106.4 CD50/ml), M41 (10
6.3 CD50/ml), D274 (10
6.75 CD50/ml), QX 
(106.3 CD50/ml), Q1 (10
5.5 CD50/ml), IS/1494/06 (10
6.3 CD50/ml) and IS/885/00 (10
6.3 
CD50/ml) 
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3.2.3 Inoculation of FTA cards:  
FTA cards35 were inoculated with 100µl (Figure 3.1A) of ten-fold diluted allantoic fluid in 
TOC media (Chapter 2.2) for each virulent strain after carefully handling and labelling. The 
inoculated FTA cards were stored at three different temperatures; 4°C, 40°C (Figure 3.1B) 
and room temperature (RT, 22-26 °C). For each sampling point (1, 2, 3, 7, 14, 21 days post 
inoculation), the extraction was carried out from one disc (FTA cards). 
3.2.3 RNA extraction  
3.2.3.1 Allantoic fluid  
The allantoic fluid was collected and stored until used for either titration in TOCs or FTA 
cards inoculation. From the AF, the viral RNA was extracted using the QIAamp viral RNA 
Mini Kit36, according to the manufacturer’s instructions, from 100 µl of neat and tenfold 
diluted allantoic fluid (in TOC media). In brief, seven labelled tubes (1-7) were. A 10 fold 
dilution of 100 µl of the warm (37 oC) AF was added to a 900 µl of warm TOC media (after 
vortex and changing the pipettes tips) a 100 µl volume was removed and the process was 
repeated until the dilution 107 was reached (Tube number 7). The AF also used directly for 
extraction undiluted (Chapter 2.11). 
3.2.3.2 Extraction from FTA cards 
One complete disc from the FTA card was removed (of each dilution) using sterile scissors, 
placed into 1000 µl of TE buffer37 [10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0)] and 
                                                 
 
 
35WhatmanTM, Marlborough, USA 
36 Qiagen, Manchester, UK 
37 Thermo Fisher Scientific, USA 
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incubated for 10-15 minutes for elution (Sakai et al., 2015). After vortexing, 100 µl was 
taken and processed for RNA extraction using the QIAamp viral RNA Mini Kit 38according 
to manufacturing instructions (Chapter 2.13).  
 
Figure 3.1. Inoculation and storage of FTA cards, inoculation a 100 µl of FTA cards from 
either neat AF or diluted (tenfold), and left to air dry for 1 hour, and then moved to different 
storage conditions (4oC, 40oC and (RT). 
3.2.4 IBV RT-PCR 
Partial S1. Extracted RNA was used for both partial and full S1 amplifications. For partial 
S1 amplification, RT-PCR targeting a 393bp partial sequence of the S1 gene was conducted, 
as previously described (Ganapathy et al., 2015; Ball et al., 2016c) followed by gel 
electrophoresis (Chapter 2.15).  
                                                 
 
 
38 Qiagen, UK 
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Full S1. During the process for identifying the correct primers, the different pairs tested are 
presented in (Table 3.2) in order to obtain the full S1 amplification and sequences. However, 
for successful full S1 amplification, reverse transcription was conducted using the primer 
22.51 which is located at the 22.51 KB position (Figure 3.2). The reaction mix comprised 5x 
first strand buffer [250 mM Tris-HCl (pH 8.3), 375 mM KCl, 15 mM MgCl2
39], dithiothreitol 
(DTT) [100 mM40], deoxynucleotidetriphosphates (dNTPs)(deoxyadenosine triphosphate 
(dATP), deoxyguanosine triphosphate (dGTP), deoxycytidine triphosphate (dCTP), 
deoxythymidine triphosphate (dTTP)) [10mM], RNasin ribonuclease inhibitor [20 U/µl;41], 
Superscript III Reverse Transcriptase [200U/µl;42], oligonucleotide [10 pmol (picomoles 
per litre)], sterile distilled water [2.13 µl] and 0.5 µl of template RNA. RT-PCR conditions 
were: 48°C for 45 min, and 94°C for 5 min. Generated complementary DNA (cDNA) was 
then amplified in a one-step PCR using primer A (Figure 3.2) and primer 22.51 (Table 3.2). 
The PCR mixture included PCR Supermix43 [22 mM Tris-HCl (pH 8.4), 55 mM KCl, 1.65 
mM MgCl2, 220 µM dNTPs, 22 U/ml recombinant Taq DNA polymerase, and stabilizers] 
for efficient PCR amplification, forward and reverse primers [10 pmol] and 0.5 µl of cDNA. 
Cycling conditions were: 35 cycles of denaturation at 94 °C for 60 s, annealing at 54 °C for 
30 s, extension at 72°C for 60 s, and a final extension at 72°C for 10 min. These conditions 
                                                 
 
 
39 Invitrogen, Inchinnan, UK 
40 Invitrogen, Inchinnan, UK 
41 Promega, Inchinnan, UK 
42 Invitrogen, Inchinnan ,UK 
43 Invitrogen, Inchinnan ,UK 
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were found to be the optimal after the process of optimization after different attempts. For 
example, different voltage were tried and different time for agarose and with super script II 
and different ions (Mg+2) concentrations. All the optimization condition were applied for 
all stages of RT-PCR including the RT stage and PCR amplifications when different primers 
and or different times were tested. Different genotypes were aligned according to the full S1 
using MEGA6 and conserved region were determined. Such regions must be free from stop 
codons and have a GC ratio between 40-60%. Several primer locations were chosen 
throughout the full S1 gene to ensure full coverage. 
 
Table 3.2. Primers tested at the process of optimization for amplification and sequencing of 
IBV 
 
 
 
 
 
 
Oligonucleotide Sequence 5’3’ Length Reference 
Primer 22.06 - CATATCTTCTTTTTGACC  18 In-house 
Primer 50 (F) AAACTGAACAAAAGAGACACTTAG  24 (Zulperi et al., 2009) 
IBVc2 (R) GCCATAACTAACATATGG ACAA  22 (Zulperi et al., 2009) 
Primer 745 + YGAYRRNTCMCCHAVRGGYT  20 In-house 
Primer 1.57 - YTGYTGGTTRACATCTTCRC  21 In-house 
Primer 1.45+ TYTRGCWGAYGSHGGKTTRG 20 In-house 
Primer 1.77- TGGCAAATTGAGCCATCAGGT  21 In-house 
RT QX S1 neg CATCTTTAACGAACCATCTGG  21 Falchieri et al., 2013 
QX S1 start+ CCAGTTGTGAATTTGAAGAAAGAACAA- 
AAGACCGACTTAG 
40 Falchieri et al., 2013 
QX S1 end CGAACCATCTGGTTCAATACAAAATCTGC 29 Falchieri et al., 2013 
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Table 3.2. Primers used for successful amplification and sequencing of all IBV strains used 
in this study. 
Oligonucleotide Sequence 5’3’ Length Reference 
Primer A GCCAGTTGTTAATTTGAAAAC  19 (Pohuang et al., 2011) 
Primer 22.51 GAACGTCTAAAACGACGTGTTCC  23 In house 
1050+ GGTTTAATTCCTTGTCAGTTTCTCTTACTTATGG  34 (Falchieri et al., 2013) 
1380+ GCTGCTAATTTTAGTTATTTAGCAGATGGTGG  32 (Falchieri et al., 2013) 
SX3+ TAATACTGG C/T AATTTTTCAGA  21 (Worthington et al., 2008) 
 
 
 
 
 
 
 
Figure 3.2. Schematic representation of the four primer binding sites (Kb= kilo base) used 
to sequence the full S1 gene. The grey bar indicates sequence coverage by the scheme. 
3.2.5 Agar gel electrophoreses 
The results of RT-PCR reactions were verified using agarose gel electrophoresis. After either 
partial or full S1 PCR, the PCR products were examined by electrophoresis on a 1.5 % 
agarose gel (Chapter 2.15.4) with the exception of full S1 electrophoresis when the duration 
was changed to 75 minutes as compared to 50 minutes for the partial S1 sequence.  
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3.2.6 Cleaning of the positive PCR products  
For full S1 products (more than 1700 bp, and partial S1 around 400bp (Figure 3.3)) were 
visualised on an agarose gel, and positive amplicons were purified44 (as mentioned in details 
below and sent for commercial sequencing45 http://www.ncbi.nlm.nih.gov/)) using the 
following primers; primer A (Pohuang et al., 2011), SX3+(Worthington et al., 2008) 1050+ 
and 1380+ (Falchieri et al., 2013) (Figure 3.2). As our amplification primers were not able 
to amplify the QX strain, a previously published RT-PCR scheme was utilised (Falchieri et 
al., 2013). In brief, the primer RT QX negative 5’-CATCTTTAACGAACCATCTGG-3’ 
was used in the RT-step. Further two primers QX S1 start positive 5’-
CCAGTTGTGAATTTGAAGAAAGAACAAAAGACCGACTTAG-3’ and QX S1 end 
negative 5’-CGAACCATCTGGTTCAATACAAAATCTGC-3’ were used in one step PCR 
amplification.  
 
                                                 
 
 
44 ExoSAP-IT, Affymetrix, Santa Clara, CA, USA 
45 Source BioScience, Nottingham, UK 
10-1 10-2 10-3 10-4 10-5 10-6 10-7 
10-1 
10-2 
      Chapter Three                                                                             Full S1 sequencing 
                                                                                        
                                                
                                                          
76 
 
Figure 3.3. Detection of IBV genotypes strains used in the current study using the partial or 
full S1 schemes. (A) Sensitivity testing of partial S1 RT-PCR assay applied to 793B infected 
allantoic fluid. DNA marker (lane 1), serial dilutions of 793B infected allantoic fluid (lanes 
2-9). (B) Sensitivity testing of full S1 RT-PCR assay applied to 793B infected allantoic fluid. 
DNA marker (lane 1), serial dilutions of 793B infected allantoic fluid (lanes 2-5). 
3.2.7 Purification for sequencing  
All positive PCR products were purified using SAP and EXO as outlined in Chapter 2.15.5.  
10 -1  10 -2  10 -3  
10 -1  
10 -1  10 -2  10 –4  10 -7  10 -6  10 -5  
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3.2.8 Total quantification of the RNA by Nanodrop  
The NanoDrop™46 Spectrophotometer was used to quantify the RNA yield from 1 µl per 
sample. All RNA extracted from FTA cards at different storage conditions were tested using 
RT-PCR and data presented using R version 3.3.2 and R Studio 1.0.136. 
3.2.9 Elution of RNA from FTA cards 
After cutting the FTA cards aseptically, and were put in tubes containing TE buffer. We have 
tried to increase the elution time, this step was carried out in order to increase the yield of 
RNA from FTA cards by increasing the time up to 24 h with vortexing and shaking. 
3.2.9 IBV qRT-PCR 
Quantification of the viral RNA was carried out using qRT-PCR as previously described 
(Jones et al., 2011). All reactions were performed using the One-Step RT-PCR Qiagen kit 
and 40 ng of total RNA per reaction (Chapter 2.18).  
3.2.10 Nucleotide and amino acid comparison of partial and full S1 and gene sequences 
Using ChromasPROv1.7.3 the sequences were first cleaned and analysed 
(http://technelysium.com.au/), then, the isolate identification was confirmed after BLAST 
search (National Centre of Biotechnology Information) was carried out to the nucleotide 
alignment in Molecular Evolutionary Genetics Analysis (MEGA6) (Tamura et al., 2013), 
using Clustal W, a multiple sequence alignment programs (Thompson et al., 1994). BLAST, 
which is an algorithm for comparing primary biological sequence information, such as the 
                                                 
 
 
46 Thermofscientific, Warrington, North West England, England 
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nucleotides of DNA sequences or amino-acid sequences of proteins. BLAST analyses were 
carried out against the original inoculated neat viral sequence. Nucleotide and amino acid 
variations were carried out using MEGA6. 
3.2.11 Phylogenetic analysis 
Reads for the full S1 sequencing were initially examined for their quality and assembled 
using ChromasPRO v1.7.347. Sequences were then trimmed to cover the full S1 gene. Partial 
S1 sequences (350bp) were processed using the same methodology. BLAST comparisons 
against the NCBI database (GeneBank) were carried out to confirm strain identity. 
Alignments for all S1 sequences, and reference genomes, were carried out in MEGA6 
(Tamura et al., 2013) maximum likelihood method with 1000 bootstrap replicates. Reference 
strains used were D274 (X15832), 793B (AF093794), IS/885/00 (AY279533), IS/1494/06 
(EU780077), Q1 (AF286302), QX (KF297571), M41 (AY561711), H120 vaccine C 
(KU736750), H120 vaccine D (KU736751), Ma5 vaccine (KU736747), Beaudette strain 
(DQ001336), Ark-DPI (KX529820), IBV Quebec strain (AF349621), IBV T strain 
(AY775779) and Connecticut vaccine (EU283058). 
3.2.12 Field samples 
Twenty-four tissues and swab samples were collected from flocks and imprinted on FTA 
cards in the Middle East and were previously confirmed to carry an IBV infection 
                                                 
 
 
47 http://www.technelysium.com.au/chromaspro.html 
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(Ganapathy et al., 2015). All RNA was subjected to our full S1 RT-PCR as previously 
described in this study. The details of samples are illustrated in (Table 3.3).  
3.2.13 Analysing of RNA yield readings  
R programme for statistician was used to analyse and present the data from different days 
post inoculation and to all dilutions that were used for inoculation FTA cards then stored at 
different temperatures. 
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Table 3.3. The sample identity of tissues or swabs that were used for detection of IBV by 
partial S1 RT-PCR and sequencing. Tr= trachea, K= kidney, OP= oropharyngeal, CL= 
cloacal swabs, L=Liver, CT=Cecal tonsils 
 
 Laboratory 
ID 
Date 
Received 
IBV 
genotype 
(Partial S1) 
Sample type Partial  Positive 
full S1 
1 KG9/17.2 20/03/2017 793B FTA Card/Spleen +  
2 KG2/17.1 24/01/2017 793B Swab/K +  
3 KG53/16.2 19/10/1016 793B Swab/OP +  
4 KG16/16.5 07/04/2016 793B Swab/CL +  
5 KG10/16.1 22/03/2016 793B Swab/CL +  
6 KG29/15.27 30/06/2015 793B FTA card/CT +  
7 KG18/15.10 01/05/2015 793B FTA card/Tr +  
8 KG12/15.3 07/04/2015 793B FTA card +  
9 KG4/15.27 27/01/2015 793B FTA card/CT + Yes 
10 KG57/16.1 21/11/2016 Mass FTA Card/AF +  
11 KG12/16.1 24/03/2016 Mass Swab/Tr +  
12 KG11/16.1 23/03/2016 Mass Swab/Tr +  
13 KG29/15.9 30/06/2015 Mass FTA card/Tr +  
14 KG23/15.9 11/06/2015 Mass FTA card/Tr +  
15 KG18/15.35 01/05/2015 Mass FTA card/CT +  
16 KG14/15.2 09/04/2015 Mass FTA card/L +  
17 KG7/15.8 06/02/2015 Mass FTA card/K +  
18 KG46/14.15 22/10/2014 IS/1494/06 FTA card/Tr +  
29 KG46/14.31 22/10/2014 IS/1494/07 FTA card/K + Yes 
20 KG46/14.29 22/10/2014 IS/1494/08 FTA card/K +  
21 KG35/14.21 29/08/2014 IS/1494/09 FTA card/Tr +  
22 KG35/14.22 29/08/2014 IS/1494/10 FTA card/Tr +  
23 KG7/15.4 06/02/2015 Q1 FTA card/K +  
24 KG7/15.5 06/02/2015 IS/885/00 FTA card/Tr +  
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3.3Results 
3.3.1 Detection limits for partial versus full S1 from allantoic fluid 
Results showed that the minimum detection limits for the full S1 gene were 10-2 for all strains 
except for M41, which was 10-3. In contrast, the detection limits for the partial S1 detection 
were at 10-7 for all strains except for Q1, which was 10-6 (Table 3. 4). 
3.3.2 qRT-PCR from allantoic fluid 
The virus enriched allantoic fluid was analysed by PCR to measure the number of viral 
copies, and 793B, M41 and QX viruses were detected until dilution factor 105. While, the 
other viruses were detected until dilution factor 104 (Table 3.4). 
 
Table 3.4. The initial virus titre and the partial and full S1 detection limits from diluted 
allantoic fluid.  
 
    Detection limits  
IBV Strain 
Titre 
(CD50/ml) 
Allantoic fluid  
Partial S1 Full S1 
Real time q PCR 
detection limits 
793B 106.38 10-7 10-2 10
-5 
M41 106.33 10-7 10-3 10
-5 
D274 106.75 10-7 10-2 10
-4 
QX 106.39 10-7 10-2 10
-5 
Q1 105.5 10-6 10-2 10
-4 
IS/885/00 106.5 10-7 10-2 10
-4 
IS/1494/06 106.5 10-7 10-2 10
-4 
 
 
3.3.3 Nucleotide sequence and phylogenetic analysis 
The seven partial S1 sequences exhibited a higher than average nucleotide homology 
percentage to each other (79%) when compared to the full S1 sequences (77%) (Table 3.5). 
This was true for both the classical and variant strains. M41 demonstrated a homology of 
77% (full) and 80% (partial) to D274, whereas the closely related IS/885/00 strain had 82% 
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(full) and 83% (partial) homology with IS/1494/06. Similarly, the Q1 strain had 77% (full) 
and 79% (partial) homology with QX. 
Phylogenetic analysis further confirmed that the full S1 sequences were more distantly 
related between serotypes (Figure 3.4) compared to the partial S1 sequences (Figure 3.5) and 
this was clear when both sequences were combined in the phylogenetic analysis (Figure 3.6). 
 
Table 3.5. Nucleotide identity (%) comparison of the seven IBV strains used in this study 
based on the full S1 and partial S1. 
Nucleotide identity (%) / Full S1 
  M41 D274 793B IS/885/00 IS/1494/06 Q1 QX   
M41   77 73 77 79 73 72 M41 
D274 80   77 82 84 79 77 D274 
793B 80 81   79 77 75 76 793B 
IS/885/00 84 79 82   82 79 73 IS/885/00 
IS/1494/06 81 79 79 83   82 81 IS/1494/06 
Q1 82 80 81 83 80   77 Q1 
QX 77 75 78 72 74 79   QX 
  M41 D274 793B IS/885/00 IS/1494/06 Q1 QX   
Nucleotide identity (%) / Partial S1 
 
3.3.4 Amino acid analysis 
Similar to the nucleotide sequences, full S1 amino acid sequences had a lower homology 
compared to partial sequences overall (Table 3.6). Strain comparisons showed that M41 had 
77% and 73% similarity to D274 and 793B respectively, compared to the partial amino acid 
sequence which was higher (80% for both). IS/885/00 showed 82% (full) and 83% (partial) 
compared with IS/1494/06. Similarly, Q1 had 77% (full) and 79% (partial) compared with 
QX. 
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Table 3.6. Amino acid identity (%) comparison of the seven IBV strains used in this study 
based on the full S1 and partial S1. 
Amino acid identity (%) / Full S1 
  M41 D274 793B IS/885/00 IS/1494/06 Q1 QX   
M41   62 53 60 52 56 52 M41 
D274 76   61 66 73 63 60 D274 
793B 72 74   65 62 57 58 793B 
IS/885/00 77 78 78   67 63 54 IS/885/00 
IS/1494/06 74 79 75 85   55 61 IS/1494/06 
Q1 76 83 77 79 82   56 Q1 
QX 53 56 59 48 52 75   QX 
  M41 D274 793B IS/885/00 IS/1494/06 Q1 QX   
Amino acid identity (%) / Partial S1 
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Figure 3. 4. Phylogenetic tree based on full S1 nucleotide sequence among the IBV strains 
used in this study (filled triangle) and reference strains (between brackets). Analysis inferred 
using maximum likelihood analysis with Tamura 3-parameter and 1000 bootstrap replicates. 
 
 M41 Full S1
 M41 (AY561711)
 Beaudette strain (DQ001336)
 H120 vaccine D (KU736751)
 H120 vaccine C (KU736750)
 Ma5 vaccine (KU736747)
 Conn vaccine (EU283058)
 IBV T strain (AY775779)
 IBV Quebec strain (AF349621)
 Ark-DPI (KX529820)
 Cal99 variant (AY942737)
 D274 Full S1
 D274 (X15832)
 Q1 Full S1
 Q1 (AF286302)
 IS/885/00 Full S1
 IS/885/00 (AY279533)
 IS/1494/06 Full S1
 IS/1494/06 (EU780077)
 793B Full S1
 4/91(AF093794)
 QX Full S1
 QX (KF297571)
100
100
100
100
100
99
87
98
100
77
94
99
100
95
96
96
0.05
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Figure 3.5. Phylogenetic tree based on partial S1 nucleotide sequence among the IBV strains 
used in this study (filled circle) and reference strains (between brackets). Analysis inferred 
using maximum likelihood analysis with Tamura 3-parameter and 1000 bootstrap replicates. 
 
 4/91(AF093794)
 793B Partial S1
 QX (KF297571)
 QX Partial S1
 IS/885/00 (AY279533)
 IS/885/00 Partial S1
 IS/1494/06 (EU780077)
 IS/1494/06 Partial S1
 D274 (X15832)
 D274 Partial S1
 Q1 (AF286302)
 Q1 Partial S1
 Ark-DPI (KX529820)
 Cal99 variant (AY942737)
 IBV Quebec strain (AF349621)
 IBV T strain (AY775779)
 Conn vaccine (EU283058)
 M41 PartialS1
 M41 (AY561711)
 Beaudette strain (DQ001336)
 H120 vaccine D (KU736751)
 H120 vaccine C (KU736750)
 Ma5 vaccine (KU736747)
100
100
100
100
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88
99
97
93
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99
0.05
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Figure 3.6. Phylogenetic tree based on both the partial (filled circle) and full S1 (filled 
triangle) nucleotide sequence among the IBV strains used in this study and reference strains 
(filled triangles). Analysis inferred using maximum likelihood analysis with Tamura 3-
parameter and 1000 bootstrap replicates. 
 793B Full S1
 793B Partial S1
 4/91(AF093794)
 QX (KF297571)
 QX Full S1
 QX Partial S1
 IS/885/00 Full S1
 IS/885/00 Partial S1
 IS/885/00 (AY279533)
 IS/1494/06 (EU780077)
 IS/1494/06 Full S1
 IS/1494/06 Partial S1
 D274 (X15832)
 D274 Partial S1
 D274 Full S1
 Q1 Partial S1
 Q1 Full S1
 Q1 (AF286302)
 Ark-DPI (KX529820)
 Cal99 variant (AY942737)
 IBV Quebec strain (AF349621)
 IBV T strain (AY775779)
 Connecticut vaccine (EU283058)
 H120 vaccine C (KU736750)
 Ma5 vaccine (KU736747)
 M41 Full S1
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 H120 vaccine D (KU736751)
 M41 (AY561711)
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3.3.5 Sensitivity of IBV detection following inoculation onto FTA cards  
IBV detection using both full and partial S1 RT-PCR varied between strains. The partial RT-
PCR detected all strains, at all temperatures, up to 21 dpi. However, the assay was least 
sensitive for the FTA cards stored at 40oC at 21 dpi. For example, IS/1494/06 was only 
detected at the neat concentration for 40oC, compared to RT (10-3) and 4oC (10-4) (Table 3.7).  
For the full S1 detection, IBV was detected only from the cards stored at 4oC and RT (Table 
3.8). Additionally, the lowest dilution we identified IBV at was 10-1. No cards stored at 40oC 
were positive for the full S1 gene, and no IBV was detected at any temperatures past 14 dpi. 
 
Table 3.7. IBV detection using the partial-S1 assay from FTA cards following IBV strain 
inoculation of 10 fold dilutions (10-1-10-7) and up to 21 days incubation at varying 
temperatures (4, 24 and 40 oC) 
  Strain 
 M41  793B  IS/1494/06  Q1 
 Temperature (
oC) 
DPI 4 24 40   4 24 40   4 24 40   4 24 40 
1 10-3 10-3 10-3  10
-3 10-4 10-3  10
-4 10-4 10-4  10
-4 10-4 10-3 
2 10-3 10-3 10-2  10
-4 10-4 10-3  10
-4 10-4 10-4  10
-4 10-4 10-3 
3 10-5 10-4 10-3  10
-4 10-4 10-3  10
-2 10-4 10-4  10
-4 10-4 10-3 
7 10-4 10-3 10-1  10
-3 10-3 10-2  10
-3 10-2 10-2  10
-3 10-3 10-3 
14 10-5 10-4 10-3  10
-4 10-3 10-3  10
-4 10-5 10-1  10
-3 10-4 10-3 
21 10-5 10-4 10-3  10
-4 10-3 10-3  10
-4 10-3 +*  10
-5 10-3 10-1 
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Table 3.8. IBV detection using the full S1 assay from FTA cards following IBV strain 
inoculation and up to 21 days incubation at varying temperatures.  
  Strain  
 M41  793B  IS/1494/06  Q1  
 Temperature (
oC)  
DPI 4 24 40   4 24 40   4 24 40   4 24 40  
1 10-1  10-1  -    10-1  10-1  -    10-1  10-1  -    10-1  10-1  -   
2 10-1  + -   10
-1  10-1  -   10
-1  10-1  -   10
-1  + -   
3 10-1  + -   10
-1  -  -   10
-1  10-1  -   10
-1  -  -   
7 + -  -   + -  -   + - -   10
-1  -  -   
14 + -  -   -  -  -   - - -   -  -  -   
21 -  -  -    -  -  -    - - -    -  -  -   
(+) Only the neat concentration was detected (-) No IBV was detected. 
 
3.3.6 Total RNA from extracted FTA cards 
We have subjected RNA extracted from FTA cards to the Nano drop for quantification of 
the nucleic acid present. Approximately all the strains’ RNAs concentration dropped down 
at 7 dpi to around 40nm from a starting range of 270 from (1 mg/microliter) irrespective of 
the genotypes or the stored temperature, all the RNAs started to degrade after seven days 
post inoculation.  
3.3.7 Effect of elution time on RNA yield  
The extraction of RNA from FTA cards was attempted after using longer time up to 24h with 
vortexing and shaking procedures. Results revealed no changes in the RNA yield and no 
changes in the sensitivity of full S1 scheme from FTA cards extracted RNA. 
3.3.8 Sensitivity of IBV detection from field samples  
Twenty-five samples from FTA cards were tested using the full S1 approach (76% from 
tissue samples and 24% swabs), of which all were positive by partial S1 protocol. Only three 
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positive samples out of the submitted 25 were positive by full S1 of which sequencing was 
possible on two samples (not included in Figure 3.7). 
 
 
Figure 3.7. Total RNA Nano drop, 1 mg/microliter from RNA dilution extracted at different 
temperatures and different time points. 
 
3.4 Discussion 
The current study aimed to establish and test a universal RT-PCR protocol for detection and 
sequencing of the full S1 gene of globally distributed IBV strains (M41, 793B, D274, 
IS/1494/06, IS/885/00, Q1 and QX). Common practice for IBV research is to extract RNA 
for RT-PCR and sequencing, in order to detect and genotype amplified IBV strains, which 
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is an effective tool for the discrimination of field strains (Kwon et al., 1993; Wang and Huang 
2000). Many laboratories rely on a partial S1 gene assay, but a full S1 gene assay targeting 
a number of common IBV serotypes has not been reported to date. One limitation is that 
conserved sequences of approximately 20 nucleotides within the S1 gene are limited among 
IBV strains, decreasing the availability of applicable universal oligonucleotides (Adzhar et 
al., 1996). Additionally, the G+C ratio of a sequenced region and the primers used can affect 
both reverse transcription and PCR amplification (Dohm et al., 2008; Sendler et al., 2011). 
However, the ratio in our amplification primers (A and 22.51) (36% and 47% respectively) 
are similar to those used previously (Adzhar et al., 1996).  
The full S1 protocol described in this study gave a lower average nucleotide homology 
between genotypes when compared to the partial S1, demonstrating that full S1 sequencing 
is a more accurate method to differentiate between strains using BLAST and phylogeny 
analysis. This is partly due to a single nucleotide variation affecting 0.3% homology for a 
partial sequence (350bp), compared to 0.06% for a full gene sequence (1,600bp). In addition, 
virulence properties can be altered through minimal amino acid variations (Fang et al., 
2005), although such alterations may also occur outside of the S1 gene (Callison et al., 2001). 
IBV genotyping is commonly conducted using a partial sequence containing a hypervariable 
region (HVR) of S1. However, such an approach shows inconsistencies compared to full S1 
genotyping (Li et al., 2012; Mo et al., 2013). Significantly, our phylogenetic assessment 
demonstrated that both the full and partial sequencing were able to distinguish individual 
genotypes. However, it should be noted that relying solely on partial sequences for 
phylogeny may give a false interpretation, depending on the sequenced region used for 
analysis. The full gene sequence would give a better representation of strain differences 
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(Valastro et al., 2016). Due to this, using the full S1 sequence when possible would be 
advantageous for studies utilising this genotyping methodology. 
Not all laboratories are able to isolate and propagate IBV. Instead a number of countries are 
dependent on utilising FTA cards to transport potential IBV positive samples (such as 
tracheal or oropharyngeal swabs, lung tissue, caecal tonsil and kidneys) for diagnosis, as the 
cards are a safe method of storing and shipping genomic material (Ganapathy et al., 2015). 
For IBV, it has been shown that RNA can be successfully extracted from samples embedded 
onto FTA cards, and following RT-PCR and sequencing, genotypes can be determined based 
on the partial S1 gene (Abdel-Moneim et al., 2006; Savage et al., 2009; Ganapathy et al., 
2015; Ball et al., 2016c). Moscoso and colleagues (2005) and Awad and colleagues (2014) 
also demonstrated the effects of different temperature storage of IBV inoculated FTA cards 
(Moscoso et al., 2005; Awad et al., 2014). To date, there has been no published attempt to 
extract and sequence full S1 genome from samples embedded onto FTA cards outside ours.  
For RNA extracted from allantoic fluid or FTA cards, the partial S1 RT-PCR demonstrated 
greater detection limits compared to the full S1. This may be due to the significant difference 
in amplicon length, about 0.39kb and 1.72kb for the partial and full S1 gene respectively. 
Successful molecular characterization of small sequence lengths (383 bp) of viral RNAs 
from FTA cards, including those that were stored under non favourable environmental 
conditions (at 41oC for at least 15 days), has been previously demonstrated(Moscoso et al., 
2005). Our work has shown that the partial assay was able to detect IBV RNA inoculated 
onto FTA cards up to 21 dpi for all storage conditions (including 40ºC). However, this was 
not possible for the full S1 gene (1,700 bp). From data presented here, the sensitivity for the 
larger target (full S1) detection is affected by both time and temperature. This finding is in 
agreement with a recent study which had difficulty in amplifying a product greater than 900 
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bp, despite detecting a 290 bp product after six months of storage (Sakai et al., 2015). In our 
study, an attempt to mimic field practices, where oropharyngeal swabs or tissue samples 
collected at necropsy or IBV-enriched allantoic fluids are embedded onto FTA cards, stored, 
and/or transported at different temperatures to local or international laboratories for detection 
of IBVs. It appears that such samples are suitable for partial S1 RT-PCR and sequencing for 
IBV genotyping, but provides insufficient RNA for full S1 RT-PCR or sequencing and so is 
unadvisable from these results. 
The full S1 scheme presented in this study may be more applicable to IBVs already 
successfully enriched (e.g. SPF eggs or TOCs). Clinical samples (either swabs or tissues) 
that have been directly obtained from the field or in vivo experiments, including those 
imprinted on FTA cards, are unlikely to provide sufficient genome quantities for the full S1 
detection. 
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Chapter 4: Pathogenesis and innate immune responses of 
infectious bronchitis virus Q1 in specific pathogen free chicks 
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Abstract  
The IBV Q1 serotype was first isolated from China in the 1990s; however, there still remains 
a knowledge gap in the immunopathogenesis and tissue tropism of this now widespread 
variant. Following Q1-like infection at day-old, specific pathogen free (SPF) chicks were 
monitored daily for clinical signs and body weights were recorded at weekly intervals. At 1, 
3, 7, 14, 21 and 28 days post infection (dpi), oropharyngeal (OP) and cloacal (CL) swabs 
were used for virus detection, blood was taken from ten chicks and five birds were humanely 
killed for necropsy. Tissue lesions were scored and trachea, kidney, and proventriculus 
samples were collected for RT-PCR, quantitative RT-PCR (qRT-PCR) and histopathology. 
Infected chicks had a significantly reduced body weight compared to the control group at 14, 
21 and 28 dpi. Clinical signs of râles and nasal discharge developed in the infected group, 
which were absent in the control birds. All swabs were RT-PCR positive and the IBV viral 
load peaked in the trachea and kidneys at 9 dpi, whereas the proventriculus peaked at 14 dpi. 
At 28 dpi, 63% of birds were IBV-antibody positive by ELISA. We found a significant up-
regulation in the expression of several genes (IFNα, TLR3, MDA5, LITAF, IL1-β and IL-6) 
in the trachea and kidneys at 3, 7 and 9 dpi. Findings show that this Q1 isolate is pathogenic 
to SPF chicks with more severe lesions affecting the trachea compared to the kidneys.  
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4.1 Introduction  
In the period between 1996 and 1998, a new IBV variant was detected in Chinese layer 
flocks. This was later categorised as the Q1 genotype. Infection was associated with 
respiratory distress, proventriculitis, decreased egg production and diarrhoea. Sesti (2014) 
inoculated 25-day old broilers with Q1. The broilers presented with high mortality three days 
later, accompanied by severe septicaemia and nephritis (Sesti 2014). As acute and severe 
clinical signs are commonly shared with other pathogens (such as Newcastle disease and 
avian influenza virus), it was suggested that proventriculitis is not definitive evidence of a 
Q1 IBV infection (de Wit et al., 2011), and further characterization was required for 
confirmation (Liu et al., 2009). 
Several Q1-like IBV strains have been reported in countries such as Taiwan (2005), Italy 
(2011) (Toffan et al., 2013), Chile (2009), Peru and Argentina (Sesti 2014), and Colombia 
(Jackwood 2012). According to the findings of Toffan et al., (2013), the detected Q1 strain 
had 100% homology with the original Q1 described by Yu et al., (2001), and (99.2%) with 
CK/CHC/CLDL/97 (Toffan et al., 2013), which was previously reported from three 
countries in the Middle East (Iraq, Jordan, and Saudi Arabia) (Ababneh et al., 2012). A 
further study showed that Q1 represented around 11% of the genotypes circulating in this 
area, specifically in Saudi Arabia (Ganapathy et al., 2015). 
Key components of the innate immune response in chickens include pattern recognition 
receptors (PRRs). The cytoplasmic surfaces of host immune cells express PRRs, which 
include lymphocytes, macrophages, dendritic cells and some non-immunological cells such 
as fibroblasts, and endothelial cells (Rajesh Chhabra et al., 2015). These cells rapidly identify 
infective pathogens through PRRs such as retinoic acid-inducible gene 1 (RIG-I) like 
receptors (RLRs), nucleotide-binding oligomerisation domain (NOD) like receptors (NLRs) 
and Toll-like receptors (TLRs). Toll-like receptors are considered the central mediators of 
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the innate immune system and are responsible for recognising conserved structures in a wide-
range of pathogens (Rajesh Chhabra et al., 2015). The role of melanoma differentiation 
associated protein 5 (MDA5) is well established in the induction of interferon (IFN) 
transcription via MDA5-dependent activation of the IFN-β (Kint et al., 2015). Most cells 
have a common membrane receptor that belongs to the type I IFN family. The receptor 
comprises of dual subunits (IFNAR1 and IFNAR2), which has antiviral properties 
(Domanski et al., 1995). Type I IFNs demonstrate prominently individual anti-proliferative, 
anti-viral and pro-apoptotic actions despite sharing similar receptors (Foster et al., 1996). 
The IFN stimulated genes are the crucial effectors of IFN cellular responses and are 
responsible for their immunomodulatory, anti-proliferative and anti-viral purposes 
(Schoggins et al., 2011). 
Pro-inflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-6 (IL-6) and 
lipopolysaccharide-induced tumor necrosis factor (TNF)-α (LITAF) are important aspects of 
innate immunity. They are fundamental regulatory elements that bind to specific cell surface 
receptors to initiate cascades of intracellular signalling (Kotani et al., 2000). The IL-1β 
molecule is produced by epithelial cells and macrophages, which induce T cell and 
macrophage activation, recruiting cells to the site of infection by chemotaxis (Babcock et 
al., 2008). IL-6 is produced by endothelial cells, T cells and macrophages, and promotes 
acute phase responses and differentiation of both B and T cells (Gabay 2006). TNF-α is 
produced by T cells, macrophages and NK cells, and helps localise inflammation and 
endothelial cell activation at the site of infection, which permits greater access of other 
mediators such as antibodies and immune cells (Gruys et al., 2005).  
To date, published information on the pathogenesis and innate immune responses of Q1 virus 
has been limited. We aimed to address this by investigating the pathogenesis and tissue 
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distribution of IBV Q1 in SPF chicks. In addition, the host innate immune response to Q1 in 
the trachea and kidneys was examined. 
4.2 Materials and methods  
4.2.1 Chick welfare and management  
Commercially available fertile White leghorn SPF eggs were incubated and hatched at the 
University of Liverpool (Chapter 2.1). Chicks were kept up to 28 days of age in an isolation 
unit (Block B) throughout the experiment and reared on deep litter with antibiotic-free water 
and feed (Chapter 2.4).  
4.2.2 Infectious bronchitis virus  
The IBV Q1 virus strain (reference number 37089/2013) (Rajesh Chhabra et al., 2015) was 
propagated in embryonated SPF eggs(Chapter 2.1) , with virus-rich allantoic fluid collected 
and titrated in trachea organ cultures (TOCs) to determine a relative titre of 106.5 CD50/ml 
(Chapter 2.2).  
4.2.3 Experimental design 
Eighty day-old White leghorn SPF chicks were allocated in two groups; Group 1 (n=40) was 
mock-infected with virus free allantoic fluid, group 2 (n=40) was infected oculonasally with 
104.5 CD50/bird of IBV Q1 (first passage). All chicks were inoculate at one day of age. 
Clinical signs were observed daily and 10 randomly picked chicks from each group were 
weighed weekly. Oropharyngeal and cloacal swabs were collected from ten birds at 0, 3, 7, 
9, 14, 12, 28 days post infection (dpi). At 1, 21, 28 dpi, blood was collected and sera were 
subjected to ELISA. At 1, 3, 7, 9, 14, 21, 28 dpi, five chicks were humanely killed with the 
trachea and kidney scored for gross lesions. Tissues of trachea, kidney and proventriculus 
were collected in RNAlater (Qiagen, Crawley, UK) for real time PCR analysis (trachea and 
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kidney) and in formalin and OCT media (all tissues) for histological examination (Flaño et 
al., 2009).  
4.2.4 Swab samples  
Dry swabs were used to sample the cloaca and oropharyngeal cavity at 3, 7, 9, 14, 21, and 
28 days post infection. After sampling, swabs from each group were pooled, dipped into 1.5 
ml of TOC media, and stored at -70oC until required. 
4.2.5 Clinical observations 
Clinical signs will were recorded daily according to a previously published scoring system 
(Grgic et al., 2008) (Chapter 2.8.1). Gross lesions recorded as previously described 
(Mahgoub et al., 2010)(Chapter 2.8.2). 
4.2.6 Histopathology   
The tracheal upper part and the superior kidney part were collected and fixed in 10% buffered 
formalin were processed for histological examination (Chapter 2.11). The proventriculus 
was processed following storage in frozen OCT media (Flaño et al., 2009), (Chapter 2.11). 
4.2.7. Extraction of RNA 
4.2.7.1 Swabs, and allantoic fluid  
 RNA was extracted from OP and CL swabs, and allantoic fluid (AF) using the phenol-
chloroform method (Chapter 2.12) (Chomczynski and Sacchi 2006; Ball et al., 2016a). All 
the swabs sequencing cleaning and alignment details are present in Chapter 2.17. 
4.2.7.2 Extraction of RNA (Tissue) 
Total RNA was extracted from all collected tissues using the the RNeasy Plus Mini Kit 
(Qiagen) according to manufacturer’s instructions (Chapter 2.14).  
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4.2.7.3 Reverse transcriptase polymerase chain reaction (RT-PCR) 
Following extraction, RT-PCR to detect a partial IBV S1 sequence (393bp) was conducted 
on swabs and allantoic fluid as previously described (Ball et al., 2017), (Chapter 2.15).  
5.2.8 Quantification of IBV RNA 
qRT-PCR Viral load was quantified from extracted RNA from trachea, kidney, 
proventriculus and OP and CL swabs (Chapter 2.18). 
4.2.9 Tissue samples for virus isolation and RT- PCR  
Sampled tissues were ground aseptically using a pestle and mortar and 300µl of TOC media. 
Samples were stored at -70 oC until processed for RNA extraction.  
4.2.10 Virus isolation from proventriculus tissue 
Virus isolation was attempted from proventriculus samples taken at 3, 7 and 9 dpi (Yu et al., 
2001; Toffan et al., 2013). Ground tissues were centrifuged and 0.2 ml from the supernatant 
was inoculated into embryonated SPF eggs (Chapter 2.10).  
4.2.11 Host gene expression 
Host gene expression analysis was carried out for samples collected at 1, 3, 7, 9, and 14 dpi. 
The details of qRT PCR host genes and cytokines (Chapter 2.19). QRT-PCR of cDNA 
samples was performed in triplicate using LightCycler 480 SYBR Green I Master mix and 
primers (Chapter 2.19). 
4.2.12 Serology 
Serum samples were analysed using a commercial IBV ELISA kit (IDEXX) according to 
manufacturer’s instructions (Chapter 2.20).  
4.2.13 Immunohistochemistry  
All the details of Cryostat (tissue sections) and staining of slides from the proventriculus 
(Chapter 2.21).  
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4.2.14 Statistical analysis  
All statistical analysis was carried out in GraphPad Prism version 6 using the t test to make 
comparisons between the groups. Differences between groups were considered significant 
at P<0.05 (Chapter 2.22). 
4.3 Results  
4.3.1 Body weight  
There was no significant difference in body weight between the control and Q1-infected 
group in the first week. After 14 dpi, we saw a significant decrease (P<0.05) in the average 
weekly body weight of chicks in the infected group at 14, 21 and 28 dpi (Figure 4.1). 
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Figure 4.1. Weekly mean body weight comparison of control (C) and infected (Q1) on all 
sampling days. Birds (n=10/group) were infected with IBV strains Q1 IBV at a dose of 104.5 
CD50/bird and body weight was evaluated at 1, 7, 14 , 21 and 28 days post infection (dpi). 
Using t- test, data represents the mean with error bars as standard error with significant 
differences indicated by different letters (P<0.05). 
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4.3.2 Clinical signs 
A single bird from the infected group died at 5 dpi and on necropsy presented with swollen 
kidneys with ureters filled with urate. There were no clinical signs or mortality in the control 
group during the study period (Figure 4.2).Mild to moderate clinical signs appeared within 
infected birds at one dpi and continued until 17 dpi. Signs mainly composed of sneezing, 
râles and coughing and nasal discharge (Figure 4.4A).  
 
 
 
 
 
 
Figure 4.2. Shows the onset and duration of clinical signs and mortality within the period of 
the experiment (28 days) in controls and IBV Q1 infected group. 
 
4.3.3 Gross lesions  
Tracheal lesions were noted in all infected chicks until 14 dpi, peaking at 7 dpi (Figure 4.3). 
Lesions comprised of clear to caseous exudate with or without hyperaemia (Figure 4.4B). 
Birds showed signs of oculo-nasal discharge and periocular swelling at 14 dpi, with cloudy 
and turbid air sacs found at 9 dpi. In the kidney, gross lesions consisted of paleness, swelling 
and urate deposition. The highest mean lesion score in the kidneys was at 9 dpi. In the 
proventriculus, there was dilation and thickening in the mucosa of one bird at 14 dpi (Figure 
4.4D). There were no gross lesions observed in the control group. 
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Figure 4.3. Gross lesion score in the trachea and kidney of Q1 infected SPF birds. Birds 
(n=5/group) were infected with IBV strains Q1 IBV at a dose of 104.5 CD50/bird and 
processed for gross examination at 1, 3, 7, 9, 14 , 21 and 28 days post infection (dpi). Using 
Mann-Whitney test. Data represents the mean with error bars as standard error.  
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Figure 4.4. Developing of the gross lesion after IBV Q1 oculo-nasal inoculation into SPF 
chicks at one day old. (A). Chick with watery to frothy oculo-nasal discharge at 7 dpi (B). 
Trachea revealed congestion at 7 dpi (C). Cloudy and turbidity yellowish thoracic air sac 
developed SPF chick after infection with IBV Q1 at 9 dpi (D). Swelling kidneys with 
nephritis and deposition of uric acid in ureters and proventriculus dilation in SPF chick after 
14 days of infection (E). Proventriculus ulcer and haemorrhage in the mucosa at 14 dpi. 
 
4.3.4 Histological changes 
Lesions started early at one dpi and remained until 21 dpi. The greatest tracheal 
histopathology scores were seen at nine and 14 dpi (Figure 4.5A). In the kidney, histological 
changes started at 1 dpi and peaked at 3-9 dpi (Figure 4.5B). In the Infected group, tracheal 
lesions mainly consisted of de-ciliation and epithelial degeneration, decreased mucous cells 
and heterophil infiltration (Figure 4.6B). Kidney lesions consisted of poorly defined 
subacute interstitial lymphoid infiltration and more discrete chronic lymphoid nodules 
(Figure 4.6D). In the proventriculus, there were no significant microscopic lesions other than 
A B C 
D E 
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the presence of interstitial lymphoid nodules (Figure 4.6F). There were no histological 
changes in the control group.  
 
Figure 4.5. Histopathological score of lesions in the trachea and kidney of infected group 
(A) Trachea (B) kidney. Birds (n=5/group) were infected with IBV strains Q1 IBV at a dose 
of 104.5 CD50/bird and processed for histopathological examination at 1, 3, 7, 9, 14 , 21 and 
28 days post infection (dpi). Using Mann-Whitney test, data presented as the mean with error 
bars as standard error. 
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Figure 4.6. Haematoxylin and eosin stains of the controls; [(A. Trachea), (C. Kidney) and 
(E. proventriculus)] and infected tissues [(B. trachea at 9 dpi), (D kidney at 9 dpi) and (F. 
proventriculus at 28 dpi)].  
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4.3.5 Detection of Q1 from pooled oropharyngeal (OP) and cloacal (CL) swabs 
4.3.5.1 RT-PCR:  
All OP and CL swabs were positive by RT-PCR, with partial S1 gene sequences obtained at 
all sampling points. Amino acid (AA) sequences from OP swabs remained identical to the 
original inoculum at 3, 7, 14 and 28 dpi. For OP samples collected at 9 dpi, there were 22 
AA substitutions. At 21 dpi there were 15 AA substitutions and two AA deletions: 
tyrosine(Y) and asparagine (N) at 919 nucleotide positions within S1 gene). By 28 dpi, the 
recovered strains were identical to the inoculum. In the CL swabs, sequence changes 
presented early (3 dpi), consisting of 11 AA changes. At 7 dpi, there were 30 AA changes. 
At 9 dpi, there were 19 AA changes. At 9 dpi, there were also three AA deletions tyrosine(Y), 
asparagine (N) and phenylalanine (F) starting at the position 919 nucleotide within S1 gene 
(Table 4.1). At 21 dpi, there were over 40 AA changes. These changes were completely 
absent at 28 dpi. Comparing sequences obtained from the CL swabs and the inoculum, the 
similarity were 94%, 83%, 88% and 80% for 3, 7, 9 and 21 dpi respectively.  
4.3.5.2 qRT-PCR:  
All OP and CL swabs were positive for IBV until 21 dpi. The viral load was greatest at 3 dpi 
for both OP and CL swabs, the quantity decreased until 14 dpi where it remained at a low 
level until 21 dpi (Figure 4.7). Overall, there was a greater viral load in the OP swabs 
compared to the CL swabs for all time points. 
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Table 4.1. Sequence alignment of the partial S1 glycoprotein (starting at 267 AA level of S1 gene)of IBV Q1 strain from OP and CL swabs at 3, 
7, 9, 14, 21 and 28 dpi. Dots indicate identical amino acid to the original inoculum (first row of aligned sequences). Letters denote change in the 
amino acid. Dashes denote deleted amino acids. 
 AA 267  
 
    VNTTLVLTNF TFSNVSNAPP NTGGVHSIVL HQTQTAQSGY YNFNFSFLSS FRYVESDFMY GSYHPKCSFR LETINNGLWF NSLSVSLGYG PLQGGCKQSV 
OP 3 .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........  
OP 7 .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........  
OP 9 .......... .......... .......... .......... .L......IZ CSK.Y....P PPNLL..TIK QCS.MDD.C. ..F.....AT R.........  
OP 14.......... .......... .......... .......... .......... .......... .......... .......... .......... ..........  
OP 21.......... .......... .......... .......... --.......R ...G.A.... R.D.HRQ.C. ........GL S.......AH ..P....... 
OP 28.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... 
 
 
 
    VNTTLVLTNF TFSNVSNAPP NTGGVHSIVL HQTQTAQSGY YNFNFSFLSS FRYVESDFMY GSYHPKCSFR LETINNGLWF NSLSVSLGYG PLQGGCKQSV 
Cl 3 .......... .......... .......... .......... .......... .S........ ..NL...TIK Q.C....... ..F....A.. R......... 
CL 7 .......... .......... .......... .......... .LL.....IC CSK.Y....P PPNLL..TIK Q.CFVVD.C. ..F.F..PAT R......... 
CL 9 .......... .......... .......... .......... ---I.....F ...E.TY..S ..N.Q....K.QV...S...V ...FLF.VD. ..E....... 
CL 14.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... 
CL 21.I...K.... .......... .......... .......... FLLS.Y..IC LIK...V..P PTKLL.TTNK ..C.VVD.C. SFFWLPPAT. R..AV.INT. 
CL 28.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... 
OP swabs 
CL swabs 
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Figure 4.7. Quantification of viral RNA, expressed as a log relative equivalent units (REU) 
of RNA in the pooled OP and CL swabs from the Q1 infected group. Swabs (n=10/group), 
chicks were infected with IBV strains Q1 IBV at a dose of 104.5 CD50/bird and processed for 
qRT-PCRfrom pooled swabs. 
 
4.3.5.3 Viral load in trachea, kidney and proventriculus 
Viral RNA was detected in all tissues for all sampling days; however, each tissue exhibited 
a different expression pattern (Figure 4.8). Viral load peaked in the trachea at 7 dpi (0.533 
Log 10 REU), kidneys at 9 dpi (0.121 Log 10 REU) and proventriculus at 14 dpi (0.202 Log 
10 REU) (Figure 4.8A, B and C). Following this, viral RNA load decreased in all infected 
tissues to the lowest level at 28 dpi. In the trachea, there was significant higher differences 
(P<0.05) at 1-14 dpi when compared to 21-28 dpi.in the kidney, there, there was significant 
higher differences (P<0.05) at 1-21 dpi when compared to 28 dpi. 
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Figure 4.8. Quantification of viral RNA, expressed as a log relative equivalent units (REU) 
of RNA in (A) Trachea, (B) Kidney and(C) proventriculus of the Q1 infected group. 
Depicted are the mean values (n=5 per group) and error bars as standard error chicks were 
infected with IBV strains Q1 IBV at a dose of 104.5 CD50/ bird. Significant differences 
between the groups were detected t-test. 
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4.3.6 Isolation and immunohistochemistry detection of IBV from the proventriculus 
4.3.61 Virus isolation 
Virus re-isolation was attempted from the proventriculus at 3, 7, 9 dpi in embryonated 
chicken eggs (ECE). The virus was detected from all samples at all-time points, and on 
sequencing, the isolates had > 99% amino acid similarity to the inoculum. No virus isolation 
attempted from other tissues. 
4.3.6.2 Detection of viral antigen using immunohistochemistry  
In the proventriculus mucosa, IBV antigen was not detected and also from the proventriculus 
smooth muscle. In other words, there was no positive immunostaining in all proventriculus 
tissue (Figure 4.9).  
 
Figure 4.9. Immunohistochemically detection of Q1 IBV antigens in Proventriculus. (A) 
Control uninfected group. (B) Infected group, proventiculus negative staining, there is no 
immunolabelling of smooth muscle cells and within the vasculature cells at 7 dpi. 
4.3.7 Humoral anti-IBV antibody levels 
Serum samples at one dpi showed no positive antibodies against IBV in either the control or 
infected groups. At 21 dpi, 43% of infected birds were ELISA positive against IBV which 
had increased to 63% by 28 dpi (Figure 4.10). 
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Figure 4.10. Mean infectious bronchitis virus (IBV) antibody titres of the control and 
infected groups (n=10/group) at 21 and 28 days-old. Using Mann-Whitney test data are 
expressed as mean values ± SEM (N=10). The ELISA positive sample cut-off is 396.  
4.3.8 Host gene expression analysis in the trachea  
4.3.8.1 Relative IFN-α and IFN-β mRNA expression:  
There was significant up–regulation (P<0.05) in the IFN-α mRNA expression at 7 dpi 
compared to 3 dpi, no other changes were found in the subsequent sample points (Figure 
4.11A). There was significant up-regulation in IFN-β mRNA expression at 1 and 3 dpi only 
(Figure 4.11B). 
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Figure 4.11. mRNA expression of interferon (IFN I) (A) IFN-α and (B) IFN-β mRNA 
expression in Q1 infected chicken trachea. Data represents the mean with error bars as 
standard error and are expressed as fold change relative to the uninfected controls group. 
Significant differences between the groups were detected by t-test. Significant changes 
differences indicated with different letters  (P<0.05) at those time points. 
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4.3.8.2 Expression of mRNA of TLR3 and MDA5:  
There was significant up-regulation in TLR3 expression (P<0.05) for all sampling days 
compared to the control group (Figure 4.12A). There was significant up-regulation (P<0.05) 
seen at 3 dpi of MDA5 (Figure 4.12B). 
 
 
Figure 4.12. Transcriptional regulation of innate viral sensing molecules (A) TLR3 and (B) 
MDA5 in Q1 infected chicken trachea. Data represents the mean with error bars as standard 
error and are expressed as fold change relative to the uninfected controls group. Significant 
differences between the groups were detected by t-test. Significant changes differences 
indicated with different letters  (P<0.05) at those time points. 
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4.3.8.3 Pro-inflammatory cytokines transcription profile:  
Expression of IL1-β was significantly up-regulated (P<0.05) at 7 dpi in infected group 
compared with control group (Figure 4.13 A). The IL-6 gene was up-regulated at all 
sampling points (significant at 7 dpi; P<0.05) (Figure 4.13B). Similarly, there was significant 
up-regulated (P<0.05) in the LITAF for all sampling days (Figure 4.13C). 
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Figure 4.13. Transcription profile of proinflammatory cytokines (A) IL-1β, (B) IL- 6 and 
(C) LITAF in Q1 infected chicken trachea. Data represents the mean with error bars as 
standard error and are expressed as fold change relative to the uninfected controls group. 
Significant differences between the groups were detected by t-test. Significant differences 
indicated with different letters (P<0.05) at those time points. 
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4.3.8.4 Host gene expression analysis in the kidney 
4.3.8.4.1 Relative IFN-α and IFN-β mRNA expression:  
There was significant (P<0.05) up-regulation identified in IFN-α expression levels at all dpi 
in the infected group compared with the control group (Figure 4.14A). Similarly, there was 
significant up-regulation (P<0.05) of IFN-β mRNA expression in the kidney samples from 
the infected group compared with the uninfected control group for all sampling days (Figure 
4.14B). 
 
Chapter Four                                                          Q1 immunopathogenesis in SPF chicks 
117 
 
 
 
Figure 4.14. mRNA expression of interferon (IFN I) (A) IFN-α and (B) IFN-β mRNA 
expression in Q1 infected chicken kidney. Data represents the mean with error bars as 
standard error and are expressed as fold change relative to the uninfected controls group. 
Significant differences between the groups were detected by t-test. Significant changes 
differences indicated with different letters (P<0.05) at those time points. 
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4.3.8.4.2 Expression of mRNA of TLR3 and MDA5: 
There was significant up-regulation in TLR3 expression (P<0.05) for all sampling days 
compared to control group (Figure 4.15A). There was significant up-regulation (P<0.05) in 
MDA5 for all sampling days in comparison to the control group (Figure 4.15B). 
 
Figure 4.15. Transcriptional regulation of innate viral sensing molecules (A) TLR3 and (B) 
MDA5 in Q1 infected chicken kidney. Data represents the mean with error bars as standard 
error and are expressed as fold change relative to the uninfected controls group. Significant 
differences between the groups were detected by t-test. Significant changes differences 
indicated with different letters (P<0.05) at those time points. 
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4.3.8.4.3 Pro-inflammatory cytokines transcription profile: 
 There was significant up-regulation (P<0.05) in IL1-β at 3-9 dpi in the infected group 
compared with control group (Figure 4.16A). There was significant up-regulation (P<0.05) 
in IL-6 at 7-9 dpi in the infected group compared with control group (Figure 4.16B). There 
was significant up-regulation (P<0.05) in the LITAF for all sampling days (Figure 4.16C). 
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Figure 4.16. Transcription profile of proinflammatory cytokines (A) IL-1β, (B) IL- 6 and 
(C) LITAF in Q1 infected chicken kidney. Data represents the mean with error bars as 
standard error and are expressed as fold change relative to the uninfected controls group. 
Significant differences between the groups were detected by t-test. Significant changes 
differences indicated with different letters (P<0.05) at those time points.4.4 Discussion 
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Recently, the pathogenesis and/or the innate immune response of other IBV strains have 
been published (Awad et al., 2016; Najafi et al., 2016; Okino et al., 2017a). However, little 
Information has been published on the Q1 virus. For the current study, in addition to clinical 
signs, gross and histopathological lesions, attempts were made to examine host-virus 
interactions, including the induction of innate and humoral immune responses.  
A significant decline in the average weekly body weight was found in Q1 infected chicks 
from 14 dpi. Reduction in body weight following IBV infection has been previously reported 
for a number of strains, including the Australian T-strain (Afanador and Roberts 1994), QX 
(Ganapathy et al., 2012) and M41 (Otsuki et al., 1990). This may be due to damage to the 
kidney tubular epithelial cells (Condron and Marshall 1986), leading to defects in electrolyte 
and fluid transport. An increase in urinary water excretion can also occur, leading to an 
increase of urine osmolality and high fractional excretion of sodium, calcium and potassium 
(Afanador and Roberts 1994). This is the first study to report a reduction in body weight in 
Q1 infected chickens. 
The clinical signs and lesions reported in this study were similar to those found in 
commercial broiler (Hubbard naked neck) chickens with evidence of Q1 infections in Italy 
(Toffan et al., 2013). For SPF chicks in this study, the duration of lesions and severity was 
consistently greater in the trachea when compared to the kidney. Similar findings have been 
reported for other IBVs such as M41 (Butcher et al., 1990), QX (Ganapathy et al., 2012), It-
02 (Dolz et al., 2012), 793B (Boroomand et al., 2012), Moroccan G strain (Ambali and Jones 
1990) and more recently, for IS/885/00 (Awad et al., 2016). In one bird, there was thickening 
in the proventricular mucosa and proventricular dilation, similar to previous report of Yu et 
al. (2001). However, in contrast to the findings in this study, Yu and colleagues witnessed a 
higher mortality rate (Yu et al., 2001), which may have been due to their higher inoculation 
dosage, their smaller sample size or the age of the birds.  
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High severity of histological changes in the trachea was seen at 9 and 14 dpi, while we 
witnessed lower overall lesion scores in the kidney. Trachea changes manifested as loss of 
cilia, heterophil infiltration, epithelial hyperplasia and lymphoid infiltration, as also seen 
previously in Q1-like infected SPF chicks (Yu et al., 2001). Kidney samples showed 
interstitial lymphoid infiltration and mild lymphoid follicles similar to those reported before 
(Toffan et al., 2013). There were minimal changes in proventriculus samples, comprising of 
lymphoid follicles. This result is dissimilar with the prior report by Toffan et al. (2013), 
which found diffuse epithelial necrosis, associated with infiltration of heterophils, 
lymphocytes and plasma cells in the lamina propria of commercial broiler chickens. The 
differences could have been contributed by exacerbating factors such as co-infection with 
other pathogens, ammonia, cold, dust, type of feed and other management protocols in 
commercial broiler farms. 
Viral load was greatest at 3 dpi and then gradually declined in the OP and CL swabs until it 
became undetectable at 28 dpi. It appears that excretion of virus in Q1-infected SPF chicks 
shared similar profiles of other known IBVs such as M41, Connecticut and Arkansas 
(Callison et al., 2006). It has been shown that IBV replicates primarily in the tracheal and 
kidney tissues, with additional infections seen in the lung, liver and pancreas (Fan et al., 
2012). Results in the current study indicated that Q1 viral load was highest in the trachea 
compared to the proventriculus or kidneys. In addition, IBV Q1 was successfully re-isolated 
from the proventriculus, with the recovered isolate being more than 99% similar to the 
original Q1 inoculum, thereby further highlighting the possibility of using this tissue for IBV 
detection or isolation (Fan et al., 2012; Ganapathy et al., 2012). However, it was not clear if 
the isolation indicates primary replication in this tissue or merely those found in the blood 
vessels. 
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To date, there are no studies focusing on the partial-S1 gene changes in virulent IBV strains 
detected in OP or CL swab samples, though reports are available on vaccine strains (van 
Santen and Toro 2008; Ball et al., 2016a). We found a greater number of genetic changes in 
the CL swab sequences compared to the OP swab sequences, which may be influenced by 
the environment in the upper respiratory tract in comparison to the intestine (Zanin et al., 
2016). Since the S1 protein is associated with evasion from host immunity and viral 
proliferation (Montassier 2010), such mutations may be advantageous to the survival of Q1 
in the gastrointestinal tract.  
Findings from ELISA showed a seroconversion of 43 and 63% at 21 and 28 dpi respectively. 
The commercial ELISA kit contained an M41 coated antigen and despite Q1 being a variant 
with 77-82% nucleotide similarity (Ababneh et al., 2012) with Mass, the assay detected a 
relatively high seroconversion at 21 and 28 dpi respectively. A higher percentage of birds 
may have seroconverted if a homologous or a common recombinant IBV was used as coating 
antigen rather than that from M41 (de Wit et al., 1997; Awad et al., 2016). 
In recent years, much attention has been given to understand the early immune responses 
towards newly identified IBV isolates (Okino et al., 2017a; Chhabra et al., 2018), as this 
could improve our understanding on disease mechanisms, which could ultimately be utilized 
for better control strategies. In this study, in order to monitor early immune responses, TLR3, 
MDA5, IFN-β, IFN- α, IL-1β and IL-6 mRNA expressions were examined following Q1 
infection. For TLR3, significantly higher expression compared to the control was found at 
all sampling days, with the peak level at 7 dpi. This finding echoes data seen in similar 
studies, which also reported up-regulation in TLR3 following IBV infection of different 
chicken lines, particularly during the early stage of infection (1-8 dpi) (Smith et al., 2015; 
He et al., 2016; Okino et al., 2017a; Chhabra et al., 2018). However, the magnitude and 
onset of this up-regulation differs from others, probably due to variations in the IBV strain, 
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inoculum dosage, route of administration and age of birds used (Smith et al., 2015; He et al., 
2016; Okino et al., 2017a; Chhabra et al., 2018). 
The role of MDA5 is well established in induction of IFN-β transcription, through an MDA5-
dependent activation of the IFN response (Kint et al., 2015). In the current study, at 1 dpi, 
there was a significant up-regulation of MDA5 in the trachea, consistent with previous 
research linking IBV infection with an up-regulation of MDA5 expression (He et al., 2016; 
Chhabra et al., 2018). Limited reports are available on expression of PRRs against IBV in 
kidneys. Our study shows that significantly higher levels of TLR3 and MDA5 were found in 
the kidneys following Q1 infection. Working on IBV IS/885/00, Chhabra et al. (2018) 
reported up to a 5 fold up-regulation of MDA5, whereas we detected up to a 3 fold change 
in this study. It appears that the magnitude of MDA5 expression could reflect the degree of 
tropism of IBV strains to the kidneys (Cong et al., 2013). 
There was a lower magnitude of expression of TLR3 in the kidney compared to the trachea, 
which may be associated with a lower viral load in the kidneys. As infected cells distinguish 
virus components by PRRs, up-regulation may lead to early immune responses. Elevation of 
TLR3 is associated with an increase of inflammatory cytokines in response to viral 
pathogenesis and the subsequent deterioration of infected tissue through the downstream 
cascade antiviral state (Kameka et al., 2014; Lin et al., 2016). The onset and duration of 
TLR3 and MDA5 expression in this study differed to other studies and potentially related to 
the differences in the virulence of IBV strains (Okino et al., 2017a; Chhabra et al., 2018). 
It has been shown that IFN-β expression occurs at a later stage of infection, coinciding with 
the peak of viral replication and the complementary accumulation of double stranded RNA 
(Kint et al., 2015). This study showed significant up-regulation of IFN-α and IFN-β in both 
the trachea and kidneys, similar to the results of a previous work on virulent IBV M41 in 
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SPF chicks (He et al., 2016; Zhang et al., 2017). In this study, IFN-β expression was up-
regulated up to 3 dpi, comparable to findings by Chhabra et al. (2018) and Okino et al. (2017) 
following infection with other virulent IBVs. However, the magnitude of fold changes 
reported by them were greater compared to the current study, possibility influenced by the 
virulence of the virus, dosage, route of inoculation, age and strain of birds used.  
In addition to detecting up-regulation of PRRs and IFNs, findings in this study showed an 
up-regulation of pro-inflammatory gene expression in both investigated tissues. Such 
increase corresponds with gross lesion scores, the highest viral load in the trachea and OP 
swabs and one of the highest readings in the histological changes in the trachea, particular 
with peak detection at 7 dpi. This emphasises the combined effect of these cytokines along 
with virus load on the development of tracheal lesions. An increase in IL-1β and IL-6 was 
previously described after challenge with virulent M41, which was associated with the 
highest scores of microscopic lesions and viral load, suggesting IL-1β and IL-6 may have 
contributed to tracheal lesion induction (Okino et al., 2014).  
Following an in vivo experiment, Chhabra et al. (2018) demonstrated that a substantial and 
rapid innate immune response was induced in the kidney after infection with 
nephropathogenic strains of IS/885/00 and QX. These strains produced significantly greater 
expression of IL1-β, IL-6 and LITAF compared to the M41 strain, which reflected the 
tropism and virulence of these viruses to the kidney tissues (Chhabra et al., 2018). IL-1β 
and/or IL-6 pro-inflammatory cytokines have been reported to correspond with gross and 
histological lesions (Asif et al., 2007; Okino et al., 2014; Okino et al., 2017a). Tissue tropism 
affects viral replication and overall viral load, and the inflammatory response is secondary 
to this. All pro-inflammatory cytokines in the current study peaked at 3-7 dpi, which were 
associated with more viral load and pathology in the trachea than in the kidneys (Jang et al., 
2013). 
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In conclusion, the Q1 isolate used in this study is pathogenic to SPF chicks, has a greater 
pathology and induces greater early immune responses in the trachea compared to the 
kidneys. Following Q1 infection, increased mRNA expression was seen for TLR3, IFNs, 
and IL1-β, which are innate immune indicators of early host response to the infection.  
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Chapter 5: The immunopathogenesis of infectious bronchitis 
virus Q1 in slow or fast growing commercial broiler chicks 
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Abstract 
The pathogenesis, humoral and innate immune responses of infectious bronchitis virus (IBV) 
Q1 was investigated in two lines of commercial broiler chicks with different growth rates. 
Chicks were monitored daily for clinical signs. At 3, 7, 9, 14, 21 and 28 days post infection 
(dpi), oropharyngeal (OP) and cloacal (CL) swabs were taken for virus detection. Renal, 
tracheal and proventricular tissue was collected at post-mortem for quantitative reverse 
transcriptase polymerase chain reaction (qRT-PCR). Blood was taken at 7, 14, 21 and 28 dpi 
for IBV antibody detection. For the fast growing line (Line-A, Ross 308), swabs from the 
infected group were RT-PCR positive at all sampling days, whereas the slow growers (Line-
B, Hubbard, JA57) were positive until 14 dpi. At 7-9 dpi, higher viral loads were found in 
the trachea, proventriculus and kidney of fast growers compared to slow growers. Mean IBV 
ELISA antibody titres in Line-B were higher than Line-A. Tracheal innate immune responses 
showed IFNα up-regulation only in Line-A but IFNβ was up-regulated in both lines. For 
TLR3, an up-regulation was seen in Line-A up to 7 dpi and for all sampling days in Line-B. 
MDA5 was up-regulated in Line-A and down-regulated in Line-B at 1 dpi. In the kidneys, 
for Line-A birds, IFNα and IFNβ were up-regulated at 1 and 1-3 dpi respectively. There was 
up-regulation in TLR3 in Line-B throughout the study period but not for Line-A. MDA5 was 
up-regulated in both lines at 7 and 9 dpi. It appears that the immunopathogenesis of IBV Q1 
infection in slow growing (Line-B) chicks was milder in terms of the inflammatory cytokines 
produced when compared to the fast growers (Line-A), which could be associated with the 
genetic differences between these breeds. 
 
 
Chapter Five                                                              Q1 immunopathogenesis in broilers 
129 
 
5.1. Introduction  
Infectious bronchitis virus (IBV) is a globally important avian pathogen, of particular 
importance for intensive poultry production regions. This pathogen has the potential to 
proliferate in the epithelium of upper and lower respiratory tract tissues, the digestive tract, 
testes, oviduct, kidneys (Cavanagh 2007) and proventriculus (Yu et al., 2001; Ganapathy et 
al., 2012). It has been shown that during virulent IBV infection, different chicken breeds 
may show variable disease outcomes, which could be associated with the magnitude of the 
immune response (Cavanagh 2007).  
Poultry production faces several challenges to remain sustainable, including outbreaks of 
flock viral infection such as with IBV (Boroomand et al., 2012). These infections cause an 
increase in mortality and decline in egg production. It is also possible that heavy genetic 
selection for fast growth rates may have made some breeds more susceptible to infections 
compared to others (Zekarias et al., 2002). As IBV control is complicated by poor vaccine 
cross-protection(Jackwood and de Wit 2013), an alternative way to control infection is by 
selective breeding of resistant chicken lines, for which the adaptive and innate host immune 
responses will vary depending on the pathogen (Janeway et al., 2001), the environment and 
host fitness. Adaptive immunity is dependent on an initial exposure followed by a specific 
T memory cell response. In comparison, the innate response is non-specific, acts for a broad 
range of pathogens and is the first line of defence from infection by utilising proteins such 
as pattern recognition receptors (PRRs), interferons (IFNs) and pro-inflammatory cytokines 
(R. Chhabra et al., 2015a). 
A number of studies have investigated the pathogenesis of several IBV variants within 
different chicken lines, including SPF, commercial layer and commercial broiler chickens 
(Ignjatovic et al., 2002; Terregino et al., 2008; Benyeda et al., 2009; Boroomand et al., 2012; 
Dolz et al., 2012; Awad et al., 2016; Khataby et al., 2016). Similarly, there has been growing 
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interest in studies that analyse the genes that can influence the course of infection in different 
breeds and highlight potential genes for resistance to IBV infection (Smith et al., 2015; 
Chhabra 2016; He et al., 2016). It has been emphasised that the resistance to IBV M41 seen 
in chicken line N was due to host response following infection, rather than how the host 
prevented cell attachment and invasion (Smith et al., 2015). It has been reported how each 
IBV variant was associated with differing tracheal and kidney innate immune responses 
when three strains were compared to each other in vivo (Chhabra et al., 2018). 
Several studies have demonstrated that there are differences in gene expression in fast and 
slow growing breeds following heat stress (Rimoldi et al., 2015), Salmonella infection (van 
Hemert et al., 2006), feed removal (Benyi et al., 2010) or daily feed skip restriction in a 
specific environment (Netshipale et al., 2012). Smith and others highlighted that the 
differences in susceptibility to IBV by two different lines (susceptible - 15I, inbred White 
Leghorn versus resistant - Line N, non-inbred Cornell) of chickens (Smith et al., 2015). 
Other studies have been reported on the difference in immune responses in different broilers 
lines when infected by Campylobacter jejuni (Williams et al., 2013; Humphrey et al., 2015). 
Despite a significant number of IBV pathogenesis studies, there is limited information 
comparing immunopathogenesis of IBV in different breeds of commercial chickens. This 
study aimed to examine the differences between two commercial broiler breeds, fast grower 
Line-A versus slow grower Line-B, following infection by an IBV strain Q1. Furthermore, 
the innate immune and pro-inflammatory cytokines responses in these two lines of birds 
were examined following infection (Manswr et al., submitted).  
5.2 Materials and Methods  
5.2.1 Virus  
The IBV Q1 virus strain reference number 37089/2013 was propagated in embryonated SPF 
eggs and titrated in TOCs to determine the relative titre (Chapter 2.2).  
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5.2.2 Chicks, welfare and management  
The fast (Line-A, Ross 308) and slow (Line-B, Hubbard, JA57) growing reaches live 
slaughter weight (2.2 Kg) at 36 and 56 days old respectively. Chicks were supplied from two 
different commercial hatcheries. Chicks were kept up to 28 d 
ays of age (doa) in an isolation unit (University of Liverpool) throughout the experiment. 
Chicks were reared on wood shaving litter with food and water supplied ad libitum (Chapter 
2.4).  
5.2.3 Experimental design 
Two breeds of broiler (one day old), Line-A and Line-B chickens were at a total number of 
80 from each Line. From each Line chicks were allocated in two groups control and infected 
in total number of 40 in each group (n=40). At one day old, chicks in the infected groups 
were inoculated oculonasally with 104.5 CD50/bird of IBV Q1 in a volume of 100µl and 
chicks in the control groups were inoculated with 100µl virus-free allantoic fluid. At weekly 
intervals the body weight of 10 randomly picked chicks from each group were weighed and 
clinical signs were observed daily. Oropharyngeal (OP) and cloacal (CL) swabs were 
collected from ten birds at 3, 7, 9, 14, 21, 28 dpi. Trachea and kidney are scored for gross 
lesions after chicks humanely been killed and euthanized at 1, 3, 7, 9, 14, 21, 28 dpi. Five 
chicks from each group were sampled from the next tissues; trachea, kidney and 
proventriculus. Sections of these tissues were collected in the RNAlater (Qiagen, Crawley, 
UK), and stored at -20 ºC for later processing for virus load and expression of pro 
inflammatory cytokines and host genes mRNAs expression. In the same time, another 
portion of samples, kidney and trachea were also collected in 10% buffered formalin for 
histological examination. One portion from the proventriculus was used for virus isolation. 
At 1,7,14, 21, 28 dpi five birds from each group were bled, sera was separated and stored at 
-20 ºC for detection of IBV antibodies by ELISA. 
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5.2.4 Swab samples  
Dry swabs were used to sample the cloaca and oropharyngeal cavity at 3, 7, 9, 14, 21, and 
28 dpi for RT-PCR and qRT-PCR. After sampling, swabs from each group were pooled, 
dipped into 2.5ml of TOC media, and stored at -70oC until required. 
5.2.5 Clinical signs  
Clinical signs were recorded daily according to previously published scoring system (Grgic 
et al., 2008), (Chapter 2. 8.1). 
5.2.6 Pathological changes  
Five birds from each group was humanely euthanized on 1, 3, 7, 9, 14, 21 and 28 dpi and the 
trachea, kidney and proventriculus were removed. Gross lesions were recorded as previously 
described (Mahgoub et al., 2010), (Chapter 2.8.2). 
5.2.7 Histology  
Histological changes were scored as 0 = no change, 1= mild, 2 = moderate, 3 = severe as 
mentioned previously (Chen and Itakura 1996; Chhabra 2016), (Chapter 2.11) 
5.2.8 RNA extraction from swabs and allantoic fluid 
The RNA was extracted from the OP and CL swabs or allantoic fluid (AF) using the phenol-
chloroform method for RNA extraction as mentioned previously (Chomczynski and Sacchi 
2006; Christo et al., 2016). Total RNA was extracted from all collected tissues, extraction 
of viral RNA was conducted using the RNA easy kit (Qiagen) according to the 
manufacturer’s instructions(F. Awad et al., 2014), (Chapter 2.12). 
5.2.9 Serum  
Blood was collected from the brachial wing vein and placed in labelled 5 ml tubes without 
coagulant. Sera was collected and stored at -20 oC until needed for ELISA (Chapter 2.7.2). 
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5.2.10 Reverse transcription polymerase chain reaction RT-PCR  
IBV RT-PCR was conducted on swabs and allantoic fluid, as previously described 
(Worthington et al., 2008; Ganapathy et al., 2015; Ball et al., 2016c) that targeted a 393bp 
portion of the S1 gene which allowed to sequence the hypervariable region of the S1 gene 
(Chapter 2.15). 
5.2.11 Purification for sequencing  
The OP and CL swabs, and tissues that were positive for IBV by RT-PCR were sequenced 
for the part-S1 gene as illustrated in (Chapter 2.17). Purification of the nested PCR product 
was applied using shrimp alkaline phosphatase (SAP) mixed with Exonuclease (EXO) 
(Chapter 2.15.5). 
5.2.12 IBV Quantitative reverse transcription PCR (qRT-PCR) 
Quantification of the viral RNA was carried out using qRT-PCR as previously described 
(Jones et al., 2011). All reactions were performed using the One-Step RT-PCR Qiagen kit 
and 40 ng of total RNA per reaction (Chapter 2.18). 
5.2.13 Expression of host genes (qRT-PCR for host gene expression analysis) 
Host gene expression analysis was carried out at 1, 3, 7, 9, and 14 dpi. The mRNA expression 
levels of certain gene signatures and cytokines were evaluated using qRT-PCR (Kuchipudi 
et al., 2012). Data was normalised using a relative standard curve method to 18S ribosomal 
RNA (18srRNA) expression and the data were presented as fold difference in gene 
expression of virus vs mock infected samples (Chapter 2.19).  
5.2.14 Tissue samples for viral isolation and RT- PCR from the proventriculus  
Sampled tissue was grinded through a sterile pestle and mortar and using a sterile sand and 
100µl of TOC media. Grinding was done in a septic condition and near flame. Tissue, 
suspension was stored at -70 oC until process. When the sampled tissue dilution processed it 
Chapter Five                                                              Q1 immunopathogenesis in broilers 
134 
 
centrifuged at 3,000 g for 10m before being used (Chapter 2.10). Virus isolation was carried 
out from proventriculus samples taken at 7 and 9 dpi following tissue grinding. The RT-PCR 
positive samples were sent for commercial bi-directional sequencing (Source BioScience 
Ltd, Nottingham, UK), (Chapter 2.15). 
5.2.15 Serology 
Serum samples were analysed using a commercial IBV ELISA kit (IDEXX) according to 
manufacturer’s instructions. Sera were diluted in a ratio of 1:500 with diluent and added to 
coated antigen plates (Chapter 2.20).  
5.2.16 Statistical analysis  
Parametric and non-parametric data were analysed using graph pad prism software 7 using 
one-way ANOVA followed by LSD test and Kruskal-Wallis test followed by Dunn’s test 
respectively. Differences were considered significant at p<0.05 (Chapter 2.22).  
 
5.3 Results  
5.3.1 Body weight  
A significant reduction (P<0.05) in the mean body weight was seen in the infected Line-A 
group at 14, 21 dpi in comparison with the control group. Body weight was lower at 7 and 
28 dpi, however this was not significant (Figure 5.1A). While there was a reduction in the 
infected Line-B body weights at all time points, none were considered significant (p>0.05) 
(Figure 5.1B). There were significant differences (P<0.05) in the average body weight 
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between both the Line-A and Line-B controls and infected groups at 1, 21 and 28 dpi (Figure 
5. 1C and Figure 5.1D). 
Figure 5.1. Weekly mean body weight comparisons at 1, 7, 14, 21 and 28 dpi; (A) Line-A 
control and infected groups, (B) Line-B control and infected groups, (C) Line-A and Line-B 
controls and (D) Line-A and line-B infected groups at all sampling days. Birds (n=10/group) 
were infected with IBV strains Q1 at a dose of 104.5 CD50/bird .Data represents the mean 
with error bars as standard error. Significant differences between the groups were detected 
by t-test. Significant differences indicated with different letters (P<0.05) at those time points. 
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5.3.2 Clinical signs 
For both lines, there were no clinical signs or mortalities in the control groups. In both 
infected groups, signs started at 3 dpi and lasted until 20 and 21 dpi for Line-A and Line-B 
infected groups respectively, with moderate signs present until 14 dpi in Line-A and 13 dpi 
in line-B (Figure 5.2). Signs included sneezing, tracheal râles, coughing, head shaking, nasal 
exudate, eye scratching and mild diarrhoea. At 5 dpi, a single mortality was recorded in the 
infected Line-A group.  
 
Figure 5.2. Shows the onset and duration of clinical signs and mortality within the period of 
the experiment (28 days) in Line-B and Line-A control and infected group. 
 
Line-A Q1  
Line-B Q1 
Control 
Control 
DPI 
DPI 
 Moderate signs 
No signs 
Dead bird 
Mild signs 
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5.3.3 Gross lesions  
There were no gross lesions observed in the Line-A and Line-B control groups. In both Line-
A and Line-B infected groups there was congestion, hyperaemia, and excessive exudate in 
the trachea (Figure 5.4). There was fibrinous pericarditis in the infected Line-A group at 14 
dpi (1 of 5 birds) and fibrinous pericarditis and fibrinous perihepatitis in the infected Line-B 
group at 14 dpi (1 of 5 birds). In both infected groups, kidney lesions consisted of paleness 
and swelling and urate deposition with lower severity lesions in Line-B infected group. The 
mean lesion scores show that overall the Line-A infected group produced higher average 
lesion scores for both trachea and kidney in comparison to the Line-B infected group (Figure 
5.3A and 3B). There were no noticeable gross lesions at day 21 and 28 dpi for any groups. 
 
Figure 5.3. Gross lesion score for (A) infected Line-A trachea and kidney and (B) infected 
Line-B trachea and kidney. Birds were examined for gross lesions at 1, 3, 7, 9, 14, 21 and 
28 days post infection (dpi). Birds (n=5/group) were infected with IBV strains Q1 at a dose 
of 104.5 CD50/bird and post mortem tissue was processed for histopathological examination 
at 1, 3, 7, 9, 14 , 21 and 28 days post infection (dpi). Data represents the mean with error 
bars as standard error.* = No lesions. Significant differences between the groups were 
detected by Mann-Whitney test, P<0.05). 
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Figure 5.4. Development of the gross lesion after IBV Q1 oculo-nasal inoculation into 
broilers line-A and line-B Infected groups at one day old. (A). Conjunctivitis and nasal 
exudates after gentle pressing in Line-A at 9 dpi. (B). Trachea revealed different degrees of 
congestion in Line-A infected group (C). Exudates in Line-A infected group (D). Diarrhoea 
in Line-A Infected group at 21 dpi. (E). Fibrinous pericarditis, fibrinous per hepatitis and 
airsacculitis in Line-B infected group at 14 dpi, (F). Fibrinous pericarditis in Line-A Infected 
group at 14 dpi. (G). Line-B Infected group, swelling kidneys with nephritis and deposition 
of uric acid in ureters at 14 dpi (H). Line-A infected group, swelling kidneys with nephritis 
and deposition of uric acid in ureters at 14 dpi 
5.3.4 Histological changes 
Lesions started early at one dpi and continued up to 28 dpi. The highest tracheal 
histopathological scores were seen at 9 and 7 dpi for Line-A and Line-B respectively (Figure 
5.5A).There were no significant differences in tracheal histological changes between 
A B 
E F 
C D 
G H 
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infected groups for any time point. Tracheal lesions of infected Line-A and Line-B groups 
consisted mainly of deciliation and epithelial degeneration, decreased mucous cells and 
heterophil infiltration (Figure 5.6C and 5.6D).  
Kidney lesions appeared at 3 dpi in both infected groups and peaked at 21 and 14 dpi in Line-
A and Line-B respectively. Kidney histological changes consisted of epithelial degeneration, 
lymphoid infiltration and lymphoid nodules (Figure 5.6G and 5.6H). Similar to the trachea, 
changes continued until 28 dpi (Figure 5.5B). There were no histopathological changes seen 
in the proventriculus for the infected Line-B group, whilst lesions comprised mostly of 
glandular sinus dilation and lymphoid infiltration and scattered lymphoid follicles were seen 
at 7 and 9 dpi in the infected Line-A group.  
 
Figure 5.5. Histological score of lesions in the trachea and kidney of infected groups (A) 
Line-A and Line-B infected group tracheal histological score and (B), Line-A and Line-B 
infected groups renal histological score. Birds (n=5/group) were infected with IBV strains 
Q1 at a dose of 104.5 CD50/bird and post mortem tissue was processed for histopathological 
examination at 1, 3, 7, 9, 14 , 21 and 28 days post infection (dpi). Data represents the mean 
with error bars as standard error. Significant differences between the groups were detected 
by Mann-Whitney test, P<0.05). 
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Figure 5.6. Histological findings in trachea and kidney samples, using H&E stain.(A) 
Uninfected trachea from Line-A group showing cilia and goblet cells (B) Uninfected control 
Line-B group showing cilia and goblet cells. (C) Trachea from Line-A infected group at 9 
dpi, extensive epithelial deciliation. (D) Trachea from Line-B infected group 9 dpi with 
lymphocyte and heterophil infiltration. (E) Kidney from Line-A uninfected control group (F) 
Kidney from Line-A uninfected control group (G) Kidney Line-A infected group, tubular 
degeneration. (H) Kidney from Line-A infected group moderate lymphocyte and mild 
heterophil interstitial infiltration in kidney at 9 dpi. 
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5.3.4 Detection of Q1 
5.3.4.1 Pooled oropharyngeal (OP) and cloacal (CL) swabs RT PCR: 
In the Line-A infected group, all collected OP and CL swabs were positive for IBV by RT-
PCR. While, in the Line-B infected group, both swab sites were positive until 14 dpi. Amino 
acid (AA) changes were present early, in the Line-A infected group, with OP sequence 
changes at 3 dpi, which consist of 9 AA. In addition, Line-A 3 dpi OP swabs, there were 3 
AA deletions consisting of asparagine (N), phenyl alanine (F) and asparagine (N) 
respectively at position 308-310 at AA level in the S1 gene. At 9 dpi, there was 1 AA change 
in Line-A OP swab sequence from valine (V) to lysine (K). At 14 dpi, there were 2 AA 
changes, one threonine (T) to serine (S) and the other one being valine (V) to lysine (K). At 
21 dpi, there were 7 AA changes which were not present at 28 dpi. Noticeably, no AA 
changes were found in the Line-B infected group OP swab sequences at any sampling days. 
In the CL swab sequences, AA changes were present at 7 dpi, which consisted of 27 AA in 
the Line-A infected group. Whilst, in the Line-B infected group, there were 4 AA changes 
from CL swab sequences at 7 dpi, these being serine(S) to threonine (T); phenylalanine (F) 
to isoleucine (I); arginine(R) to glutamine (Q) and leucine (L) to lysine (K) , respectively. 
At 28 dpi, there was one AA change in the Line-A CL swab sequence from serine(S) to 
threonine (T) (Table 5.1). 
5.3.4.2 qRT PCR from swabs:  
All infected OP and CL samples were IBV positive, with the exception of 28 dpi in the OP 
swabs (both lines) and 28 dpi in the CL swabs (Line-B only). On average, the viral load from 
OP swabs was lower than from CL swabs in both infected groups, and both the OP and CL 
swabs from the infected Line-A group had a higher viral load compared to swabs from Line-
B (Figure 5.7). 
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Figure 5.7. Quantification of viral RNA from OP and CL swabs of infected groups, 
expressed as a log relative equivalent units (REU) of RNA in the OP and CL swabs of 
infected Line-A group and Line-B. Birds (n=10/group) were infected with IBV strain Q1 at 
a dose of 104.5 CD50/bird and analysed for quantification of viral RNA at 3, 7, 9, 14, 21 and 
28 days post infection (dpi). Data represents the mean from 10 swabs.* Not detected. 
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Table 5.1. Sequence alignment of the partial S1 glycoprotein (starting at 269 AA of the S1 gene) of IBV Q1 strain from OP and CL swabs at 3, 7, 
9, 14, 21 and 28 dpi. Dots indicate identical amino acid to the original inoculum (first row of aligned sequences). Letters denote change in the 
amino acid. Dashes denote deleted amino acids. A is Line-A infected group, B is Line-B infected group. AA 269                                             
OP swabs 
 
Ino:TTLVLTNFTF SNVSNAPPNT GGVHSIVLHQ TQTAQSGYYN FNFSFLSSFR YVESDFMYGS YHPKCSFRLET INNGLWFNSL SVSLGYGPLQ GGC 
A 3 ...M...... .......... .......... ........._ __....... ....A..... .....S..K.Q .......L.. .L...R....P... 
B 3 .......... .......... .......... .......... ......... .......... ........... .......... .............. 
A 7 .......... .......... .......... .......... ......... .......... ........... .......... .............. 
B 7 .......... .......... .......... .......... ......... .......... ........... .......... .............. 
A 9 ...K...... .......... .......... .......... ......... .......... ........... .......... .............. 
B 9 .......... .......... .......... .......... ......... .......... ........... .......... .............. 
A14S..K....... .......... .......... .......... ......... .......... ........... .......... .............. 
B 14.......... .......... .......... .......... ......... .......... ........... .......... .............. 
A 21...R...... .......... .......... .......... ......... .......... .....G..... ...K..G... F.G...N....... 
A 28.......... .......... .......... .......... ......... .......... ........... .......... .............. 
 
 CL swabs 
AA 269 
Ino:TTLVLTNFTF SNVSNAPPNT GGVHSIVLHQ TQTAQSGYYN FNFSFLSSFR YVESDFMYGS YHPKCSFRLET INNGLWFNSL SVSLGYGPLQ GGC 
A 3 .......... .......... .......... .......... ......... .......... ........... .......... .............. 
B 3 .......... .......... .......... .......... ......... .......... ........... .......... .............. 
A 7 ...M...... .................... ........FH .S....I.LS NI.AY..P.. K....S.IKQ. S.EID...FP W..P.T.....V. 
B 7 .......... .......... .......... .......... ......... .......... .......TIKQ .......... .............. 
A 9 .......... .......... .......... .......... ......... .......... ........... .......... .............. 
B 9 .......... .......... .......... .......... ......... .......... ........... .......... .............. 
A 14.......... .......... .......... .......... ......... .......... ........... .......... .............. 
B 14S......... .......... .......... .......... ......... .......... ........... .......... .............. 
A 21.......... .......... .......... .......... ......... .......... ........... .......... .............. 
A 28.......... .......... .......... .......... ......... .......... ........... .......... .............. 
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5.3.4.3 qRT PCR of tissues 
At 7 dpi, the tracheal tissue of the infected Line-A group had a significantly (P<0.05) higher 
viral load when compared to Line-B (Figure 5.8A). At 7-9 dpi, there was a significantly 
(P<0.05) higher differences in the viral load of the kidney of infected Line-A group when 
compared with the Line-B infected group (Figure 5.8B). The IBV viral load was detected in 
the proventriculus between 1-9 dpi in Line-A and 3-9 dpi in Line-B. Line-A showed a 
significantly (P<0.05) higher viral load compare to Line-B at 7 - 9 dpi (Figure 5.8C). No 
IBV was detected at 21 and 28 dpi for any tissues. 
 
Chapter Five                                                              Q1 immunopathogenesis in broilers 
145 
 
 
Figure 5.8 .Quantification of viral RNA in the (A) trachea, (B) and (C) proventriculus form 
infected groups of Line-A and Line-B, expressed as a log relative equivalent units (REU) of 
RNA in the tissues of infected Line-A and Line-B groups. Birds (n=5/group) were infected 
with IBV strains Q1 at a dose of 104.5 CD50/bird. Data represents the mean with error bars as 
standard error. Significant differences between the groups were detected by t-test. Different 
letters indicate significant differences within groups. 
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5.3.4.4 Isolation of IBV Q1 from proventriculus  
The re-isolation of Q1 was attempted from samples of proventriculus at 7 and 9 dpi. Isolation 
was successful for both Line-A and Line-B and upon partial S1 sequencing; the isolates had 
99 % amino acid similarity to the initial inoculum. 
 
5.3.4.5 IBV ELISA antibodies 
The mean maternal derived antibody (MDA) was 1720 and 3340 in Line-A and Line-B 
respectively. The mean antibody (Ab) titre in the Line-A infected group was 100 and 216 at 
21 and 28 dpi respectively (Figure 5.9A). While in the line -B infected group, it was 290 and 
510 respectively. In the Line-A infected group, there were positive ELISA antibodies 
detected by 21 and 28 dpi in 11% and 25% of birds respectively. In the Line-B infected 
group, the percentage of birds with positive ELISA antibodies at 21 and 28 dpi were 37.5% 
and 62.5% respectively (Figure 5.9 B).  
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Figure 5.9. Mean infectious bronchitis virus (IBV) antibody titres of the control and infected 
groups (n=10/group) at 21 and 28 days-old. Data are expressed as mean values ± SEM 
(n=10). The ELISA cut-off is 396. Significant differences between the groups were detected 
by t-test. Different letters indicate significant differences within groups. 
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5.3.5 Host gene expression analysis 
5.3.5.1 Relative IFN-α and IFN-β mRNA expression 
5.3.5.1.1 Trachea 
 In the Line-A infected group, there was significant up-regulation (P<0.05) in the mRNA 
expression of IFN-α between 1-14 dpi when compared to the control group. Expression 
peaked at 1 and 3 dpi, then gradually declined until 14 dpi (Figure 5.10A). Following the 
same trend as Line-A, there was an up-regulation in the infected Line-B group at all sampling 
days. Data for IFN-β expression in the infected Line-A group revealed significant up-
regulation (P<0.05) at all sampling days, except at 14 dpi when compared with control group 
(Figure 5.10B). Whereas data from Line-B showed significant (P<0.05) up-regulation in all 
sampling days, with the peak almost at 100 times fold change at 3 dpi.  
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Figure 5.10. Relative type I interferon (IFNs) mRNA expression in Line-A and Line-B 
control and infected groups: (A) IFN-α expression in the trachea (B) IFN- β in the trachea. 
Relative mRNA expression was determined by quantitative reverse transcription PCR (qRT-
PCR) using SYBR Green method and the data were normalised to 18S rRNA expression. 
Data represents the mean with error bars as standard error (n=5) and are expressed as fold 
change relative to the uninfected controls group. Significant differences between the groups 
were detected by t- test, different letters indicate significant differences (P<0.05). 
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5.3.5.1.2 Kidney 
In the Line-A infected group, there was significant up-regulation (P<0.05) of IFN-α mRNA 
expression at 1 dpi when compared to the control group (Figure 5.11A). There was down-
regulation in the other sampling days. In the Line-B infected group, there was up-regulation 
in all sampling days in the mRNA expression of IFN-α without any significant when 
compared to control group. The peak point was at 7 dpi (Figure 5.11A). In general, the Line-
B infected group exhibited higher up-regulation from 3-14 dpi when compared to the Line-
A infected group.  
In the Line-A infected group, there was significant up-regulation (P<0.05) in the mRNA 
expression of IFN-β at 1-3 dpi. There was up-regulation in the other sampling days when 
compared to the control uninfected group (Figure 5.11B).  
In the Line-B infected group, there was slight up-regulation in the mRNA expression of IFN-
β in all sampling days in comparison to the control uninfected group (Figure 5.11B). The 
Line-A infected group showed higher up-regulation when compared to the Line-B infected 
group.  
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Figure 5.11. Relative type I interferon (IFNs) mRNA expression in Line-A and Line-B 
control and infected groups: (A) IFN-α expression in the kidney (B) IFN- β in the kidney. 
Relative mRNA expression was determined by quantitative reverse transcription PCR (qRT-
PCR) using SYBR Green method and the data were normalised to 18S rRNA expression. 
Data represents the mean with error bars as standard error (n=5) and are expressed as fold 
change relative to the uninfected controls group. Significant differences between the groups 
were detected by t- test, different letters indicate significant differences (P<0.05). 
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5.3.5.2 Expression of mRNA of TLR3 and MDA5 in the trachea and kidney 
5.3.5.2.1 Trachea 
There was significant (P<0.05) up-regulation of TLR3 expression for Line-A between 1-7 
dpi (Figure 5.12A). The same pattern was seen for Line-B, except up-regulation continued 
until 14 dpi (Figure 5.12). Generally, TLR3 was up-regulated to a greater extent in Line-A 
compared to Line-B. There was a significant up-regulation of MDA5 for Line-A at 1 dpi, 
whereas Line-B was significantly down-regulated (Figure 5.12B). No further changes were 
seen in the subsequent sampling times (Figure 5.12B). 
 
Figure 5.12. Transcriptional regulation of innate viral sensing molecules in the trachea (A) 
TLR3 and (B) MDA5 in the trachea of Line-A and Line-B control and infected groups. 
Relative mRNA expression was determined by quantitative reverse transcription PCR (qRT-
PCR) using SYBR Green method and the data were normalised to 18S rRNA expression. 
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Data represents the mean with error bars as standard error (n=5) and are expressed as fold 
change relative to the uninfected controls group. Significant differences between the groups 
were detected t- test, different letters indicate significant differences (P<0.05). 
5.3.5.2.2 Kidney 
Higher up-regulation of TLR3 mRNA expression was seen in the Line-A infected group 
between 1-9 dpi when compared to the control uninfected group (Figure 5.13A). In the Line-
B infected group, there was significant (P<0.05) up-regulation in the mRNA expression of 
TLR3 between 1-14 dpi when compared to control uninfected group (Figure 5.13A). In the 
Line-A infected group, there was significant (P<0.05) up-regulation in the mRNA expression 
of MDA5 between 7-9 dpi. Up-regulation was seen in the remaining sampling days when 
compared to the control uninfected group (Figure 5.13B). The peak point was at 9 dpi in the 
Line-A infected group. In the Line-B infected group, there was significant (P<0.05) up-
regulation in the mRNA expression of MDA5 between 7-9 dpi (Figure 5.13B). The extent 
of MDA5 was higher in the Line-A infected group, for all sampling day and roughly up to a 
6 fold increase. 
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Figure 5.13. Transcriptional regulation of innate viral sensing molecules in the kidney (A) 
TLR3 and (B) MDA5 in Line-A and Line-B control an infected groups. Relative mRNA 
expression was determined by quantitative reverse transcription PCR (qRT-PCR) using 
SYBR Green method and the data were normalised to 18S rRNA expression. Data represents 
the mean with error bars as standard error (n=5) and are expressed as fold change relative to 
the uninfected controls group. Significant differences between the groups were detected by 
t test, different letters indicate significant differences (P<0.05). 
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5.3.5.3 Transcription profile of pro-Inflammatory cytokines in the trachea and kidney 
5.3.5.3.1 Trachea 
For Line-A, there was significant (P<0.05) up-regulation of IL-1β mRNA expression 
between 1-14 dpi, which peaked at 1 dpi and steadily declined until 14 dpi (Figure 5.14A). 
A similar pattern was seen for Line-B, however only 1 dpi was significant and expression 
returned to the base level by 9 dpi (Figure 5.14A).  
There was significant up-regulation of IL-6 expression in Line-A between 3-9 dpi, which 
peaked at 9 dpi (Figure 5.14B). Interestingly, there was initial significant down-regulation 
for Line-B at 1 dpi, which was then up-regulated from 3-14 dpi (Figure 5.14B).  
Down-regulation was seen for LITAF expression, in Line-A, for all sampling points (Figure 
5.14C). In Line-B infected group, there was down-regulation of mRNA expression of LITAF 
at 1-3 dpi which gradually increased until 14 dpi when compared to control uninfected group 
(Figure 5.14C). 
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Figure 5.14.Transcription profile of pro-inflammatory cytokines in the trachea (A) IL-1β 
and (B) IL- 6 and (C) LITAF in Line-A and Line-B from control and infected groups. 
Relative mRNA expression was determined by quantitative reverse transcription PCR (qRT-
PCR) using SYBR Green method and the data were normalised to 18s rRNA expression. 
Data represents the mean with error bars as standard error (n=5) and are expressed as fold 
change relative to the uninfected controls group. Significant differences between the groups 
were detected by t-test, different letters indicates significant differences (P<0.05). 
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5.3.5.3.2 Kidney 
In the Line-A infected group, there was up-regulation in the mRNA expression of IL-1β 
between 1-7 dpi. In the Line-A infected group, there was significant (P<0.05) up-regulation 
in the mRNA expression of IL-1β between 9-14 dpi when compared to control uninfected 
group. The magnitude of up-regulation in line-A was nearly 20 times more than the control 
uninfected group at 9 dpi when it was at the peak point (Figure 5.15A). Unlike Line-A, in 
the Line-B infected group, there was significant (P<0.05) up-regulation in the mRNA 
expression of IL-1β between 1-14 dpi which peaked at 9 dpi to up about 80 fold (Figure 
5.15A). 
In the Line-A infected group, there was significant (P<0.05) up-regulation in the mRNA 
expression of IL-6 between 7-9 dpi (Figure 5.15B). The peak point was at 9 dpi at an 
approximately a 6 fold increase compared to the control uninfected group. In the Line-B 
infected group, there was significant (P<0.05) up-regulation in the mRNA expression of IL-
6 between 3-14 dpi (Figure 5.15B). The peak point was at 9 dpi to approximately 20 times 
more than the control uninfected group. 
In the Line-A infected group, there was significant (P<0.05) up-regulation in the mRNA 
expression of LITAF between 7- 9 dpi when compared to the control uninfected group. The 
peak point was at 9 dpi (Figure 5.15C). In the Line-B infected group, there was significant 
(P<0.05) up-regulation in the mRNA expression of LITAF between 1-14 dpi when compared 
to control uninfected group (Figure 5.15C).  
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Figure 5.15.Transcription profile of pro-inflammatory cytokines in the kidney (A) IL-1β and 
(B) IL- 6 and (C) LITAF in Line-A and Line-B kidneys from control and infected groups. 
Relative mRNA expression was determined by quantitative reverse transcription PCR (qRT-
PCR) using SYBR Green method and the data were normalised to 18S rRNA expression. 
Data represents the mean with error bars as standard error (n=5) and are expressed as fold 
change relative to the uninfected controls group. Significant differences between the groups 
were detected by t-test different letters indicates significant differences (P<0.05). 
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5.4 Discussion 
In this study, the pathogenicity and host gene expression responses to Q1 infection, were 
studied in two broiler lines with different growth rates. Though Q1 has been reported in 
many countries (Ababneh et al., 2012; Ganapathy et al., 2015; Sesti et al., 2014), few reports 
have been published on the pathogenicity and immune responses of this important variant, 
particularly in commercial broiler chicks with IBV-maternal antibody . In recent years, it has 
been reported that slow growing broiler chickens may be more resistant to common poultry 
pathogens compared to fast growing birds (van Hemert et al., 2006; Williams et al., 2013; 
Humphrey et al., 2015). To further investigate the differences, we studied two breeds of 
commercial broilers, one with fast growth (Line-A) and another with slower growth (Line-
B) to assess the impact of Q1 infection and evaluate the innate and cytokines responses in 
the trachea and kidney.  
Weekly live body weight (LBW) measurements of chicks confirmed that Line-B chicks were 
slow growing in comparison to Line-A. Both infected and non-infected chicks had a lower 
LBW at 21 and 28 dpi compared to Line-A. However, it appears that Q1-infection of Line-
B birds had no significant impact on weight gain. In contrast, Q1 infection caused a reduction 
in the LBW of Line-A at 14 and 21 dpi. Previous work, examining the effect of QX and Q1 
infection, also noted a reduction in body weight for broiler and SPF chicks (Mahgoub et al., 
2010; Ganapathy et al., 2012). The loss of LBW for infected Line-A birds is likely associated 
with the greater susceptibility of this breed IBV induced disease. 
The clinical signs, gross lesions and histopathology findings showed that both bird lines are 
susceptible to Q1 infection, however the clinical sign, severity and duration of lesions was 
consistently greater in Line-A than Line-B. Respiratory signs and mortality have been 
previously associated with Q1 infection (Yu et al., 2001), however, in this study a much 
lower mortality rate was found. In addition, a higher mortality rate was reported for 
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IS/885/06 and IS/1494/06 (wad et al., 2014; Awad et al., 2016). The severity of clinical signs 
caused by IBV vary due to many factors related to the virus, host and environment 
(Jackwood and de Wit 2013). The tracheal and kidney lesions reported here are similar to 
those reported previously in other IBV strains such as IS/885/00 and 793B (Boroomand et 
al., 2012; Awad et al., 2016). Histopathologic changes were much more severe in the trachea 
and kidney from Line-A compared to Line-B. The histopathologic changes in the 
proventriculus seen in the Line-A infected group were similar to those reported previously 
in commercial broiler farms with Q1 infection (Toffan et al., 2013), whereas no lesions were 
found in the Line-B birds proventriculus. It appears that due to genetic characteristics of 
Line-A, it is significantly more susceptible to Q1 infection and subsequently showed a 
greater severity of gross and microscopic lesions compared to Line-B. 
In this study, it appears that the replication of Q1 in the Line A is greater than in the Line B. 
This was reflected by higher levels of viral load in the swabs and tissues in the Line A 
compared to Line B. In addition, in the Line A, the Q1 was continuously detected up to 28 
compared to 14 dpi in the Line B. These differences may be due to variations in the levels 
of IBV MDA (Darbyshire and Peters 1985; Terregino et al., 2008; Awad et al., 2016) or 
genetic make-up of the birds, which may have affected virus infection and clearance.  
In this experiment, Line-A infected group OP swab sequences shown amino acids changes 
at 3, 9, 14 and 21 dpi. No changes occurred in Line-B OP swabs sequences at any of the 
sampling days. Such amino acid changes lead to alterations in the S1 antigen, which could 
allow evasion of host immune responses (Promkuntod et al., 2014), since the S1 gene 
contains epitopes targeted by neutralizing antibodies and inducing immunity (Cavanagh 
2005). The findings in this study show a high number of AA changes in the Line-A group 
infecting Q1 virus that may have promoted better survival in the respiratory epithelium of 
the chicks. As this appears to be first study to highlight such differences between breeds of 
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chickens, further studies would be helpful to understand the molecular evolution of virulent 
or vaccine strains of IBV in different breeds of chickens. 
In term of humoral immune responses, results indicate that maternal antibody levels to IBV 
followed a similar pattern of decline in both lines of chicks, with re-emergence of active 
humoral antibody levels (above the positive ELISA cut-off level) started at 21 dpi in Line-B 
but not Line-A . The percentage of birds with IBV positive titres was higher in Line-B 
compared to the Line-A, reflecting a greater ability of the slow growing chicks in providing 
efficient immunological response to the Q1 infection. An experiment carried by Cook and 
colleagues (1990) indicated that IBV-resistant breed line C showed an earlier and higher 
degree of humoral antibody titres to IBV M41 compared to line 151 (Cook et al., 1990).  
Previous studies have reported conflicting data regarding host gene expression in the trachea 
and kidney following IBV infection (Kameka et al., 2014; Chen et al., 2015) and this could 
be related to the strain of IBV used, the breed of birds, the route or dose of inoculation, or 
the environment where the chicks were kept (Gough and Alexander 1979; Cook et al., 1990; 
Caron 2010; Okino et al., 2017a). And most probably, a combination of the previous factors.  
In the current study, Line-A birds presented with a significant up-regulation of IFN-α at 1-
14 dpi, similar to previous work using SPF birds (He et al., 2016). No changes were seen for 
IFN- α in Line-B, which may be connected to the fact that these genes can be switched off 
through inhibition of host protein synthesis by accessory protein 5b of IBV (Kint et al., 
2016). Up-regulation of IFN-α in Line-A appears to be associated with increase in the 
severity of clinical signs, viral load and lesions. In both lines, there was significant up-
regulation of IFN-β at 1-9 dpi that continued up to 14 dpi in Line-B, a magnitude of increase 
in the Line-B is substantially higher than Line-A. However, the reason for the higher levels 
in Line-B is unknown, it appears to be associated with more rapid virus clearance.  
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The recognition of pathogen-associated molecular patterns is developed by TLR3 through 
sensing double-stranded (ds) RNA, and then mediated immune responses, which have 
central and key component in host resistance (Ruan et al., 2015). There was significant up-
regulation of TLR3 up to 7 dpi for Line-A, however Line-B continued until 14 dpi. Okino et 
al., (2017b) working with Brazilian A and B strains, reported a significant up-regulation of 
TLR3 at the end of their experiment (8 dpi). It appears that greater expression of TLR3 over 
a shorter period might be associated with disease severity and IBV RNA load as seen in the 
Line-A. 
Chicken MDA5 recognise long-duplex RNA in infected cell cytoplasm (Wu et al., 2013). 
At 1 dpi, tracheal mRNA of MDA5 in Line-A chicks had a significantly higher expression 
in contrast to the down-regulation occurring in the Line-B. Similar to previous publications, 
this finding confirms that MDA5 mRNA can be detected less than 3 days following IBV 
infection (He et al., 2016; Okino et al., 2017a). The higher MDA5 expression at 1 dpi could 
be implicated in the greater infection severity in Line-A. For Line-B, the value was down-
regulated, reflecting an association between MDA5 and disease as well as viral load, as these 
values were much lower compared to the Line-A. It is apparent that that different breeds 
respond differently to the same causative agent.  
There was significant up-regulation of IL1-β in Line-A at 1-14 dpi, similar to previous work 
(Jang et al., 2013; Okino et al., 2014). A different response was witnessed for Line-B, which 
saw only significant up-regulation at 1 dpi. Such results further suggest the participation of 
these cytokines in forming lesions in the trachea of Line-A (Okino et al., 2014), as the 
duration and extent (3-9 dpi, up to 6 fold higher change) of expression of mRNA IL-6 was 
greater than Line-B. Such a result is consistent with gross and histological changes 
accompanied with higher viral load seen in Line-A. Expression of cytokines IL1-β and IL-6 
could be a consequence of a secondary response to infection, not as a direct response to viral 
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infection (Jang et al., 2013). IL-6 has previously been associated with tissue damage, the 
extent of which depends on the IBV strain, as lesions and the pro-inflammatory response in 
the host could vary to a certain degree (Jang et al., 2013; Okino et al., 2014; R. Chhabra et 
al., 2015a).  
In the kidney, there was significant up-regulation of IFN-α and IFN-β at 1 and 1-3 dpi 
respectively in Line-A. Type I IFNs have been shown to play a significant role in bird 
survival during viral infection of different chicken breeds to those examined in the current 
study (Li et al., 2006). In addition, it has been demonstrated that all types of IFNs (I, II, III) 
are up regulated in both IB-vaccinated and non-vaccinated birds following IBV challenge 
(Yang et al., 2018). The early overexpression of type I interferon in Line-As infected kidney, 
could be as a result of greater virus proliferation since the IFNs are induced directly in 
infected tissues in Line-A breed. 
There was significant up-regulation of TLR3 at 1-14 dpi in Line-B. It has been reported that 
IBV induced TLR3 at 3 dpi, when in vivo IBVs QX, M41, IS/885/00 and 
ck/CH/LDL/091022 were tested in using SPF chicks (Smith et al., 2015; Chhabra 2016). 
The continuous detection of TLR3 reflects that the expression of TLR3 could be variable in 
different chicken breeds, providing divergent resistance (Ruan et al., 2015). For the MDA5, 
though up-regulation was noticed in both infected groups, it was 20 times higher in the Line-
A, where more severe disease and greater viral load was found. It appears that MDA5 could 
be considered as an indicator for IBV disease severity, with higher values being positively 
associated with disease severity and viral load, and vice-versa. 
Kidney innate immune responses have been induced in the early stage of infection after 
inoculation of pathogenic M41 in SPF chicks (He et al., 2016). In the current study, the pro-
inflammatory cytokines in the Line-B infected group started early in the kidney at 1 dpi, 
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which continued up to 14 dpi. These differences in the kinetics could be related to the 
resistance in Line-B in which a more rapid inflammatory response occurred and to a greater 
extent that limited viral replication and prevented lesion development in the kidney. 
Nevertheless, the inflammatory responses in Line-A was found until 7 dpi. Similar to Line-
B, an early pro-inflammatory cytokine response was seen in a resistant line (BrL) but not in 
a susceptible line (White Leghorn line), accompanying infection with infectious bursal 
disease virus (Ruby et al., 2006). 
This study has demonstrated that IBV Q1 is pathogenic to both slow and fast growing IBV-
maternal antibody positive broiler chicks. The slow growing chicks showed earlier clearance 
of the virus, less severe gross and histopathological lesions, a higher percentage of birds that 
seroconverted with a greater titre of IBV antibodies and resisted body weight losses 
compared to the fast growing chicks. Innate immune responses broadly demonstrated that 
Line-B showed longer expression of host genes such as TLR3 in both trachea and kidney  
compared to Line-A, demonstrated by resilient responses in the slow growing chicks. Further 
studies on the differential immune responses to IBV strains by different types (broiler, layer, 
breeder, slow or fast growing) of chicks in relation to disease and losses could be useful for 
better prevention strategies against classical and variant IBVs.
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Chapter 6: Pathogenesis assessment of vaccine or virulent 
infectious bronchitis viruses in chick embryo tracheal organ 
cultures 
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Abstract 
Much uncertainty still exists regarding the relationship between in vitro pathogenicity (or 
virulence) and the genetic characteristics of different infectious bronchitis virus (IBV) 
strains. Three virulent (Massachusetts, 793B, and QX) and eight vaccine strains of IBV were 
inoculated in tracheal organ cultures (TOCs) to evaluate in vitro pathogenicity on ciliated 
epithelia of trachea. At 24 and 72 hours post infection (hpi), TOC media and tracheal rings 
were collected, and assessed for virus load (by RT-PCR and qRT-PCR), innate immune 
response and total apoptotic cell differences. Evident differences in the virulence were noted 
between strains within the same serotype, and certain vaccines resulted in cilia degradation 
comparable with the virulent strain. The average cilia motility readings in Mass group, 
Mass1 and VirMass reached complete ciliostasis at 72 and 96 hpi respectively. Whereas, in 
the 793B and QX groups complete ciliostasis was reached for all strains by 120 hpi. The 
qRT-PCR analysis revealed decreased viral presence in the media at 24 and 72 hpi. 
Differences were found between the total apoptotic cell counts in the tracheal rings among 
virulent and vaccine strains. Down-regulation in mRNA expression of IFN-α at 24 and 72 
hpi occurred in all virulent and vaccine infected TOCs. At 24 hpi, there was up-regulation in 
IFN-β which was down-regulated by 72 hpi in virulent infected TOCs. At 24 and 72 hpi, 
there was up-regulation in the mRNA expression of TLR3 in all vaccine and variant strains. 
An up-regulation of MDA5 was seen at 24 hpi in Mass serotype strains, Vir793B, 793B1 
and QX serotypes. This study demonstrates the successful use of the in vitro TOC model for 
distinguishing differences in virulence and replication rate among classical and variant 
strains of IBVs. This study demonstrated that TOCs can be used for concurrent screening 
and evaluation of several virulent and attenuated IBV strains 
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6.1 Introduction 
Infectious bronchitis virus (IBV) variants are appearing regularly in large commercial 
chicken flocks; these variants often completely or partially escape the immune responses 
provided by currently available commercial live IBV classical and variant vaccines 
(Jackwood 2012). Vaccination is the primary method for controlling IBV infection. 
However, there is an emergence of variant IBV strains in commercial farms for which the 
current vaccines are unable to cross-protect (Bru et al., 2016). Vaccines, produced from 
endemic IBV strains, have improved flock health against commonly circulating virulent 
strains. The first vaccine type produced, Massachusetts (H120) serotype, has been used 
globally and was the only vaccine available for many years (Jordan 2017). With the 
increasing emergence of new IBVs variants around the world, there are few available 
vaccines that are effective against certain IBV strains such as QX (Cook et al., 2001; 
Jackwood 2012). 
To reduce time, costs, and for humane purposes, an alternative method from using live 
experimental birds have been sought for experimentation. There are recommendations from 
national animal experimentation regulatory authorities to increase the use of in vitro 
biological methods such as Tracheal organ cultures (TOCs) (Cardoso et al., 2005), rather 
than in vivo work. The advantages of TOCs are that they are simple to prepare and can be 
used to study IBV infection using parameters such as antigenic relationships, genetic 
mutations and the prediction of tissue tropism (Raj and Jones 1996b; Wang et al., 2012; Ball 
et al., 2016b). Also, several TOC rings can be prepared from a single trachea of an embryo, 
and these can be used for testing a number of virus isolates.  Tracheal variations between the 
groups can be kept to a minimum as the rings come from the same birds or group of birds.  
Strain variations may be related to viral replication mechanics or as a consequence of the 
alteration of signalling pathways, such as cell stress and host innate immune response, to 
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facilitate viral pathogenesis (Zhong et al., 2012). Several viruses, such as IBV, tend to use 
two central common strategies to infect and invade host cells which ultimately initiate 
apoptosis and influence the host cell cycle (Li et al., 2007). In the same way, during virus 
infection, apoptosis can be considered an innate cellular response to limit viral propagation, 
however it might also facilitate virus dissemination (Alcami and Koszinowski 2000). 
Recently, Chhabra et al. (2016) outlined an association between apoptosis and an increase in 
specific mRNA gene expression which was also indicated the IBV tissue tropism. The up-
regulation of Toll-like receptor 3 (TLR3), Melanoma differentiation association protein 5 
(MDA5) and interferon β (IFN-β) occurred during virulent IBV infection of tracheal organ 
cultures or kidney cells (Chhabra et al., 2016). Further understanding of the importance of 
how various innate response factors interact during IBV infection, particularly regarding 
apoptosis, will aid future IBV research. To date, studies utilising TOCs have produced results 
that associated innate immune responses and apoptotic cell counts (Chhabra et al., 2016). 
The aim of this study is to examine the virulence of common and important live IBV vaccines 
in TOCs and to cross-compare findings against virulent strains from the same serotypes. As 
increasing numbers of live IBV vaccines are available in UK and globally, we were aiming 
to develop an in vitro model, whereby the virulence of several IBV vaccine viruses could be 
assessed concurrently. 
 
6.2 Materials and methods 
6.2.1 Viruses  
Eight monovalent vaccines, from different producers, comprising of three common IBV 
serotypes (793B, Massachusetts and QX) were used to compare strain pathogenesis and host 
innate immune responses. Strains included; Mass1, Mass2 and Mas3 (H120 or Ma5), 793B1, 
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793B2 and 793B3 (4/91, CR88 or 1/96) and QX1 and QX2 (L1148 or D388). Vaccine strains 
were passaged a single time in ECE and titrated in TOCs prepared from 19 to 20-day old 
SPF ECE (Chapter 2.1) (Cook et al., 1976b). For comparison, a virulent strain from each 
serotype was also included. 
6.2. 2 Tracheal organ culture 
Tracheal organ cultures (TOC) were prepared as previously described (Chapter 2.2). 
Titration of vaccine and virulent viruses was carried out in TOCs (Chapter 2.2) (Cook et al., 
1976b).  
6.2.3 Experimental design 
Three virulent strains of IBV, virulent Mass (VirMass (106.33 CD50/ml)), virulent 793B 
(Vir793B (106.38 CD50/ml)) and virulent QX (VirQX (10
6.39 CD50/ml)) were included in the 
study, which were previously grown in embryonated SPF chicken eggs and titrated in TOCs 
(Chapter 2.2). 
Eight commercial vaccines, Mass1 (104.75 CD50/ml), Mass2 (10
6.5 CD50/ml), Mass3 (10
5.75 
CD50/ml), 793B1 (10
7.25 CD50/ml), 793B2 (10
5.75 CD50/ml), 793B3 (10
4.5 CD50/ml), QX1 
(105.75 CD50/ml) and QX2 (10
4.4 CD50/ml) were used in this study. All commercial vaccines 
were reconstituted in TOC media according to manufacturer’s instructions. For each vaccine, 
0.1 ml of reconstituted vaccine was separately inoculated into the allantoic cavity of 10 SPF 
eggs and incubated for 48h at 37°C ( Raj and Jones 1996; Raj and Jones 1997a) , then the 
collected allantoic fluids were titrated in TOCs (Chapter 2.2).  
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Under sterile conditions, tracheas were removed and cut into 0.6-mm-thick rings using a 
tissue chopper48 and individually transferred into sterile tubes containing 0.6 ml of TOC 
medium (Chapter 2.2). Tubes were incubated at 37°C in a rotating incubator (Ball et al., 
2016b; Chhabra et al., 2016). 
Cilia motility was monitored over a five day period (8, 24, 32, 48, 56, 72, 96, 120 hours post 
infection), and 15 samples per strain were collected at 24 and 72 hpi (Raj and Jones, 1996) 
(Figure 6.1). For the entire experimental period, mock infected TOC tubes were included as 
control, for cilia motility readings and tissues for host gene expression or counting apoptotic 
cells. TOC medium collected at sampling time points was used for molecular analysis and 
were stored at -70°C. Tracheal rings were stored in 200 µl RNAlater® (Qiagen, UK) at -
70°C. Ciliary beating was scored as follows: 0= 76-100% beating; 1= 51-75% beating; 2= 
26-50% beating; 3= 1-25% beating; 4= 0% beating; (Cook et al., 1999; Ball et al., 2016b). 
The ciliostasis 50% end point (time at which only 50% of cilia remain viable) was calculated 
for each strain (virulent and vaccine) using a combination of both the ciliary beating score 
and cilia vigour score (Ciliary vigour was measured at each time point as follows: 0 for lack 
of beating, 1 for slow in co-ordinated beating, 2 for moderate co-ordinated beating and 3 for 
fast harmonic beating (Gabridge et al., 1974; Stadtlander et al., 1991).  
 
 
                                                 
 
 
48 McIlwain, Mickle Laboratory Engineering, Gomshall, UK 
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Figure 6.1. Clarify what samples were used for each assay during in this experiment. At 
each sampling times, 24 and 72 hpi, TOCs were collected and processed as in the figure 
illustration.  
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6.2.4 Virulent and vaccine viruses’ infection of TOCs 
The prepared TOCs were inoculated five days post preparation, during this period signs and 
symptoms associated with the inflammatory response subsided (Reemers et al., 2009a). For 
all virulent and vaccine strains, a dose of 102 CD50/ml was chosen based on preliminary data 
for which this titre caused 100% ciliostasis in TOCs by 72 hours post infection (hpi).  
At each sampling point, from five TOC tubes, tracheal rings and supernatant were collected 
at 24 and 48 hpi for conventional RT-PCR and sequencing, quantification of infectious virus, 
with the TOC rings also used for quantification of host gene expression analysis. Using 4% 
paraformaldehyde (PFA) for fixation, TOC rings were evaluated for apoptotic cells using in 
situ Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay 
(Chhabra et al., 2016).  
6.2.5 Ciliostasis quantification  
Before infection, TOCs used in this study had 100% cilia beating. Ciliary vigour was 
measured at each time point as follows: 0 for lack of beating, 1 for slow in co-ordinated 
beating, 2 for moderate co-ordinated beating and 3 for fast harmonic beating (Gabridge et 
al., 1974; Stadtlander et al., 1991). The relative ciliary activity (RCA) was calculated by 
multiplying the cilia beating with cilia vigour. The ciliostasis 50 % end point (50% EP) for 
each strain was determined using polynomial regression (Raj and Jones 1996b)  
6.2.6 Extraction of RNA 
6.2.6.1 TOC media:  
The total RNA from TOC media was extracted using the RNeasy Mini kit (Qiagen) (Chapter 
2.13). Extracted RNA was quantified using a Nano-Drop 1000 spectrophotometer and stored 
at -70oC until used for quantitative reverse transcription PCR (qRT-PCR) analysis (Chhabra 
2016). 
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6.2.7 TOC rings:  
In brief, the total RNA from five TOC rings was extracted using an RNeasy Plus Mini-QIA 
Kit (Qiagen, UK) following the manufacturer's instructions. The concentration of extracted 
RNA was quantified by Nano-Drop ND-1000 49 (Chapter 2.14). 
6.2.8 Conventional IBV RT-PCR partial S1 
IBV RT-PCR was conduct as previously described (Worthington et al., 2008) that targeted 
a 393bp portion of the S1 gene (Chapter 2.15). Positive amplicons were sent for commercial 
Sanger sequencing using the forward SX3+ primer (Chapter 2.15.5). 
6.2.9 Quantification of IBV RNA 
At sampling points (0, 24, 72 and 120 hpi), qRT-PCR viral load was quantified using Rotor 
Gene Probe RT-PCR (Qiagen, UK). All the reagents and times are illustrated in details in 
Chapter 2.18 as described previously (Roh et al., 2014). 
 
6.2.10 Host gene expression analysis 
The transcription of innate immune genes, such as IFN-α and IFN-β TLR3 and MDA5 were 
nominated based on previous experimental results (Chhabra et al., 2016). Quantitative 
reverse transcription PCR (qRT-PCR) of cDNA was conducted in triplicate from each 
sample using a Light Cycler® 480. The details on this procedure and primers are illustrated 
in Chapter 2.19. 
                                                 
 
 
49 Labtech international, Heathfield, UK 
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6.2. 11 Detection of apoptotic cells in TOCs 
Apoptotic cells were identified by the TUNEL assay using the peroxidase (POD) in situ cell 
death detection kit with Fluorescein according to the manufacturer's instructions (Roche, 
sigma-aldrich). In brief, tracheal rings were taken at 24 and 48 hpi and fixed in 4% PFA, for 
de-waxing, the TOC sections were incubated with 0.1 % Triton X-100 in 0.1% sodium citrate 
for 8 min at room temperature. Then PBS was used for washing 3 times, at that time sections 
were overlaid with 50 μl TUNEL reaction mixture and incubated in a humidified atmosphere 
for 60 min at 37°C in the dark. After repeating the washing step with PBS, 50 μl Converter-
POD was added and the slides were incubated in a humidified atmosphere for 1 hour at 37°C. 
The washing step was repeated and the peroxidase reaction was developed using the DAB 
Peroxidase Substrate kit according to the manufacturer's instructions. Haematoxylin counter 
stain was applied to the sections for 1 min and mounted with Aquatex. Five sections were 
analysed for each time point and calculation the average total apoptotic cells. 
6.2.12 Statistical analysis 
Data from the TUNEL assay and gene expression analysis were analysed by ANOVA using 
Graph Pad Prism, then the post-hoc LSD multiple comparison test. Differences between 
groups at that time point were considered significant at P<0.05. 
 
6.3 Results  
6.3.1 TOCs reading 
6.3.1.1 Complete ciliostasis reading 
There was no ciliostasis seen in the control group at the end of the experiment at 120 hpi. 
The VirMass strain showed the shortest time needed to reach complete ciliostasis at 72 hpi, 
earlier than both Vir793B and VirQX which achieved complete ciliostasis 120 hpi. 
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In the Mass group, VirMass showed complete ciliostasis earlier than the vaccines at 72 hpi. 
Mass1 showed complete ciliostasis later at 96 hpi, and both Mass2 and Mass3 showed 
complete ciliostasis by 120 hpi. 
All 793B strains (Vir793B, 793B, 793B2 and 793B3) presented with complete ciliostasis at 
120 hpi. 
Two QX strains (VirQX and QX1) presented with complete ciliostasis at 120 hpi, while QX2 
retained some viable cilia at 120 hpi.  
The Mass1 strain reached complete ciliostasis at 96 hpi, earlier than other vaccines used in 
this study which showed complete ciliostasis at 120 hpi. 
6.3.1.2 Ciliostasis 50% end point 
There was no statistical differences for the 50% EP between serotypes (Figure 6.2). 
Data for the 50% EP within the Mass group revealed significant differences (P<0.05). Both 
VirMass (23.8 hpi) and Mass2 (24 hpi), showed a significantly lower duration to reach 50% 
EP when compared to Mass1 (36 hpi), and Mass3 (34 hpi) (Table 6.1).  
In the 793B group, the 793B3 strain displayed a significantly late 50% EP at 39 hpi in 
comparison to 793B1 (24.1 hpi) and 793B2 (23.9 hpi). In the QX group, there were 
significantly earlier differences (P<0.05) for the 50% EP in both VirQX (24.5 hpi) and QX1 
(28.3 hpi) when compared to QX2 which reached 50% EP at (46.5 hpi). 
Comparisons among vaccines of different serotypes showed that Mass2, 793B1, 793B2 and 
QX1 had a significantly (P<0.05) lower 50% EP than Mass1, Mass3, 793B3 and 793B2 
(Figure 6.1). 
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Table 6.1. Shows the IBV virulent and vaccine strains comparisons of ciliary activity over 
time (complete ciliostasis and 50 % RCA). 
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Figure 6.2. The 50% RCA end point values comparison between each serotype. For each 
strain, average 50% ciliostasis threshold values, representative of readings of 8 tubes each, 
were used to calculate the mean value of the strain. Significantly different (p<0.05) values 
are shown with different letters. 
Strains Complete ciliostasis  
           (hpi) 
50% RCA time point 
(hpi) 
VirMass 72 23.8 
Mass 1 96 36.6 
Mass2 120 24.1 
Mass3 120 34.1 
   
Vir793B 120 30.9 
793B1 120 24.1 
793B2 120 23.8 
793B3 120 39.1 
   
VirQX 120 24.5 
QX1 120 28.3 
QX2 120 46.5 
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6.3.2 RT-PCR and SNP analysis 
Media samples from 24 and 72 hpi were tested with conventional RT-PCR and sent for 
sequencing to be compared with the original inoculum sequences. No mutations, deletions 
or insertions occurred with the exception of one strain (Figure 6.3). 
The virulent 793B inoculum had one sample at 72hpi with two single nucleotide 
polymorphisms (SNPs), Guanine to Alanine at position 856 bp (full S1 gene) and Thymine 
to Alanine at position 1013 bp (full S1 gene), that trigger amino acid changes (from Aspartic 
acid to Asparagine in the former, and from Phenylalanine to Leucine in the latter). However, 
there was no suspected change to the protein structure, as indicated by no hydrophobicity 
change (Aspartate and Asparagine polar, Phenylalanine and Leucine non-polar). 
 
 
Figure 6.3. DNA sequence alignment of the partial S1 hypervariable region for vir793B. 
Lines D1 to 5 correspond with 24hpi samples, D6 to 10 correspond with 72 hpi samples. The 
starting position at 756 bp in the full S1, highlighted letters indicated changing in the 
nucleotides.  
Vir 793B  T T T A T T G T A T A T C G A G A A A G T A G C A C T A A C A C T A C T T T A G A G T T A A C T A A T T T C A C T T T T A C T A A T G T A A G T A A T G C T C A T C C T A A T T C A G G T G G C G T T G
D1  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D2  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D3  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D4  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D5  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D6  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D7  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A
D8  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D10  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vir 793B  A T A C T T T C C A A T T A T A T C A A A C A C A T A C T G C T C A G G A T G G T T A T T A T A A T T T T A A T T T A T C A T T T C T G A G T A G T T T T G T G T A T A A A T C A T C T A G T T T T A T
D1  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D2  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D3  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D4  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D5  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D6  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D7  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D8  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D10  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vir 793B  G T A T G G G T C A T A C C A C C C A A A G T G T A A T T T T A G A C C A G A G A A T A T T A A T A A T G G C T T T T G G T T T A A T T C A T T A T C T G T G T C A C T T A C T T A C G G A C C C A T T
D1  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D2  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D3  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D4  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D5  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D6  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D7  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D8  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D9  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D10  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vir 793B  C A A G G T G G T T G T
D1  . . . . . . . . . . . .
D2  . . . . . . . . . . . .
D3  . . . . . . . . . . . .
D4  . . . . . . . . . . . .
D5  . . . . . . . . . . . .
D6  . . . . . . . . . . . .
D7  . . . . . . . . . . . .
D8  . . . . . . . . . . . .
D9  . . . . . . . . . . . .
D10  . . . . . . . . . . . .
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6.3.3 Viral RNA Quantification using qRT-PCR  
6.3.3.1 Comparison over the incubation period  
There were significant differences among strains at (P<0.05) for all three time points (Figure 
6.4). Viral load of all strains of IBVs showed significantly lower values between 0 and 24 
hpi, and 793B1, 793B2, 793B3 and QX1 had significantly (P<0.05) lower values at 72 hpi 
when compared to 24 hpi. There were significantly (P<0.05) lower differences at 72 hpi 
when compared to 0 hpi in all strains. 
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Figure 6.4. Quantification of viral load, values are shown in log REU (relative equivalent 
unit). Data from the three groups (A) Mass, (B) 793B and (C) QX group’s qRT-PCR time 
point comparison. Significant differences between the groups were detected by one-way 
ANOVA and values (P<0.05) are shown with different letters.  
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6.3.3.2 Comparison between strains 
In the Mass serotype, at 24 hpi there was a significantly (P<0.05) higher viral load in 
VirMass and Mass1 in comparison to the Mass2 and Mass3 serotypes. At 72 hpi, there was 
a significantly (P<0.05) higher viral load in VirMass in comparison to Mass1, Mass2 and 
Mass3. 
In the 793B serotype, Vir793B, at 24 hpi, there was a significantly (P<0.05) lower viral load 
in comparison to 793B1, 793B2 and 793B3. At 72 hpi, there were significantly (P<0.05) 
higher viral loads in Vir793B and 793B3 in comparison to 793B1 and 793B2. 
At 72 hpi, the VirQX had a significantly (P<0.05) lower viral load in comparison to QX1 
and QX2. At 72 hpi, there was a significantly (P<0.05) higher viral load in QX2 in 
comparison to QX1. 
6.3.4 Apoptotic cells in TOC rings 
Results for virulent or vaccine infected TOC rings are illustrated in Figure 6.5. Total 
apoptotic cells following infection with different IBV serotypes and differences between 
vaccines and virulent strains within the same serotype or mock infected TOCs were 
evaluated by TUNEL assay (Figure 6.6).  
At 24 hpi, there was a significant higher difference (P<0.05) in VirM41 in comparison to the 
vaccine strains (Mass1, Mass2 and Mass3). No significant differences were found between 
the Mass1, Mass2 and Mass3 and mock infected control group or between these strains.  
At 72 hpi, in the Mass serotype group there was a significant higher difference (P<0.05) in 
VirM41 in comparisons to the mock infected control group. There was a significant higher 
difference (P<0.05) in VirM41 in comparison to other vaccine strains (Mass1, Mass2 and 
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Mass3). No significant differences between Mass strains Mass1, Mass2 and Mass3 and mock 
infected control group occurred. There were no significant differences between Mass strains 
Mass1, Mass2 and Mass3. At 24 hpi and 72 hpi, the highest average number of apoptotic 
cells was found in the Mass1 group (Figure 6.5A). 
At 24 hpi, in the 793B serotype group, there was a significant higher difference (P<0.05) in 
Vir793B in comparison to the mock infected control group. There was a significant higher 
difference (P<0.05) between Vir793B and other vaccine strains (793B1, 793B2 and 793B3). 
No significant differences occurred between 793B1, 793B2 and 793B3 and the mock 
infected control group or between these vaccine strains. At 72 hpi, in the 793B serotype 
group, there was a significant higher difference (P<0.05) between Vir793 and the mock 
infected control group, and the 793B vaccine strains (793B1, 793B2 and 793B3). There were 
no significant differences between 793B1, 793B2 and 793B3 and the mock infected control 
group or between these vaccines. At 24 hpi and 72 hpi, strain 793B1 had the highest average 
number of apoptotic cells among the vaccine strains (Figure 6.5B). 
In the QX serotype group, at 24 hpi, there was a significant higher difference (P<0.05) in 
VirQX in comparisons to the mock infected control group, and against the QX vaccine 
strains (QX1 and QX2). No significant differences occurred between QX1 and QX2 and the 
mock infected control group. At 72 hpi, in the QX serotype group, the VirQX was 
significantly higher (P<0.05) in comparison to the QX vaccine strains (QX1 and QX2) and 
control group (Figure 6.5C). 
Cross-comparisons indicated that there were significantly higher differences (P<0.05) at 24 
and 72 hpi between the three virulent serotypes (VirMass, Vir793B, VirQX) in comparison 
to respective vaccines within the same serotype (Figure 6.5).  
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Figure 6.5. Total apoptotic cells in TOCs evaluated by TUNEL assay. TOCs were infected 
with IBV variant M41, 793B and QX, or with vaccine based from the virulent strains, or 
mock infected and evaluated at 24 and 72 hpi. Data from the three groups (A) Mass, (B) 
793B and (C) QX group’s apoptotic cells counts time point comparison. Data represents 
mean with error bar showing standard error. Differences between the groups were detected 
by one-way ANOVA, followed by the post-hoc LSD multiple comparison test. Significant 
differences are indicated with different letters (P<0.05). 
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Figure 6.6. In situ Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) 
staining of TOCs; (A) Mock infected 24 hpi, (B) VirMass infected at 24 hpi, (C) Vir793B 
infected at 24 hpi, (D)VirQX infected 24 hpi, (E) Mass1 at 24 hpi, (F) Mass2 at 24 hpi, (G) 
Mass3 at 24 hpi, (H) 793B1 at 24 hpi, (I) 793B2 at 24 hpi, (J)793B3 at 24 hpi, (K) QX1 at 
24 hpi and (L) QX2 at 24 hpi. Apoptosis TUNEL staining of TOCs infected with IBVs show 
multiple apoptotic cells with degeneration and loss of cilia. Arrows indicate apoptotic cells. 
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6.3.5 Host gene expression analysis 
6.3.5.1 Relative IFN-α and IFN-β mRNA expression 
6.3.5.1.1 Within each serotype mRNA IFN-α expression comparison 
In the Mass serotype, at 24 hpi, there was significant (P<0.05) down-regulation of IFN-α 
mRNA expression in the Mass1 strain in comparison to the control. There was significant 
(P<0.05) down-regulation of IFN-α mRNA expression in the Mass1 strain in comparison to 
VirMass, Mass2 and Mass3. At 72 hpi, there was significant (P<0.05) down-regulation of 
IFN-α mRNA expression in the VirMass, Mass1, Mass2 and Mass3 strains in comparison to 
the control group (Figure 6.7A). 
In the 793B serotype. At 24 hpi, there was significant (P<0.05) down-regulations of IFN-α 
mRNA expression in the Vir793B, 793B1, 793B2 and 793B3 strains in comparison to the 
control group. The Vir793B, 793B1 and 793B3 strains showed significantly (P<0.05) lower 
expression levels in comparison to 793B2 (Figure 6.6B). At 72 hpi, there were significant 
(P<0.05) down-regulations of the mRNA expression of IFN-α in the 793B1, 793B2 and 
793B3 strains in comparison to the control group. The 793B1, 793B2 and 793B3 strains 
showed significantly (P<0.05) lower expression levels in comparison to Vir793B (Figure 
6.7B). 
In the QX serotype, at 24 hpi, there was significant (P<0.05) down-regulations of the mRNA 
expression of IFN-α in the VirQX, QX1 and QX2 strains in comparison to the control group. 
There was significant (P<0.05) down-regulation of the mRNA expression of IFN-α in the 
QX2 strain in comparison to the VirQX and QX1. At 72 hpi, there were significant (P<0.05) 
down-regulations of the mRNA expression of IFN-α in the VirQX, QX1 and QX2 strains in 
comparison to the control group (Figure 6.7C).   
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Figure 6.7. mRNA expression of IFN-β within each of the genotype. (A) Mass group, (B) 
793B group and (C) QX group. Relative mRNA expression was determined by real-time 
PCR normalised to 18S mRNA. Graph values are the mean of three biological replicates 
with error bars showing standard error (n=5) and are expressed as fold change relative to the 
mocked-infected group. Significant differences between the groups were detected by one-
way ANOVA, followed by the post-hoc LSD multiple comparison test. Different letters 
indicate significant differences (P<0.05). 
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6.3.5.1.2 Within each serotype mRNA IFN-β expression comparison 
In the Mass serotype. At 24 hpi, there were significant (P<0.05) up-regulations of IFN-β 
mRNA expression in the VirMass, Mass1, Mass2 and Mass3 strains in comparison to the 
control group. There was a significantly (P<0.05) higher difference in the VirMass of IFN-
β mRNA expression in comparison to Mass1. At 72 hpi, there were significant (P<0.05) 
down-regulations of IFN- β mRNA expression in the VirMass, Mass2 and Mass3 in 
comparison to Mass1 (Figure 6.8A). 
In the 793B serotype. At 24 hpi, there were significant (P<0.05) up-regulations of IFN-β 
mRNA expression in the Vir793B, 793B1, 793B2 and 793B3 strains in comparison to the 
control group. There were significant higher differences (P<0.05) in 793B1 in comparison 
to the Vir793B and 793B3 groups. At 72 hpi, there was a significant (P<0.05) down-
regulation of IFN-β mRNA expression in the 793B1 group in comparison to the control 
group (Figure 6.8B). 
In the QX serotype. At 24 hpi, there were significant (P<0.05) up-regulations of IFN-β 
mRNA expression in the VirQX and QX1 strains in comparison to the control group. There 
was significant (P<0.05) down-regulation of IFN-β mRNA expression in the QX2 strain in 
comparison to the VirQX and QX1. At 72 hpi, there was significant (P<0.05) down-
regulation of IFN-β mRNA expression in comparison to the control group. There was 
significant (P<0.05) down-regulation of the VirQX in comparison to QX2 (Figure 6.8C).  
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Figure 6.8. mRNA expression of IFN-β within each genotype. (A) Mass group, (B) 793B 
group and (C) QX group. Relative mRNA expression was determined by real-time PCR 
normalised to 18S mRNA. Graph values are the mean of three biological replicates with 
error bars as standard error (n=5)  which are expressed as fold change relative to the mock-
infected group. Significant differences between the groups were detected by one-way 
ANOVA, followed by the post-hoc LSD multiple comparison test. Significant differences 
(P<0.05) are indicated with different letters. 
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6.3.5.2 Expression of mRNA of TLR3 and MDA5  
6.3.5.2.1 Within each serotype mRNA of TLR3 expression comparison 
In the Mass serotype. At 24 hpi, there were significant (P<0.05) up-regulations of the mRNA 
expression of TLR3 in the VirMass, Mass1, Mass2 and Mass3 strains in comparison to the 
control group. There were significantly (P<0.05) higher differences in the Mass2 and Mass3 
TLR3 expression in comparison to VirMass. At 72 hpi, there were significant (P<0.05) up-
regulations of TLR3 mRNA expression in the VirMass, Mass1, Mass2 and Mass3 in 
comparison to the control group (Figure 6.9A).  
In the 793B serotype. At 24 hpi, there were significant (P<0.05) up-regulations of TLR3 
mRNA expression in the Vir793B, 793B1 and 793B2 strains in comparison to the control 
group. At 72 hpi, there were significant (P<0.05) up-regulations of TLR3 mRNA expression 
in the Vir793B, 793B1, 793B2 and 793B3 strains in comparison to the control group (Figure 
6.9B). 
In the QX serotype. At 24 hpi, there were significant (P<0.05) up-regulations of TLR3 
mRNA expression in the VirQX, QX1and QX2 strains in comparison to the control group. 
At 72 hpi, there was a significant (P<0.05) up-regulation of TLR3 mRNA expression in 
VirQX in comparison to the control group. There were significantly (P<0.05) higher 
differences in the QX2 in comparison to VirQX and QX1. There was a significantly (P<0.05) 
higher differences in the QX1 in comparison to the VirQX (Figure 6.9C).  
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Figure 6.9. mRNA expression of TLR3 within each genotype. (A) Mass group, (B) 793B 
group and (C) QX group. Relative mRNA expression was determined by real-time PCR 
normalised to 18S mRNA. Graph values are the mean of three biological replicates with 
error bars as standard error (n=5) and are expressed as fold change relative to the mock-
infected group. Significant differences between the groups were detected by one-way 
ANOVA, followed by the post-hoc LSD multiple comparison test. Significant differences 
(P<0.05) are indicated with different letters. 
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6.3.5.2.2 Within each serotype mRNA of MDA5 expression comparison 
In the Mass serotype. At 24 hpi, there were significant (P<0.05) up-regulations of MDA5 
mRNA expression in the VirMass, Mass1, Mass2 and Mass3 strains in comparison to the 
control group. There were significantly (P<0.05) higher differences in the VirMass and 
Mass1 in comparison to Mass2 and Mass3. At 72 hpi, there was significant (P<0.05) up-
regulation of MDA5 mRNA expression in Mass1 in comparison to the control group (Figure 
6.10A).  
In the 793B serotype. At 24 hpi, there were significant (P<0.05) up-regulations of MDA5 
mRNA expression in the Vir793B and 793B1 in comparison to the control group. There were 
significantly (P<0.05) higher differences of MDA5 mRNA expression in the Vir793B and 
793B1 in comparison to 793B2 and 793B3 strain groups. At 72 hpi, there was a significantly 
(P<0.05) higher differences of MDA5 mRNA expression in 793B2 in comparison to 793B3 
(Figure 6.10B). 
In the QX serotype. At 24 hpi, there were significant (P<0.05) up-regulations MDA5 mRNA 
expression in the VirQX, QX1and QX2 strains in comparison to the control group. There 
was a significantly (P<0.05) higher difference in the QX1 in comparison to the QX2 (Figure 
10.9C).  
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Figure 6.10. mRNA expression of MDA5 within each genotype. (A) Mass group, (B) 793B 
group and (C) QX group. Relative mRNA expression was determined by real-time PCR 
normalised to 18S mRNA. Graph values are the mean of three biological replicates with 
error bars as standard error (n=5) and are expressed as fold change relative to the mock-
infected group. Significant differences between the groups were detected by one-way 
ANOVA, followed by the post-hoc LSD multiple comparison test. Significant differences 
(P<0.05) are indicated with different letters. 
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6.4 Discussion 
In this experiment, the in vitro system (TOCs) was used to an attempt to find a possible in 
vitro model for comparison of live IBV vaccines, where a number of IBV vaccines can be 
simultaneously cross-compared. Major live IBV vaccines belonging to three main serotypes, 
Mass, 793B and QX from different producers were included in this study. In addition, 
virulent IBVs belonging to the same serotype were also included for comparison. A number 
of parameters were examined including ciliostasis, time taken to reach 50% RCA, 
quantification of IBV replication, apoptosis and host innate immune responses, including 
mRNA expression of interferons (IFN-α, IFN-β) and sensing molecules (TLR3 and MDA5). 
In this study, in vitro analysis on IBV-infected TOCs has illustrated a possible experimental 
model that could distinguish the virulence between live IBV vaccine viruses. 
Relative ciliary activity (RCA) data showed that VirMass has the shortest time to reach 50 
% EP (23.8 hpi). This finding broadly supports the work of other studies in this area linking 
the pathogenesis of M41 with lesions or damage to the tracheal epithelia ( Raj and Jones 
1996b; Chhabra 2016). For all strains tested in this study, the QX2 vaccine strain took the 
longest time to reach 50% EP (46.5 hpi), which also had the highest expression of TLR3 and 
the lowest expression of IFN-α and IFN-β. Such data may emphasise that QX variants have 
a lower replication rate compared to other serotypes (Benyeda et al., 2009). As a result, it 
would take a relatively longer time to start an effective infection, as seen with previous work 
reporting QX infections of the reproductive tract and kidney rather than the respiratory tract 
(Benyeda et al., 2010; Chhabra et al., 2016).  
In this study, the virulent strains (VirMass, Vir793B and QX) and Mass1, 793B1 and QX1 
reached the 50% EP at the same time. During this experiment, at 24 hpi, a higher expression 
of MDA5 and IFN-β was detected in the previous strains, suggesting that MDA5 and IFN-β 
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are linked to pathogenicity and tissue damage and could be used as a virulence indicator in 
TOCs. 
Viral load in the media was lower at 72 hpi, compared to the point of inoculation. This may 
be due to intracellular movement of viral particles from the media (where they were added 
for infection) into the tracheal cells. Moreover, epithelial cell death could occur, as apoptosis 
is initiated as a result from virus replication (Liu et al., 2001; Fung et al., 2014), and 
apoptosis progression could impair virus proliferation, effecting viral load (Chhabra et al., 
2016). A previous study has explored the relationship between viral titre and infection 
duration in TOCs, which proved that viral titres reduced over the duration of the study; while 
the total amount of detected viral genome increased (Ball et al., 2016b).  
IBV infection modulates apoptosis by restricting activation of the extracellular signal-
regulated kinase pathway (Chhabra et al., 2016). In addition, a strong association has been 
noted between apoptosis in TOCs and respiratory lesions in chickens (Li et al., 2007). At 24 
and 72 hpi, there were significant higher differences in the total number of apoptotic cells in 
TOCs infected within the virulent serotypes but no differences between vaccines. This is 
also in accordance with earlier observation, which showed that apoptosis is associated with 
viral virulence and pathogenicity in TOCs (Chhabra et al., 2016). Notably, there were low 
numbers of apoptotic cells for all vaccine strains, which could be due to the high passage 
level or that vaccine strains require a longer time or higher dosage to produce a greater 
number of apoptotic cells.  
The expression of IFN-α showed a significant down-regulation in approximately all strains, 
which contradicts previous work when TOCs were infected with virulent M41, 885 and QX 
(Chhabra et al., 2016). Probably this is due to the fact that during infection of their host cells, 
IBVs deter the production of host proteins, in a process of shut off, which hampers host 
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proteins, limits production of antiviral proteins and increases the capacity of viral proteins 
and type I interferon (Kameka et al., 2014; Kint et al., 2016). Such a shut off has an effect 
on the level of expression of the mRNA IFN-α during the early stages of infection. 
Coronaviruses are well known to down regulate host gene expression and increase host 
mRNA degradation in order to suppress host innate immune responses (Kamitani et al., 
2006; Tohya et al., 2009). Results indicate that both the virulent and vaccine strains used in 
this study are reducing host production of IFN-α.  
At 24 hpi, there was a significant up-regulation in the mRNA expression of IFN-β from both 
variant and vaccine strains. The profile of IFN-β expression is very similar to Chhabra et al., 
(2016), where a higher level IFN-β expression was found in the early stages of infection after 
9 and 24 hpi. Interferons can activate the up-regulation of TLR3, which, in some cell types, 
induces them to become responsive to dsRNA (Karpala et al., 2008).  
Within the sampling times, the expression of TLR3 was strongly up regulated in all virulent 
and vaccine serotypes. Increased activation of this gene in this study corroborates with earlier 
findings when M41, QX and IS/885/00 serotypes were tested (Chhabra et al., 2016). It has 
been reported that TLR3 engagement is important to the outcome of viral infection due to its 
role in the induction of IFNs and the diverse antiviral effects that these molecules induce 
(Karpala et al., 2008).  
In the current study, our data showed that MDA5 mRNA expression, was significantly up 
regulated in VirMass, Mass1, Mass2, vir793B, 793B1, 793B3 and QX1 strains at 24 hpi. 
However, at 72 hpi, it was also significantly up regulated in 793B1 in comparison to the 
control and other strains. MDA5 has been reported to inhibit the growth of vesicular 
stomatitis virus and encephalomyocarditis virus (Yoneyama et al., 2005), and in influenza 
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A virus-infected epithelial cells, it has also been demonstrated that expression of MDA5 lead 
to the stimulation of the IFN-β (Siren et al., 2006). 
Considering our data, we observe there was a robust relationship between expression of 
TLR3, IFN-β and MDA5 for both variant and vaccine infected TOCs. Further studies are 
needed to strengthen this relationship, in conjunction with in vivo work to establish other 
pathways for determining the innate responses towards IBV infection of differing virulence. 
In this study there is an association between MDA5 and IFN-β with the 50% EP and 
apoptosis, where all were associated with increase in virulence. The opposite results were 
found in the QX2 strain, which has the longest time to reach the 50% EP, showing no change 
in IFN-β expression and a lower expression of MDA5 within the QX serotype. It is therefore 
likely that MDA5 and IFN-β mRNA expression coincides with ciliostasis of TOCs.  
In conclusion, it appears that IBV infection of TOCs was a representative in vitro method 
for exploration of the pathogenesis of IBV infection, and it is valuable in differentiating 
virulence between the IBV viruses. The use of TOCs for an IBV pathogenesis study has been 
shown to be practical and beneficial to markedly reduce the numbers of birds used for in vivo 
studies. The TOC is applicable and analogous to in vivo work, helping to reduce the number 
of required animal model experiments and work towards the 3Rs, (Reduction, Replacement 
and Refinement). 
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Chapter 7: Assessment of virulence and innate immune 
responses following administration of infectious bronchitis 
vaccine viruses in specific pathogen free chicks 
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Abstract  
Following inoculation of different infectious bronchitis virus (IBV) vaccine strains in 
specific pathogen free (SPF) chicks, the pathobiology was evaluated in conjunction with the 
host immune responses (innate, local, humoral and cellular). Four attenuated live IBV 
vaccines Mass1, Mass2, 793B1 and 793B3 were administered by the oculo-nasal route and 
chicks were monitored daily for clinical signs. At 1, 3, 5, 7, 9 and 14 days post infection 
(dpi), oropharyngeal (OP) and cloacal (CL) swabs were collected for virus detection, and 
blood was collected for antibody quantification. Necropsy was carried out on 1, 3. 5, 7, 9 
and 14 dpi, with gross lesions observed and tracheal tissues collected for qRT-PCR, 
CD4+:CD8+ ratio, immunohistochemistry, histopathology and innate immune gene 
expressions. Variations in the virulence were found. Clinical signs were found in all 
vaccinated groups. Viral load was lower in the 793B3 group at 5-7 dpi, compared to other 
groups. Higher expression of IFN-β was seen at 3 dpi in 793B groups, whereas 793B1 
showed a lower expression of TLR3 at 5-7 dpi compared to other groups. Down-regulation 
of IL-6 was seen at 7-9 dpi in all inoculated groups (not Mass2). Lachrymal IgA increased 
at 14 dpi in all groups. There was higher up-regulation of IFN-γ at 7-9 dpi in Mass2 and 
Mass2 compared to the control and 793B1 and 793B3. There was higher up-regulation in 
IgG expression in the Mass2 and 793B at 7-9 dpi. The 793B1 inoculated groups 
demonstrated higher cell mediated immune responses, represented by higher CD8β gene 
expression in the period of 5-9 dpi, higher counting of CD4+ and CD8+ at 14 dpi, and higher 
CD4:CD8 ratio at 7 and 14 dpi. The in vivo study has shown a high level of agreement with 
the in vitro findings, where the 793B 1 demonstrated the highest virulence among the tested 
IBV vaccines. 
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7.1 Introduction  
Since the first vaccine was developed against Massachusetts serotype, a number of other 
vaccines from other serotypes were introduced for higher and better protection against 
classical and variant IBVs. The most widely used live IBV vaccines, such as H52/H120/Ma5 
are derived from the Massachusetts serotype (Bijlenga et al., 2004; Jackwood and de Wit 
2013; Zhou et al., 2016).  Other common live vaccines belonging to Dutch (eg. D274), 793B 
(e.g. 4/91, CR88 and 1/96) and QX strains have been reported in poultry-producing countries 
(Jones 2010; Ball et al., 2016a). Vaccination is an efficient way to prevent and control 
disease and production losses caused by IBV infection. Following vaccination large numbers 
of T and B cells and plasma cells are found in the trachea (Matthijs et al., 2009). Responses 
in the lung and upper and lower trachea are comparable and do not seem to be location 
dependent (Reemers et al., 2009b). Many researchers outlined distinct categories of innate 
immune response often observed in either IBV vaccination or infection, such as IFNs, TLRs, 
MDA5, and pro-Inflammatory cytokines (Okino et al., 2013; Śmiałek et al., 2016; Okino et 
al., 2017a; Chhabra et al., 2018).  
There is a growing body of literature that recognises the importance of local and cellular 
immune responses in the trachea and lachrymal fluid after IBV vaccine inoculation, either 
with or without challenge. It has been shown that such immune responses are dose dependant 
(Okino et al., 2013). No previous research has been conducted to monitor a number of 
vaccine strains from the same serotype, particularly measuring the local, cellular and 
humoral immunity at the molecular level (Okino et al., 2013; Zhang et al., 2017). This study 
was carried out to examine the host responses of tracheal tissue, tracheal washes and 
lachrymal fluid to inoculated vaccines (belong to Mass or 793B serotypes) based on 
monovalent vaccine application viruses in SPF chicks. 
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7.2 Materials and methods 
7.2.1 Vaccine viruses 
In this experiment, four different vaccine strains belonging to two serotypes were used; see 
Chapter 6 (in vitro work); Mass1 and Mass2 (H120 or Ma5) and 793B1 and 793B3 (CR88 
or 4/91). All four vaccines were passaged once in embryonated SPF eggs (Chapter 2) and 
titrated in TOCs (Cook et al., 1976a) (Chapter 2.6). Titres were determined according to the 
Reed-Muench method (Reed 1938) and expressed as cilliostasis dose 50 (CD50) (Chapter 6).  
7.2.2 Chicks 
Day-old SPF chicks were hatched at Leahurst Campus, Liverpool University. All birds were 
housed in an animal house, reared on deep litter, and feed and drinking water were given ad 
libitum (Chapter 2.1).  
7.2.3 Experimental design 
Two hundred day-old SPF chicks were split into five groups (n=40 chicks/group) and 
vaccinated via the oculo-nasal route with 104.5 CD50 as follows: Group 1 = Mass1, Group 2 
= Mass2, Group 3 = 793B1, Group 4 = 793B3 and Group 5 = mock infected control group. 
All groups were maintained in separate, isolated rooms. Lachrymal fluid, blood and tracheal 
washes were collected from five birds on 0, 7 and 14 days post inoculation (dpi). At 1, 3, 5, 
7 and 9 dpi the tracheas were collected for qRT-PCR and host gene analysis. The lachrymal 
fluid and serum samples were stored at -20 °C and blood samples were processed 
immediately for peripheral blood mononuclear cells isolation. For immunohistochemistry, 
to count CD4+ and CD8+ cells, the middle section of the trachea after post-mortem was 
placed in OCT and snap-frozen in liquid nitrogen. Another tracheal portion was collected in 
RNALater and stored at -20 °C until further processing for detection of viral load and host 
innate genes.  
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From each group, lachrymal fluid was collected from five birds at each sampling interval. 
Approximately 90-100 µl of lachrymal per bird was collected in 0.5ml Eppendorf tubes using 
a micropipette and stored at -20 °C for later use.  
7.2.4 RNA extraction  
7.2.4.1 Tracheal tissue 
 Samples were collected in RNA later50 and stored at -20 °C. RNA extraction was carried out 
on 30 mg of trachea using the RNeasy Mini Kit51 according to manufactures instructions for 
total RNA extraction (Chapter 2.14). 
7.2.4.2 Tracheal washes and lachrymal fluid 
Viral RNA was extracted from 150µl of trachea washes after centrifugation at 3000 g for 10 
min, using the QIAamp viral RNA Mini Kit (Qiagen, UK), according to the manufacturer’s 
instructions. Lachrymal fluid was pooled and RNA extracted from 80-100 µl (Chapter 2.13). 
7.2.5 IBV RT-PCR partial S1 
IBV RT-PCR was conducted as previously described (Worthington et al., 2008) (Chapter 
2.15). 
                                                 
 
 
50 Qiagen, Manchester, UK 
51 Qiagen, Manchester, UK 
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7.2.6 Real-time RT-PCR 
Quantification of extracted viral RNA was done by quantitative real-time RT-PCR (qRT-
PCR) using IBV 3’untranslated region (UTR) gene-specific primers and probes as described 
previously (Jones et al., 2011) (Chapter 2.18). 
7.2.7 Measuring IgA in the lachrymal fluid and mRNA expression of IgA from tracheal 
washes 
Lachrymal fluid samples were centrifuged at 3000 g for 10 m and the supernatant were stored 
at -20°C until used for ELISA. Following the manufacturer’s instructions, assessment of 
immunoglobulin A (IgA) in the lachrymal fluid was carried out using IgA chicken ELISA 
kit (Abcam, UK).  
Samples were incubated for 10-15 m at room temperature, vortexed and diluted to 1:25. Each 
sample (100 µl) was added to a 96-well immunoplate, pre-coated with anti-IgA antibodies, 
and incubated for 20 minutes at room temperature (22-26°C). Then, unbound samples were 
removed in a wash step using PBS. Anti-chicken IgA antibodies conjugated with horseradish 
peroxidase (HRP) were then added to the plate and incubated for 20 min at room temperature, 
followed by another wash step. The enzyme complex was quantified by adding 3, 3’, 5, 5’ - 
tetramethylbenzidine (TMB) substrate (100 µl). The reaction was stopped by adding stop 
solution (100 µl) for 10 min and absorbance was measured at 450 nm using a multi plate 
reader. The quantity of IgA in the test sample was interpolated from a standard curve 
constructed from the standards, and corrected for sample dilution according to the 
manufacturer’s guidelines. 
Tracheal washes were collected at 7 and 14 dpi for measuring the IgA mRNA expression 
antibody titres. In brief, using two sterile artery forceps, clamped trachea was collected from 
glottis to syrinx and washed with PBS using 0.5-1 ml by syringe with 19 gauge needle. The 
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collected samples were centrifuged at 3000 x g for 5 min and supernatant was collected for 
RNA extraction QIAamp viral RNA Mini Kit (Qiagen, UK) (Ganapathy et al., 2005). 
7.2.8 Enzyme Linked Immunosorbent Assay (ELISA) 
Sera samples were processed using a commercial IBV ELISA kit (IDEXX, USA) according 
to manufacturer instructions (Chapter 2.20). Sample/positive ratio (S/P) ratios were 
calculated and expressed as the mean serum anti-IBV antibody. 
7.2.9 Host gene expression analysis 
Samples of trachea was analysed for expression of mRNA of IFN-α, IFN-β TLR3, MDA5, 
IL-1β and IL-6, and results were compared against the control birds (mock infected), 
expressed as fold change relative to the 18S reference gene. Quantitative reverse 
transcription PCR (qRT-PCR) of cDNA was carried out using Light Cycler® 480 in 
triplicate (Table 7.1; Chapter 2.19). For IFNγ, CD8β, Myeloid differentiation primary 
response gene 88(MYD88), IgA and IgG, the calculation of fold change were carried out as 
previously described (Livak and Schmittgen 2001; Okino et al., 2017a), using 18S as a 
reference gene.  
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Table 7.1. Sequence of primers used in RT-qPCR for relative quantification of gene 
expression. 
 
7.2.10 Cellular immune response  
7.2.10.1 T lymphocyte (CD4+:CD8a+) ratio from blood 
Immediately after pentobarbitone intravenous injection, blood was collected from chicks in 
5 ml tubes contain heparin52 10 USP/ml (United States Pharmacopeia) of blood. Once in the 
laboratory, it was diluted (1:1) with RPMI 1640 medium53 (Roswell Park Memorial 
Institute). Subsequently, 1 ml of prepared blood was over layered on to 0.5 ml of Histopaque 
- 1.077 gradient54 and centrifuged in a 1.5 ml Eppendorf tube for 90 sec at 10,000 rpm at 
room temperature. Mononuclear cells formed a buffy coat which was gently collected and 
washed twice with RPMI 1640 medium. Cells were re-suspended in 0.5% Bovine serum 
                                                 
 
 
52 Sigma, Gillingham, Dorset, UK 
53 R8758, Sigma Aldrich, Gillingham, Dorset, UK 
54 10771, Sigma Aldrich, Gillingham, Dorset, UK 
Oligonucleotide Sequence Length Reference 
    IFNγ( F) 5’ AGCCGCACATCAAACACATA 3’ 20 (Okino et al., 2017a) 
    IFNγ( R) 5’ AAGTCGTTCATCGGGAGCTT 3’ 20  
  MYD88( F) 5’ AGAGTTGGAGCAAACGGAGTTC 3’ 22 (Okino et al., 2017a) 
  MYD88( R) 5’ CATCCTCCGACACCTTCTTTCT 3’ 22  
CD8β( F) 5’ CTGCATGGCTCCGACAATGG 3’ 20 (Okino et al., 2017a) 
CD8β( R) 5’ ATCGACCACGTCAAGCTGGG 3’ 20  
ChIgA( F) 5’TGCAGGGCAATGAGTTCGTCTGTA 3’ 24 (Ndegwa et al., 2012) 
ChIgA( R) 5’AGGAGGTCACTTTGGAGGTGAAT 3’ 23  
ChIgG( F) 5 GACGAAGCTT TTCCTCTTCT’3’ 20 (Zheng et al., 2001) 
ChIgG( R) 5’ CCCGATTGTA CCCTCTATCG 3’ 20  
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albumin (BSA)55 in PBS (blocking solution) and incubated at room temperature for 15 min 
and samples were allocated in 100μl. Samples were incubated with antibodies against surface 
domains at 0.2 μl per 100 μl of sample for 30 min in the dark. Targets included chicken CD4 
(mouse anti-chicken CD4-FITC (Fluorescein Isothiocyanate) clone CT-4, 8210-02, Southern 
Biotech) and CD8 (mouse anti-chicken CD8a-FITC clone CT-8, 8220-02, Southern Biotech) 
receptors of T-lymphocytes (Appendix). After a final washing in PBS, the samples were 
fixed in 200 μl of 2% paraformaldehyde in PBS. The CD4+ and CD8+ lymphocytes were 
measured using a flow cytometer56. Negative unstained cells were used to adjust the 
threshold.  
 
7.2.10.2 Detection of CD4+ and CD8+ cells by immunohistochemistry 
Tracheal samples were cut into 5 μm sections on poly-l-lysine-coated glass slides57 using a 
cryostat58. Sections were fixed in cold acetone for ten minutes and air dried for a further ten 
minutes. To each slide, 0.03% hydrogen peroxide in PBS was added for 20 minutes to inhibit 
endogenous peroxidase. Following inhibition, the VECTASTAIN Elite ABC kit 59 was used 
to block endogenous biotin or biotin-binding proteins. Then, mouse monoclonal antibodies 
                                                 
 
 
55 A9418, Sigma Aldrich, Gillingham, Dorset, UK 
56 BD Accuri C6, San Jose, CA, USA 
57 631-0107, VWR International, Leuvan 
58Leica CM 3050 S; Leica Microsystems, Heidelberger, Germany  
59 PK-6100, Vector Laboratories, Burlingame, USA 
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against chicken CD4+ and CD8a at 1:1000 (Southern Biotechnology Associates 60) was 
added and incubated overnight at 4ºC in the dark to detect CD4+, CD8a+ cells. Slides were 
washed and avidin-biotinylated horseradish peroxidase reagent61 was added to the slides for 
30 minutes. Finally, peroxidase substrate kit DAB62 was added to each slide, followed by a 
counterstain with haematoxylin63 and mounted with DPX (dibutyl phthalate, polystyrene 
granules and xylene) neutral mounting medium. Five sections were randomly selected for 
counting positive stained cells under the light microscope (400 × magnifications). The final 
average was obtained for each slide after calculating the total positive cells/400× 
microscopic fields (Appendix).  
7.2.11 Statistical analysis 
Data were analysed using GraphPad Prism version 7 with one-way ANOVA, followed by 
the LSD for parametric data and Kruskal–Wallis followed by Dunn’s tests for non-
parametric data. Differences were considered significant at p < 0.05 (Chapter 2.22).  
7.3 Results  
7.3.1 Clinical signs and gross lesions  
In the control group, there were no clinical signs observed during the period of the 
experiment. In all inoculated groups, there were mild respiratory signs, such as snicking and 
                                                 
 
 
60 Southern Biotechnology Associates, Birmingham, AL, USA 
61 VECTASTAIN ABC kit, Burlingame, USA 
62 SK-4100,Vector Laboratories, Burlingame, USA 
63 1.09234, Merck, Darmstadt, Germany 
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head shaking, starting from 3 dpi (more prominent in the 793B1 group) and lasted to the end 
of the experiment (Figure 7.1). There were no gross lesions in the control group, with only 
mild tracheal congestion seen for the inoculated groups (more prominent for the 793B1 
group). At 9 dpi, for one bird in the 793B1 group, there was transparent serous to caseous 
exudate in the trachea and the infraorbital sinuses. 
 
 
Figure 7.1. Onset and duration of clinical signs in the inoculated and control groups.  
 
 7.3.2 Histopathological changes  
No histological changes were found in the control group. There were minor histopathological 
tracheal lesions in the inoculated groups, mainly consisting of a small amount of deciliation 
and lymphocyte infiltration. However, these changes were substantially greater in the Mass1 
and 793B1 inoculated groups, especially at 5–14 dpi (Figure 7.2).  
 
 
 
No signs 
Mild signs 
 
3 
1 
1 
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Figure 7.2. Means of histopathological scores of lesions in the trachea in the vaccinated 
groups. Significant differences between the groups were examined by the Kruskal–Wallis 
test, followed by Dunn’s mean test (p < 0.05). There were no significant differences between 
the vaccine virus inoculated groups. Data represented by mean with stander errors (n=5). 
 
7.3.3. IBV virus detection from OP and CL swabs using RT-PCR 
The virus was detected by RT-PCR in the OP and CL swabs from all vaccinated groups at 
all sampling days, except Mass1 and Mass2 at 1 dpi from CL swabs.  
7.3.4. IBV virus detection from OP swabs using qRT-PCR 
No virus detected in the control group. Viral load was at detectable levels from pooled OP 
swabs at all sampling days (1–9 dpi) using qRT-PCR in all inoculated groups. The Mass1 
and 793B1 groups had the highest averages at 1 dpi, with quantifications decreasing on 
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subsequent sampling points. Interestingly, viral load increased in all groups on 7 dpi, only to 
decrease again on 9 dpi (Figure 7.3). 
 
Table 7.1. Virus detection by partial S1 RT-PCR from OP and CL swabs of inoculated 
groups on all sampling days and from both swabs 
 
 
 
 
 
 
        Mass1     Mass2 
 
       793B1          793B3 
 
dpi OP CL OP CL OP CL OP CL 
1 + - + - + + + + 
3 + + + + + + + + 
5 + + + + + + + + 
7 + + + + + + + + 
9 + + + + + + + + 
14 + + + + + + + + 
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Figure 7.3. Quantification of infectious bronchitis virus (IBV) from OP swabs, expressed as 
log10 REU of RNA following infection in day-old chicks. Data presented as mean of 10 
swabs collected at each sampling day. 
7.3.5 IBV RNA detection from tracheal tissue using qRT-PCR 
Viral RNA was detected in tracheal tissue for all sampling days; however, each group 
showed a different pattern (Figure 7.4A). In the Mass1 and Mass2 groups, there were 
significantly (p < 0.05) higher differences in the period of 1–7 dpi compared with 9 dpi. 
Between the Mass1 and Mass2 vaccines, there were no significant differences in the viral 
load at 3, 5, 7 and 9 dpi. The Mass2 vaccinated viral load was significantly (p < 0.05) higher 
than that of Mass1 at 1 dpi. 
In the 793B1 group, there was a significantly higher differences (p < 0.05) in the period of 
1, 5, 7 dpi compared with 2 and 9 dpi (Figure 8.5A). At 1 dpi, the Mass1 group was 
significantly (p < 0.05) lower than the other groups, while at 5 and 7 dpi, the 793B3 showed 
a significantly lower viral load. Between the 793B vaccines, there were significantly (p < 
0.05) higher levels in 793B1 at 5 and 7 dpi (Figure 7.4B). 
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Figure 7.4. Quantification of infectious bronchitis virus (IBV) expressed as log 10REU of 
RNA in the trachea by real-time RT-PCR following infection in day-old chicks. (A) Within 
each strain at 1-9 dpi. (B) Within strains at each sampling day. (n = 5; significant differences 
indicated with different letters, p < 0.05). Significant differences were determined using 
ANOVA.  
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7.3.6 Local and humoral immunity 
7.3.6.1 Measurement of lachrymal antibodies (IgA) by ELISA: 
 The IgA titres from lachrymal fluid showed no statistical difference among the groups at 7 
and 14 dpi. The titre was significantly higher (p < 0.05) at 14 dpi compared with 7 dpi in all 
inoculated groups (Figure 7.5A). 
7.3.6.2 mRNA expression of IgA in the lachrymal fluid:  
From the three pooled samples, no significant differences were found among the groups. 
There was up-regulation in the mRNA expression of IgA in the lachrymal fluid at 7 and 14 
dpi. The Mass2 vaccine showed the highest expression of IgA compared with the other 
inoculated groups (Figure 7.5B).  
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Figure 7.5. Measurement of IgA titre using ELISA and relative mRNA expression from the 
lachrymal fluid. (A) Mean IgA from tears at 7 and 14 dpi, data expressed as mean (ng/ml). 
(B) Relative mRNA expression of IgA in the lachrymal fluid, expressed as fold changes 
divided by the control non-infected group at 7 and 14 dpi. Significant differences are 
indicated with different letters (n=5). Significant differences were determined using 
ANOVA. 
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7.3.6.3 IgA expression from tracheal washes:  
There was no significant upregulation (p > 0.05) in IgA mRNA gene expression for all 
timepoints (Figure 7.6A).  
7.3.6.4 IgA expression from the tracheal tissue: 
 In the tracheal tissue, there was higher up-regulation in the mRNA of IgA starting from 1–
9 dpi in all inoculated groups in comparison to the control group. At 7–9 dpi, the Mass2 and 
793B3 inoculated groups were significantly (p < 0.05) higher compared with Mass1 and 
793B1 (Figure 7.6B). 
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Figure 7.6. Relative mRNA expression of IgA in the tracheal washes and trachea. (A) IgA 
mRNA expression in the trachea washes at 7 and 14 dpi. (B) IgA mRNA expression in the 
tracheal tissues at 1–9 dpi. Data is expressed as fold change compared to the control group 
(n=5). Significant differences are indicated with different letters. Significant differences 
were determined using ANOVA. 
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7.3.6.5 IgG mRNA expression from lachrymal fluid: 
Higher up-regulation of IgG mRNA expression was detected in the Mass1 and Mass2 
groups, up to 10 times greater than that of the other vaccinated groups, at 7 dpi. At day 14, 
mRNA expression of IgG was up-regulated to similar levels in all groups, without any 
significant differences between them, which was up to 100 times that of the control group 
(Figure 7.7A). 
7.3.6.6 Anti-IBV-specific antibody titre using ELISA (systemic Ab): 
There were no significant differences (p > 0.05) between the inoculated groups at 7 and 14 
dpi for serum IgG (Figure 7.7B).  
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Figure 7.7. Relative mRNA expression of IgG and IgG anti-IBV titre in the lachrymal fluid 
and serum. (A) mRNA expression of IgG in the lachrymal fluid expressed as fold change 
divided by the control non-infected group at 7 and 14 dpi (n=5). (B) Mean IgG serum level 
expressed as mean S/P ratio at 7 and 14 dpi. Significant differences were determined using 
ANOVA. Different letters indicate significant differences. 
7.3.6.7 IgG expression from tracheal washes: 
Expression of IgG mRNA was up-regulated at 7 and 14 dpi in all inoculated groups with 
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peak expression levels, which was higher in the Mass1 and 793B1 groups than the other 
inoculated groups and up to 20 times more than the control group (Figure 7.8A).  
7.3.6.8 IgG expression from tracheal tissue:  
Expression of IgG mRNA was up-regulated early at 3 dpi in the Mass1 and 793B1 groups 
compared with the other vaccinated groups. At 3-5 dpi, there was higher significant changes 
(p < 0.05) in the Mass2 and 793B3 groups in comparison to the other inoculated groups. The 
highest up-regulation was at 7–9 dpi in all vaccinated groups, with Mass2 having the highest 
up-regulation (Figure 7.8B). 
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Figure 7.8. Relative mRNA expression of IgG in the trachea and tracheal washes. (A) IgG 
mRNA expression in the trachea washes at 7 and 14 dpi. (B) IgG mRNA expression in the 
trachea at 1–9 dpi expressed as fold change divided by the control non-infected group. 
Graphed values are the mean with error bars as standard error and are expressed as fold 
change relative to the mocked-infected group (n=5). Significant differences between the 
groups were detected by one-way ANOVA. Different letters indicate significant differences. 
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7.3.7 Innate immune responses in the trachea 
The host innate immune responses were evaluated by assessing the mRNA expressions of 
IFN-α, IFN-β, MYD88, TLR3 and MDA5 of the tracheal tissues. 
7.3.7.1 Relative IFN-α, IFN-β and MYD88 mRNA expression 
No significant upregulation (p < 0.05) was seen in the mRNA expression of IFN-α at any 
sampling interval (Figure 7.9A). There was significantly higher up-regulation (p < 0.05) in 
IFN-β mRNA expression at 3 dpi for the 793B1 and 793B3 groups compared with the other 
inoculated groups (Figure 7.9B). There was up-regulation in the mRNA expression of 
MYD88 gene in all inoculated groups in comparison with control group. No significant 
differences were seen among inoculated groups, where 793B1 had the highest expression for 
all the sampling days (Figure 7.9C). 
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Figure 7.9. Relative expression of innate immune response mRNA genes in tracheal samples 
experimentally inoculated with IBV vaccines or mock-infected chicks. (A) IFN-α, (B) IFN-
β, (C) MYD88; different letters indicate significant differences (p < 0.05). Graphed values 
are the mean with error bars as standard error and are expressed as fold change relative to he 
mocked-infected group(n=5). Significant differences between the groups were detected by 
one-way ANOVA. 
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7.3.7.2 TLR3 and MDA5 mRNA expression 
There was up-regulation in the mRNA of TLR3 in all inoculated groups at 1–7 dpi, which 
was significant (p < 0.05) at 5 and 7 dpi compared with the control group (Figure 7.10A). 
The Mass1, Mass2 and 793B1 groups were significantly higher when compared with the 
793B3 group at 5 and 7 dpi. For the MDA5 mRNA, there were significant up-regulation (p 
< 0.05) at all sampling days when compared with the control group. Among the vaccinated 
groups, the 793B3 and 793B1 groups were significantly higher (p < 0.05) at 3 and 5 dpi 
respectively, when compared to the other vaccine groups (Figure 7.10B).  
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Figure 7.10. Relative expressions of sensing molecules for mRNA genes in tracheal samples 
after infection. (A) TLR3 mRNA expression and (B) MDA5 mRNA expression; different 
letters denote significant differences (p < 0.05). Graphed values are the mean with error bars 
as standard error and are expressed as fold change relative to the mocked-infected 
group(n=5). Significant differences between the groups were detected by one-way ANOVA. 
7.3.7.3 Proinflammatory cytokine responses in the trachea 
There were no significant changes in the levels of IL-1β gene expression at any timepoints, 
with the exception of the Mass1 group, which was significantly (p < 0.05) down-regulated 
at all sampling days compared with the control and other inoculated groups (Figure 7.11A). 
At 3 and 5 dpi, significant (p < 0.05) down-regulation in the mRNA expression of IL-6 was 
seen in the Mass1-inoculated group compared with the control and other inoculated groups. 
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At 5 dpi, there was significantly (p < 0.05) higher up-regulation in the 793B1-inoculated 
group compared with the control and other inoculated groups. There was significant down-
regulation (p < 0.05) at 7 and 9 dpi in the Mass1, 793B1 and 793B3 groups compared with 
the control non-infected group (Figure 7.11B). 
 
 
Figure 7 .11. Relative expression of proinflammatory mRNA gene expression in tracheal 
samples from inoculated or mock-infected chicks. (A) IL-1β, (B) IL-6 in tracheal samples; 
different letters denote significant differences (p < 0.05). Graphed values are the mean with 
error bars as standard error and are expressed as fold change relative to the mocked-infected 
group(n=5). Significant differences between the groups were detected by one-way ANOVA. 
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7.3.8 Cell-mediated immune responses in the trachea 
The mRNA expressions of IFN-γ and CD8+, and changes in the CD4+:CD8+ ratio, together 
with the immunohistochemistry counts of CD4 and CD8, were evaluated from either the 
trachea or blood. 
7.3.8.1 mRNA expression of type IFN-γ and CD8+ 
There was over-expression of IFN-γ mRNA in all inoculated groups on all sampling days 
compared with the control group. At 1–7 dpi, there was significantly (p < 0.05) higher up-
regulation in the Mass1, Mass2 and 793B3 groups compared with the 793B1 group. At 7–9 
dpi, there was significantly (p < 0.05) higher up-regulation in the Mass groups compared 
with the 793B groups (Figure 7.12A). 
There was over-expression of CD8β mRNA in all the inoculated groups on all sampling days 
compared with the control group. At 1, 5 and 7 dpi, there was significant up-regulation (p < 
0.05) in the Mass1, 793B1 and 793B3 groups compared with the Mass2 group. At 9 dpi, 
there was significant up-regulation (p < 0.05) in the 793B1 group compared with the Mass1, 
Mass2 and 793B3 groups (Figure 7.12B).  
7.3.8.2 Immunohistochemistry counts of CD4+ and CD8+ 
There were no significant differences in the CD4+ and CD8+ counts at 7 dpi in all the 
inoculated groups compared with the control group. However, at 14 dpi, the counts were 
significantly (p < 0.05) higher among the inoculated groups compared with the control group. 
At 14 dpi, the average total number of CD4+ cells was significantly (p < 0.05) higher in the 
Mass1, Mass2 and 793B1 groups compared with the control group. In the 793B1 group, the 
average total number of CD4+ cells was significantly (p < 0.05) higher compared with the 
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other inoculated groups. The CD4+ counts were significantly (p < 0.05) higher in Mass1 
compared with Mass2. 
At 14 dpi, the average total number of CD8+ cells was significantly (p < 0.05) higher in the 
Mass1, Mass2 and 793B1 groups compared with the control group. In the 793B1 group, the 
average number of CD8+ cells was significantly (p < 0.05) higher compared with the other 
inoculated groups. The average number of CD8+ cells was significantly (p < 0.05) higher in 
the 793B1 group compared with the 793B3 group. No differences were found in the Mass 
groups (Figure 7.12C and Figure 7.13). 
7.3.8.3 Mean CD4+: CD8+ T ratio in blood samples 
There were no statistically differences in the CD4+ and CD8+ T ratios in the peripheral blood 
among the groups. At 14 dpi, all inoculated groups had a higher ratio compared to the control 
group (Figure 7.12D), whereas at 7 and 14 dpi, the 793B1 group had a non-significant 
increase of CD4+ and CD8+ in comparison with the other groups.  
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Figure 7.12. Cell-mediated immune responses in the trachea and blood. (A) Relative 
expression of IFN-γ in the trachea. (B) mRNA expression of CD8β gene in the trachea. (C) 
Total counting of CD4+and CD8+ cell using immunohistochemistry from the trachea. (D) 
Mean CD4+: CD8+ T ratio in blood samples using the flow cytometer in different groups at 
7 and 14 dpi. Significant differences at different timepoints was determined using by 
ANOVA (as p < 0.05) in comparison with the control group (n=5). Different letters denote 
significant differences (p < 0.05). 
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Figure 7.13. Immunohistochemical detection of CD8+ cells; (A) control group at 7 dpi (B) 
Mass1 inoculated group, 7 dpi. (C) Mass2 inoculated group, 7 dpi (D) 793B3 inoculated 
group, 7 dpi. (E) 793B1 inoculated group, 7 dpi. (F) 793B1 inoculated group, 14 dpi. 
Magnification = 400x. Arrows indicate positive cells. 
 
7.4 Discussion  
It is well known that IBVs mainly replicate in epithelial cells of the bird’s upper respiratory 
tract, leading a series of processes, including pathogen recognition and robust immune 
responses, often resulting in tissues damages reflected by pathology and clinical signs. The 
underlying mechanisms such as host innate immune responses, to date, have not been well 
investigated. Few reports are available on innate immune responses following either virulent 
infection (Okino et al., 2017a) or vaccine inoculation (Smialek et al., 2017). These 
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publications reported variable results, possibly due to differences in the virulence of viruses 
used (Chhabra et al., 2018), dosages applied (Okino et al., 2013) or the particular chicken 
lines used in the studies (Smith et al., 2015). In the current study, the pathobiology and innate 
immune responses were assessed following oculonasal application of four common but 
widely used live vaccines (Mass2, Mass1, 793B3, 793B3) in day-old SPF chicks. 
In this study, mild respiratory signs were accompanied by mild histopathological lesions in 
the trachea. Such changes may associated with the virulence levels of these live vaccine 
viruses (see Chapter 6, TOC). Similar to the current study, the histological changes 
frequently reported after IBVs infection in SPF chicks such as virulent M41(Chhabra et al., 
2018) and 793B(Chhabra 2016).   
Tracheal viral load differed, depending on the vaccine strain. Within-period comparisons 
showed a significantly greater increase in Mass2 and Mass1 at 1–7 dpi compared with 9 dpi. 
Moreover, 793B3 demonstrated a lower viral load at 3 and 9 dpi compared with the other 
sampling days. Despite the same inoculation dose, 793B3 infected trachea had a much 
significant lower viral load compared to other groups in the period of 5–7 dpi. With this, 
there was also lower mRNA expression of IL-1β at 1–9 dpi and the lowest MDA5 expression 
at 5 and 9 dpi compared with the levels in the other inoculated groups. This suggests that 
with greater virus proliferation, there are higher innate immune responses at the molecular 
level. It is well known that virulent 793B strains are acknowledged for their diverse antigenic 
structures, pathogenicity levels and tissue tropisms (Cook et al., 1999). In the in vitro work, 
it was explained that 793B3 has a late RCA 50% time point, indicating a lower proliferation 
rate and less virulence. 
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In this study, data revealed upregulation in MYD88 gene expression in the period of 1–9 dpi 
for all the inoculated groups. These results is similar to those of Okino et al., (2017), who 
also found up-regulation in this gene up to 8 dpi; however our vaccine strains induced a 
lower fold change compared to the virulent strains used by Okino et al., (2017). This 
discrepancy suggests that expression likely associated to IBV virulence. This gene (MYD88) 
is one of several involved in signal transduction, resulting in the production of IFN-β (Schat 
et al., 2014). At the end of activating MYD88, macrophage inflammatory protein(MIP)-1β, 
IL-12, IL-8, IL-6 and IL-1β become activated by the cytokine cascade, normal T cells 
expressed and secreted (RANTES) are expressed (He et al., 2016). 
A key finding from this study is that up-regulation of IFN-β, TLR3 and MDA5 mRNA 
expression occurs in the period of 1–9 dpi, with greater expression in the primary stage of 
inoculation at 1–5 dpi. It has been found that these cytokines and PRRs (TLR3 and MDA5) 
are activated with either IBV infection or vaccination (Wang et al., 2006; Kameka et al., 
2014; Zhang et al., 2017). Such findings support the theory that TLR3 pathways are 
stimulated by all IBVs, however more so for virulent strains, initiating greater production of 
IFN-β through TIR-domain-containing adapter-inducing interferon-β (TRIF) (He et al., 
2016). 
In all the groups, the highest average IgA titre from the lachrymal fluid was observed at 14 
dpi, suggesting the delay in humoral immune response is due to B lymphocyte recruitment, 
which are the main precursor of this antibody isotype. Similar patterns were found for H120 
(Okino et al., 2013) and H120+CR88 vaccines (Chhabra et al., 2015b). Lachrymal fluid–
specific IgA antibodies to IBV is reported to indicate immune status against challenge in the 
field (Toro and Fernandez 1994). In this study, lachrymal fluid IgA antibody levels were 
highest when compared with this immunoglobulins levels tested from tracheal washes and 
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tracheal tissue. This suggests the importance of the Harderian gland (HG) in contributing to 
local immunity through IgA immunoglobulin production. Oculonasal inoculation potentially 
results in a robust local immunity present in the HG, originating from the higher IBV 
exposure, although in the HG the viral load was not investigated in the current study. 
Expression of mRNA of IgA from tracheal tissue was significantly higher in the Mass2 and 
793B3 groups at 7–9 dpi compared to other inoculated groups, as well as grater expression 
compared to the other groups from the tracheal washes at 7 dpi, in the Mass2 group. This 
increase might be associated with resistance factors that are present in White Leghorn lines, 
such as line C, but not line 151, despite having similar average IgG levels over a certain time 
period after infection with M41 (Cook et al., 1992). In the tracheal washes, a similar increase 
of IgA antibody has been reported in broiler chickens vaccinated with either Ma5 or Ma5 
combined with 4/91 (Smialek et al., 2017).  
Proinflammatory cytokine (IL-1β and IL-6) findings indicated higher up-regulation in IL-1β 
mRNA expression at 3 dpi in the 793B3 and 793B3 groups, which became almost double 
that of the Mass and control groups. Conversely, previous work has shown that M41 resulted 
in greater upregulation in the expression of IL-1β and IL-6, which was connected with higher 
viral loads, gross lesions and microscopic changes (Okino et al., 2014). High expression of 
IL-6 has a detrimental effect on lesions (Asif et al., 2007), and both IL-1β and IL-6 are well 
known to be accompanied by a high viral load and damaged tissue in the trachea and/or 
kidney (Chhabra et al., 2015b). This could be the consequence of reduced up-regulation of 
MYD88 in the current study. The effect of the TLR7 pathway (which incorporates MYD88), 
should be considered in future work. It is likely that the TLR7 pathway is mostly activated 
by virulent IBVs, which then mediates the IL-6 and IL-1β proinflammatory cytokines, 
resulting tissue damage. 
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Significant differences were found within all inoculated group tracheas at 14 dpi for both 
CD4+ and CD8+ counts using immunohistochemistry. Data showed that 793B3 had the 
highest average in CD4+ and CD8+ at 14 dpi compared with other inoculated groups. Apart 
from Mass1, the recruiting of CD8+ was greater than that of CD4+, which is a similar finding 
to what has been previously reported after 793B infection in SPF and broiler chickens (G. 
D. Raj and R. C. Jones 1996a). These significant differences have been reported not only for 
single IBV vaccine applications, but also for combinations of vaccines from other viral 
species, such as Newcastle Disease virus and avian metapneumovirus (Awad et al., 2015). 
In the current study, the peripheral blood CD4+:CD8+ ratio peaked in all vaccinated groups 
at 14 dpi. These results is comparable to those outlined previously (Kjærup et al., 2014; 
Chhabra et al., 2015b). The increase in this ratio indicates the status of immune protection 
against viral infection (Dalgaard et al., 2010). It may be debated which IBV strains induce a 
higher host immunological response and which cells are more imperative during viral 
invasion and clearance, as an increase in CD4 cells was found in SPF chicks after infection 
with VI648 in (Janse et al., 1994), but higher CD8 cell components were reported after 793B 
IBV infection ( Raj and Jones 1996a).  
In the 1–7 dpi period, there was up-regulation of IFN-γ mRNA in all vaccinated groups. 
However, the magnitude of expression was variable, with little expression in 793B3. This 
type II IFN is predominantly produced by NK cells, NK T cells, dendritic cells and Th1 
CD4+ and CD8+ effector cytotoxic T lymphocytes (Vervelde et al., 2013). Previous work 
outlines that this IFN is up-regulated after either infection or vaccination with IBV (Okino 
et al., 2013; Okino et al., 2014; Okino et al., 2017a). IFN-γ and Granzyme homolog A are 
well documented to combine with the action of NK cells, which initiate the innate 
immunological response during IBV M41 challenge (Vervelde et al., 2013). Data in the 
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current study showed that there is significantly higher up-regulation in type II IFN at 3–9 dpi 
in the Mass group when compared with the 793B group; the causes of such differences are 
unclear.  
The CD8β mRNA gene expression was up-regulated in all groups, with reduced expression 
in Mass2 at 1–7 days compared to the other vaccines. This cell-mediated immune (CMI) 
gene is considered a marker of the effector activity of CD8 T cells induced by IBV 
vaccination in tracheal tissues. Similar up-regulation was reported at 5–8 dpi in SPF chicks 
with Brazilian IBV isolates (Okino et al., 2017a). It has reported that, after IBV infection in 
the trachea, the adaptive immunity will be established against infection in 3–7 days; 
moreover, an influx of cells, such as CD8+ and CD4+ lymphocytes, will occur, and the local 
CMI response will be initiated (Kotani et al., 2000; Chhabra et al., 2015b). At the molecular 
level may be such differences arose due to changes in the non-structural and structural 
proteins of IBV strain, which interacted during viral invasion and initiated the immune 
response, as well as different pathways followed by various strains (Zhong et al., 2012). 
In the previous chapter, 793B3 reached EP50% in the shortest timeframe, suggesting this 
strain causes a higher level of virulence amongst the vaccines investigated. In addition, the 
793B3-inoculated group showed higher cell-mediated immune responses, represented by 
higher CD8β gene expression in the period of 5–9 dpi, higher CD4 and CD8 counts at 14 dpi 
and higher CD4:CD8 ratios at 7 and 14 dpi. The cause of such response is not known, but it 
may be connected to virulence, and further studies could look to interpret these differences.  
Data gathered in this study indicated that the prominent components of resistance against 
IBV challenge such as CD8+, IFN-β, IFN-γ gamma, IgG and IgA. All strains used in the 
current study were immunogenic in SPF chicks. Furthermore, the 793B3 group induced the 
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high level of CD8 cells, systemic antibodies and MYD88 and the highest IgA fold change, 
which could be associated to the virulence of this strain. Further investigation is needed using 
bivalent vaccination regimes rather than the monovalent one used in the present study. 
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Chapter 8: General discussion and future work 
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The causative agent of infectious bronchitis (IB) is avian infectious bronchitis virus (IBV), 
which is a positive sense RNA virus that infects the respiratory tract, kidneys and digestive 
organs depending on the tropism of respective IBV strains. The virus S1 gene is 
characterized by high genetic variability and possesses three hypervariable regions (HVRs) 
that are responsible for the induction of neutralizing antibodies, which is generally serotype 
specific (Moore et al., 1997). A number of factors promotes emergence of new genotypes of 
IBVs in different parts of the world and further evolution of these strains plays the central 
role in the development of new variants (Jackwood 2012). Point mutations, insertions, 
deletions, and recombination among strains have influenced the emergence of new variant 
(Hewson et al., 2014). Therefore, lack of cross-protection between the immunity produced 
by currently available vaccines and emerging variants have been widely reported in recent 
years. This has led to substantial economic losses due to IBV, where after NDV and AIV, 
IBV is considered as the most important threat to chicken health, production and welfare 
worldwide.  
An RT-PCR scheme was developed to amplify and sequence the full S1 gene of classical 
(M41) and variant (D274, 793B, IS/885/00, IS/1494/06, Q1 and QX) IBV strains (Chapter 
3). The sensitivity of this scheme was evaluated after FTA cards were inoculated with four 
IBV viruses and stored at three temperatures (4, 24 and 40 ºC). Partial S1 sequences exhibited 
a higher average nucleotide homology percentage (79%; 352bp) when compared to full S1 
sequences (77%; 1,756bp), suggesting that the full S1 protocol has shown a greater efficacy 
for strain identification. The work in Chapter 3 showed the following: - 
a. The greater sensitivity seen with partial S1 amplification may be in part due to 
the considerable difference in amplicon length. Data has shown that the partial 
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assay was able to detect IBV RNA inoculated onto FTA cards up to 21 dpi for all 
storage conditions (including 40ºC). However, this was not possible for the full 
S1 gene, showing that the sensitivity for amplifying the larger region (full S1) is 
affected by both incubation time and temperature. This finding is in agreement 
with a recent study which had difficulty in amplifying a product greater than 900 
bp, despite detecting a 290 bp product after six months of storage (Sakai et al., 
2015). 
b. Usual practice of IBV diagnosis in local or international laboratories is through 
the collection of oropharyngeal swabs, tissue samples collected at necropsy or 
IBV-enriched allantoic fluids embedded onto FTA cards. Samples are then 
stored, and/or transported at different temperatures for variable lengths of time. 
The study was designed to mimic conditions that field samples may be subjected 
to prior to extraction of RNA and our full S1 scheme. It appears that storage of 
FTA cards at 40 ºC must be avoided and least favoured for detection of IBVs. For 
samples on FTA cards, detection of partial rather than full S1 is preferred, as for 
the latter protocol, it appears higher RNA quantities are needed.  
Future work to improve the sensitivity of the assay would improve the usefulness for field 
sample testing. Currently, the full S1 sequencing scheme appears to be suited for samples 
enriched in growth medium (e.g. eggs) rather than those obtained directly from the field (e.g. 
tissues, swabs and impression smears).  
 
As stated in the previous chapters, despite the wider detection of IBV Q1 in different 
continents of the world (except Central and North America and Australasian counties), the 
pathogenicity of this virus has not been studied. Also, Chabbra et al. (2018) reported on the 
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virulence, pathogenicity and early immune responses to IBV M41, QX and 885 but not on 
Q1. As such, in Chapters 4 and 5, the immunopathogenesis of Q1 IBV was investigated in 
SPF (Chapter 4) and two broiler lines, Line-A and Line-B, with differing growth rates 
(Chapter 5). The relative importance of the various resistance factors, such as innate immune 
responses, which play a key part in IBV pathogenicity, is not yet fully understood. Research 
onto the three types of chickens provided scientific findings for the following conclusions: - 
a. The Q1 variant isolate used in this study was pathogenic to SPF and both breeds 
of broiler chicks. It appears that the Q1 has higher tropism to the trachea rather 
than the kidneys.  
b. In both SPF and broiler chickens, the Q1 infection can cause significant body 
weight reduction. Further studies could be helpful in terms of including more 
breeds to assess this point.  
c. The Q1 was isolated from the proventriculus from all infected groups but 
attempts to show the replication of the virus in this tissue by IHC was not 
successful. Probably, the investigation should include use of other monoclonal 
antibodies, different dilutions of the antisera, green fluorescent protein (GFP) 
labelled IBV, more frequent sampling intervals, as truly demonstrating local 
replication of IBV in the proventriculus would add new dimension on IBV 
pathogenesis. 
d. Comparison between the broiler lines (fast versus slow growers), it was 
demonstrated that the fast-growing birds are more susceptible to IBV Q1, where 
the virus able to persist throughout the experimental duration in various tissues. 
This interesting and important finding likely to raise welfare questions on the use 
of fast growing broiler breeds in the industry. In fact, higher susceptibility for fast 
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growing broiler breeds to Salmonella infection (van Hemert et al., 2006), 
Campylobacter jejuni (Williams et al., 2013; Humphrey et al., 2015) have been 
reported before. 
e. For the sensing genes, IFNs and pro-inflammatory cytokines, in SPF infected 
trachea were up regulated. In the SPF infected kidney, the next genes were up 
regulated in all sampling days IFNα, IFNβ, TLR3, MDA5 and LITAF. IFN-α was 
up regulated only in Line-A but IFN-β was up regulated in both lines. For TLR3, 
an up-regulation was seen in Line-A up to 7 dpi and for all sampling days in Line-
B. MDA5 was up-regulated in Line-A and down-regulated in Line-B at 1 dpi. In 
the kidneys, for Line-A birds, IFN-α and IFN-β were up-regulated at 1 and 1-3 
dpi respectively. There was up-regulation in TLR3 in Line-B throughout the 
study period but not for Line-A. MDA5 was up-regulated in both lines at 7 and 9 
dpi. These mentioned host genes are clear from our data that have a role on the 
course of infection and then influenced signs or gross and histological alteration 
extent and then the pathogenicity degree. 
 
In Chapter 6, the aim was to provide further information about the in vitro pathogenicity and 
genetic characteristics of 11 IBV strains (virulent and vaccine strains). Comparisons were 
made between eight commonly used vaccines and three virulent strains belonging to 
common serotypes worldwide 793B, Massachusetts and QX. During the study, we utilised 
trachea organ cultures (TOCs), a commonly described method of assessing the in vitro 
pathogenicity of IBV on respiratory tract ciliated epithelia. The results demonstrated the 
following:- 
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a. Confirmed that there are evident differences between the pathogenic effect of 
strains in the same serotype and some vaccines can show cilia degradation 
comparable with that of the virulent strain.  
b. The qRT-PCR analysis, which was limited to the TOC media in this study, 
showed a significant decrease of the viral load in the 24- and 72-h post-infection 
samples, potentially due to the movement of viral particles from the media into 
the cells. To explore this hypothesis, further studies focussing on molecular 
biology analysis on tracheal rings would be necessary to expand the genetic 
difference evaluation. In addition, cytopathic characteristics could be 
investigated alongside expanding the study to a larger number of serotypes and 
extending the interval of TOC incubation. Despite similar ciliostasis effects seen 
in certain vaccine strains, a greater number of apoptotic cells were found in 
groups infected with virulent strains. Our conclusion is that linking the MDA5, 
and IFN-β with the 50% time-point and apoptosis with pathogenicity was 
associated with greater expression and increased pathogenicity. This study 
demonstrated the usefulness of using TOCs for experiments investigating 
pathogenesis, host invasion and genetic variation, reducing the need for in vivo 
trials. 
 
The Chapter 6 provided scientific evidences that pathogenicity and early immune responses 
between various live vaccines that are available in the market could be differentiated using 
an in-vitro system. Such infectious model is useful, as use of live animals can be reduced or 
avoided, and a large number of live IBV vaccines could be screened simultaneously. 
However, it was important to validate the results on the Chapter 6, at least few of the vaccines 
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in in-vivo, to assure that the differentiation can be presented in birds. For this, work in 
Chapter 7 was undertaken, basically investigating the pathobiology and host immune 
responses following administration of single live vaccines in day-old SPF chicks. To avoid, 
excess usage of birds, only two Mass (Mass1, Mass2) and two 793B (793B1, 793B3), 
vaccines were used. Following findings were derived from the Chapter 7:- 
a. From the study data, pathogenicity assessment indicated that, the 793B1 was the 
most virulence strain among the other vaccinal strains.  
b. All vaccines induced local, cellular and innate immune responses. Cloacal swabs 
and RT-PCR were positive at 1 dpi for 793B1 and 793B3, but not for Mass1 and 
Mass2. This indicated that the 793B virus induced viraemia in a short time (less 
than 24 h) and spread to the digestive or kidneys, or possibly the 793B virus has 
tropism for replication in the intestine. 
c. In the lachrymal fluid, there was a higher IgA titre at 14 dpi compared with 7 dpi 
in all the groups. Levels of IgA antibodies in lachrymal fluid have been associated 
with IBV infection or vaccination (Gelb et al., 1998; Chhabra 2016; Okino et al., 
2017a).  
d. IgA mRNA expression in tracheal washes indicated higher expression at 7 dpi in 
the Mass2 vaccinated group when compared with the other vaccinated groups, 
and little expression at 14 dpi. This is the first report measuring the expression of 
IgA in tracheal washes, tears and tracheal tissues individually. Others working 
on whole IgA in tracheal washes, reported an increase in the titre following either 
vaccination or virulent virus infection (Davelaar et al., 1982; van Ginkel et al., 
2008). This highlights the importance of this isotype in immune responses and 
protection against challenges.  
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e. The host innate immune mRNA gene expressions were elevated for IFN-β, 
MDA5, TLR3, IL-1β and IL-6 after inoculation. Overall, each vaccine induced a 
protective level of innate responses, which would help during field homologous 
challenge. The CMI genes tested in the current study outlined that upregulation 
of IFN- γ mRNA expression occurred early, at 1 dpi, in all the vaccinated groups. 
This may suggest an increased importance of this gene in acting as an antiviral 
agent, as previous work also showed that IFN-γ is the main immunological 
component of cells like dendritic cells, NK T cells, CD8+ effector cytotoxic cells 
and Th1 CD4+ T lymphocytes (Vervelde et al., 2013). 
f. The data indicated that the 793B1 inoculated group showed higher cell-mediated 
immune responses, represented by higher CD8β gene expression in the period of 
5–9 dpi, increased CD4+ and CD8+ counts at 14 dpi and higher CD4:CD8 ratios 
at 7 and 14 dpi. This may be considered a promising aspect of these components 
of host innate, humoral and cellular responses, which could be crucial in 
protection when homologous challenges occur.  
Overall, study findings have significant implications for the understanding of how host and 
virus interactions at the molecular level represented by innate immune responses. The 
present study provides the first comprehensive assessment of immunopathogensis of virulent 
IBV (Q1) and vaccinal viruses.  
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Study limitations 
 
 In this study, storage of FTA at temperatures below 0 was not investigated. It would 
have been interesting to shed some answers on this aspect, as temperatures below 0 
likely to preserve the viability of RNA. This may allow better detection of IBV, 
particularly for the full-S1 sequencing. 
 The Q1 immunopathogenesis in SPF chicks; current study is not in line with the field 
conditions, as exacerbations by various adverse environments and other factors such 
as age and MDA level were not assessed.  
 More details have been added on some of the limitations that already stated in the 
Chapter 5 (The immunopathogenesis of infectious bronchitis virus Q1 in slow or fast 
growing commercial broiler chicks). The findings in different lines of broiler 
chickens could have been influenced by variable levels of IBV maternal antibodies.  
 For the Chapter 6 (Pathogenesis assessment of vaccine or virulent infectious 
bronchitis viruses in chick embryo tracheal organ cultures), critics of laboratory-
based experiments contend that such studies are short and may not represent the in 
vivo host–virus interactions. In addition, factors such as study duration, dosages, 
incubation temperatures and pH of media may have influence the survivability and 
pathogenesis of the viruses.  
 In all Chapters, consistently, 18S was used as the reference gene.  Probably, in the 
future studies, other housekeeping genes such as HMBS, ACTB, GAPDH and 
HPRT1 as outlined by (Batra et al., 2017) should be included.   
 In advancing our understanding on the patho-biology of IBVs, it would be 
advantageous to utilize techniques such as transcriptomics, proteomic and NGS 
analysis could be used.  
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Appendix І (Reagents and protocols) 
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Stock solution D  
Guanidine thiocyanate 64                                         100.00 g                              
0.75M sodium citrate 40                                          7.04 ml     
            
10% lauryl sarcosine 40                                      10.50 ml    
                 
Sterile distilled water                                             7.04 ml     
           
Kept for one month at 4oC 
 
 
Working solution D  
Stock solution D (see sol D)                                        25 ml  
Mercaptoethanol40                                              180 μl     
             
TOC culture medium and supplements  
10x Minimum Essential Medium-Eagles 65                            100 ml                                 
7.5% sodium bicarbonate 40                                         20 ml                                                 
Sterile distilled water                                             900 ml                                                 
Penicillin-streptomycin solution                                       4 ml                                            
 
                                                 
 
 
64 Sigma-Aldrich, UK 
65 Life Technology, UK                            
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Stock antibiotic solution 
Crystapen66                                                     600 mg                                                            
Streptomycin sulphate BP 67                                         1.0 g                                                
Sterile distilled water                                               4 ml                                                       
4ml of this stock solution was added to 1000 ml of medium for a 1x solution. For preparing 
10x antibiotic medium, 4ml was added to 100ml of medium. 
 
 
Phosphate buffered saline (PBS) 
NaCl                                                         85.00 g                             
Di-sodium hydrogen orthophosphate (Na2HPO4)                     10.70 g    
           
Sodium dihydrogen orthophosphate (NaH2PO4.2H2O)                3.90 g              
Made up to 1 litre with sterile distilled water 
 
2M sodium acetate 
Glacial acetic acid68                                            19.00 ml                  
Sodium acetate69                                              5.46 g     
             
Made up to 200 ml with sterile distilled water 
 
                                                 
 
 
66 Glaxo, Greenford, UK 
67 Evans Medical, Greenford, UK 
68 VWR International Ltd 
69 Sigma-Aldrich, UK 
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0.75M Sodium citrate pH7.0 
Citric Acid Monohydrate                                              31.52 g                                                      
NaOH pellets                                                        16.8 g                                                               
Sterile distilled water                                                  200 ml                                                                                                                      
 
 
Resuspending (RS) water  
RNasin, RNAse inhibitor 70                                        2.5 μl    
              
Dithiothreitol (DTT) 71                                               5 μl     
                    
Ultra-pure water 47                                               92.5 μl     
             
 
Reconstitute stock primers according to delivery details, Dilute stock oligos 1:10 to give 
working solutions  
 
IBV Oligos72 
Working Oligo       Stock Oligo               Sigma Water          
SX4-      10µl                    90 µl                       
      A    B 
                                                 
 
 
70 Promega, Madison,USA 
71 Invitrogen, Paisley, Scotland 
72 Invitrogen, Paisley, Scotland 
Chapter Nine            References 
281 
 
 
 
SX1+    10 µl   10 µl                   80 µl                        
SX3+    10 µl   10 µl                             80 µl                    
SX2-    10 µl  10 µl                   80 µl                        
 
10mM dNTP’s Working Solution 
dATP, dCTP, dGTP, dTTP at 100mM 51  
Take 20µl of each dNTP, total volume 80µl 
Add 120µl of sigma water to give 200µl of 10mM dNTP’s 
 
Nested PCR 1 protocol 
PCR Supermix 73                                                  19 µl                  
+ Oligo (IBV SX1+) (aMPV G1+) (MSF-)                             0.5 µl                             
- Oligo (IBV SX 2- ) (aMPV G6-) (MSF+)                             0.5 µl                                
 
Nested PCR 2 protocol  
 PCR Supermix                                                  23.5 µl                                                        
+ Oligo (IBV SX3+) (aMPV G8-A)                                   0.5 µl                                        
- Oligo (IBV SX 4- ) (aMPV G9+B)                                  0.5 µl 
- Oligo (aMPV G5-0 (aMPV)                                        0.5 µl                                         
 
                                                 
 
 
73 Invitrogen, Paisley, Scotland 
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Loading Buffer  
Ficol                                                             3 g                                                                    
1XTBE                                                         20 ml                                                                 
10x Tris-borate-EDTA (TBE)74 
This was purchased at 10X concentration and diluted to1X concentration when required. 
Gel preparation 
1.5% agarose 53                               0.7g                   
       
TBE                                                            35 ml  
                                   
 
cDNA synthesis reaction mixture I75 
Random hexamers                                                       1μl 
 
10mM dNTP mix                                                         1μl diethyl-pyrocarbonate (DEPC) 
treated water (up to)                          10μl  
cDNA synthesis mix76 
10X RT buffer                                                            2μl 
 
                                                 
 
 
74 Sigma-Aldrich, UK 
75 Invitrogen, Paisley, Scotland 
76 Invitrogen, Paisley, Scotland 
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25 mM MgCl2                                                                                         4μl 
0.1 M DTT                                                              2μl RNasrOUT (40U/μl)                                                      
1μl Superscript III (200 U/µl)                                                 1µl 
 
 
 
Quantitative reverse transcription PCR (qRT-PCR) reaction mixture 
 
 
2x Rotor Gene probe77 12.5 µl 
IBVRT1 2 µl 
 
IBVRT2 
 
2 µl 
 
IBVRT3 TaqMan® probe 
 
0.5 µl 
Rotor-Gene RT Mix78 
 
0.25 µl 
RNase-free water 5.75 µl 
 
10x Tris-borate-EDTA (TBE)79 
 
This was purchased at 10X concentration and diluted to1X concentration when 
required. 
 
                                                 
 
 
77 Qiagen, UK 
78 Qiagen, UK 
79 Sigma-Aldrich, UK 
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Oligos 80for RT-PCR 
 
Oligos received were reconstituted as per manufacturer’s instructions. The stock 
 
oligos were diluted to 1:10 to make working solutions 
 
RNA extraction protocol using the Qiagen RNeasy Plus kit 
Weigh out no more than 30mg of tissue in a 2ml Eppendorf and cut into small pieces using 
sterile scissors 
1. Make up Mercaptoethanol (ME) + RLT Buffer solution 
A. 10µl ME into 1 ml RLT 
B. 100µl ME into 10ml RLT 
C. 500µl ME into 50ml RLT 
2. Add 600µl ME+RLT to each 2ml Eppendorf and add a sterile magnetic bead 
3. Lyse the tissue for 10 min (trachea or proventriculus) or 8 min (kidney) 
4. Centrifuge for 3 min at 13,000rpm 
5. Carefully remove the supernatant (around 550µl) and add to a gDNA eliminator spin 
column (provided in the kit) 
6. Centrifuge for 30 sec at 8000g/10,000rpm, discard the spin column and save the flow 
through in the collection tube. NB make sure that no liquid remains on the column, if 
necessary repeat the spin  
7. Add equal volume of 70% ethanol (e.g. 550µl ethanol into 550µl sample) and mix using 
the pipette. For max RNA yield from liver use 50% ethanol 
                                                 
 
 
80 Invitrogen, Paisley, Scotland 
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8. Transfer 700µl into an RNeasy spin column (provided), centrifuge for 15 sec at 
8000g/10,000rpm and discard the flow through.  
A. Repeat this step for any remaining sample. 
B. Reuse the collection tube in next step 
9. Add 700µl RW1 buffer and centrifuge for 15 sec at 8000g/10,000rpm then discard the 
flow through 
A. Reuse the collection tube in next step 
10. Add 500µl RPE buffer and centrifuge for 15 sec at 8000g/10,000rpm then discard the 
flow through 
A. Reuse the collection tube in next step 
B. RPE buffer is supplied as a concentrate – ensure the correct volume of 100% ethanol 
is added (indicated on the bottle) before using 
11. Add 500µl RPE buffer and centrifuge for 2 min at 8000g/10,000rpm then discard the 
flow through and collection tube 
12. Optional: Place RNeasy spin column in new 2ml collection tube and centrifuge for 1 min 
at13,000rpm 
13. Place the spin column in a new 1.5ml collection tube (provided), add 30µl RNase-free 
water and centrifuge for 1 min at 8000g/10,000rpm to elute the RNA 
A. Repeat this step by adding the flow through back into the collection tube 
B. This ensures a higher yield of RNA in the final 
C.  
DNA Extraction using Qiagen Q1A DNA Mini Kit 
1. Heat water bath to 56oC and heat lock to 70oC  
2. Take 1ml of Solution D (After leaving at -20oC with cut up FTA card for at least 2h) 
for Virus or Mycoplasma 
3. Place in Screw capped eppendorf 
4. Centrifuge @13,000g/15min 
5. Remove supernatant and discard (you need the pellet) 
6. Invert on blue paper to dry 
7. To each tube add 180µl of ALT buffer and 20µl pK (proteinkinase) 
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8. Incubate @ 56oC /15min, vortexing occasionally 
9. Add 200µl AL buffer to each tube 
10. Votex/15secs 
11. Incubate @70oC/10min 
12. Add 210µl 100% ethanol to each tube 
13. Vortex /15secs 
14. Transfer to Q1Aamp spin column 
15. Centrifuge @10,000g (11,300rpm)/1min 
16. Discard flow through 
17. Using new collection tube 
18. Add 500µl AW1 buffer 
19. Centrifuge @10,000g (11,300rpm)/1min 
20. Discard flow through 
21. Using new collection tube 
22. Add 500µl AW2 buffer 
23. Centrifuge @10,000g (11,300rpm)/3min 
24. Discard flow through 
25. Centrifuge @10,000g (11,300rpm)/3min 
26. Discard flow through 
27. Place spin column in clip top eppendorf 
28. Add 150µl Sigma water, stand @room temperature for 1min 
29. Centrifuge @10,000g (11,300rpm)/1min 
30. This is the DNA extract, store @ 4oC over night or longer @ -20oC 
 
QlAamp viral RNA extraction 
Equilibrate samples and buffers to RT 
Addition of carrier RNA to buffer AVL 
1. Add 310 µl Buffer AVE to the tube containing 310 µg lyophilized carrier RNA 
2. Dissolve the carrier RNA completely  
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3. If extracting 55 samples add the 310 µl reconstituted carrier RNA to 31ml Buffer 
AVL 
4. This is stable in the fridge for 48h. Look out for precipitation. To dissolve any 
precipitate, heat at 80oC for no more than 5 min (no more than 6 times) 
5. If extracting smaller numbers of RNA see table in booklet with kit for amounts and 
storage of reconstituted carrier RNA   
Protocol 
1. Add 560 µl of prepared buffer AVL containing reconstituted carrier RNA into 1.5 
ml eppendorf tubes 
2. Add 140 µl of sample 
3. Vortex for 15sec 
4. Incubate at RT for 10min 
5. Pulse centrifuge  
6. Add 560 µl of 100% ethanol 
7. Vortex for 15sec 
8. Pulse centrifuge 
9. Label spin columns 
10. Carefully remove 630µl from tube (step 6) into spin column 
11. Centrifuge at 8000 rpm for 1minute, discard flow through 
12. Place spin column in clean collection tube and repeat steps 10 and 11 
13. Place spin column in clean collection tube add 500 µl of buffer AW1 
14. Centrifuge at 8000 rpm for 1min, discard flow through 
15. Place spin column in clean collection tube add 500 µl of buffer AW2 
16. Centrifuge at 13,000 rpm for 3minutes, discard flow through 
17. Place spin column in clean 1.5 ml eppendorf tube add 60 µl of sigma water 
18. Incubate at RT for 1 minute 
19. Centrifuge at 8000 rpm for 1min, discard spin column and save flow through (RNA)  
20. Store RNA at -20oC 
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Cell Preparation for Flow Cytometry 
1. Heparin Preparation (Sigma H4784-250 mg @ 180 usp/mg) 
a. Need to use it @10 usp per 1ml blood 
b. Take 10 mg heparin into 1 ml Normal sterile saline (NSS) 
c. Equals 1800 usp/1000µl NSS, equals 1.8 usp/1µl, equals 9.9 usp/5.5 µl 
2. Therefore add 5.5 µl of heparin solution per 1ml of blood to each collection tube 
3. Further dilute sample 1:1 with saline or RPMI 1640 medium 
4. Add 0.5 ml of histoplaque to a 1.5 ml Eppendorf tube 
5. Overlay 1 ml of blood mixture on top of the histoplaque 
6. Centrifuge @8000 g or 10000 rpm @ Room Temp for 90 secs 
7. Remove the formed buffy layer (middle layer) very carefully by going through the 
top layer, using a pipette and steady hand 
8. Wash gently two to three times with saline or RPMI 1640 medium, spinning @ 500g 
or 1200 rpm for 5 mins 
9. Adjust the cell count to 1 x107 cells per ml  
(1ml at 1:1 suspension = more than 1 million cells (Ross 308))  
Immunostaining for flow cytometry 
1. Re-suspend cells in 0.5 % BSA in PBS( Blocking solution) final volume 500 µl 
2. Aliquot into 100 µl  
3. incubate @ room temp for 15 mins  
4. Spin down cell suspension @ 1200 for 5 mins 
5. Prepare the antibodies @ 0.5µg/106 cells (Normally obtain 106 cells after histoplaque 
separation thus, in 100 µl have approx. 2 x 105 cells, then you need to add 0.1µg of 
antibody which is 0.2 µl in 100 µl of cell suspension  
6. Incubate cells with antibodies conjugated to FITC in blocking solution in the dark 
for 30 mins 
7. Spin down cells @1200 rpm for 5 mins and wash twice with PBS 
8. Finally re-suspend cells in 2% paraformaldyde (final volume 500µl) 
9. Stained cells are detected by flow cytometry to determine the % of CD4 and CD8 
lymphocytes, using unstained cells as a negative control to adjust the threshold 
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Protocol for Flow Cytometer Accuri C6 
1. Ideally 106 cells/ml per sample 
2. Ideally 106 cells/ml per sample 
3. Samples can be as small as 25 µl, but it is best to use 50-100 µl (50000 counts is 
good enough) 
4. Always include an unstained control 
5. FITC-B1(FL1) channel 
Procedure 
1. Instrument will need 15-30 mins to warm up 
2. Switch on by touching screen 
3. Check all bottles are blue 
4. Instrument has three lasers: 
a. 405 (Violet, VI) 
b. 488 (Blue, B1-B4) 
c. 635 (Violet, R1-R2) 
5. Can work on Eppendorfs 
6. Create a user folder 
7. Switch symbol – acquisition 
8. Follow instructions for priming (Cleaning/washing instrument takes about 5 mins) 
9. Green lights – Ready 
Calibration 
1. Go to ‘’New Workspace’’ or select a previous workspace 
2. Go to collect 
3. Select an empty well 
4. Check settings:  
a. Speed Low is best  
b. Limits – 10000- to 50000 events 
c. Threshold (400000) 
d. Uptake volume 
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e. Sample volume 
f. Mixing 
5. Select the channels you want to work with, always select FSC and your stain, in this 
case FITC 
6. Press Run 
7. Adjust plot specifications 
8. Use ‘’Backflush’’ between samples 
9. Always wash instrument after use 
10. Switch off (will take 7 mins)  
 
H&E Frozen Sections 
1. 95% Ethanol - dip until clear 
2. Running tap water - dip until clear 
3. Distilled water - dip until clear 
4. Haematoxylin 30 seconds 
5. Running tap water - 30 seconds 
6. 95% Ethanol - dip 3-4 times 
7. Eosin Y - dip 1-2 times 
8. 2x 95% ethanol- dip 5-10 times 
9. 3x 100% Ethanol - dip 5-10 times 10. 2x Xylene - dip 5-10 times 
11. Coverslip with DPX 
 
 
Virus isolation in eggs 
Centrifuge ground up tissue samples 
First passage (10) 
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1. Use 3 eggs per sample plus 3 control eggs 
2. Inoculate eggs with 200 µl of sample 
3. Incubate for 48h 
4. Candle eggs after 24h and discard any dead embryos 
5. After 48h candle eggs, note any dead’s then put all eggs in the cold room for 
24h/overnight 
6. Collect the allantoic fluid (AF) and centrifuge (Beware of any contaminated AF) 
7. Then carefully remove the embryos to examine for typical signs of IBV infection 
Second passage (20)  
1. Use 3 eggs per sample plus 3 control eggs 
2. Inoculum is 10 allantoic fluid 
3. Then as above from No 3 
Third passage (30) 
1. 3 eggs per sample plus controls 
2. Inoculum is 20 allantoic fluid 
3. Incubate for 5 days 
4. Candle eggs after 24h and discard any dead embryos 
5. After 3 dpi candle eggs, note any dead’s then put in the cold room 
6. After 5 dpi candle eggs, note any dead’s then put all eggs in the cold room for 
24h/overnight 
7. Collect the allantoic fluid (AF) and centrifuge (Beware of any contaminated AF) 
8. Then carefully remove the embryos to examine for typical signs of IBV infection 
 
After collecting the AF from the 30, extract the RNA and carry out RT-PCR 
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If positive for IBV then send the PCR product for sequencing 
Protocol for IBV IHC from, frozen sections  
1. Fix in acetone 10 min room temperature 
2. Air dry room temperature 10 min 
3. Draw around sections with FAT pen  
4.  Wash slides 3x2min TBS  
5. Peroxidase Block - apply 100µ1 (or enough to cover section) DAKO REAL 10mins, 
room temperature 
6. 3x2min TBS wash 
7. Apply 100µ1 (or enough to cover section) of primary antibody mouse monoclonal anti 
chicken IBV (Prionics) dilution? (1: 1000)µ used in formalin fixed paraffin 
embedded IHC).  
4'C overnight Use humidified chamber to prevent slides drying out. 
8. 3x2min TBS wash  
9. Apply 3 drops of DAKO ENVISION +HRP (a mouse), 30mins room temperature 
10. 3x2min TBS wash 
11. DABW5mins (use Impress Kit)  
12 .5min TBS wash  
13. 5min dH20 wash   
14. Counterstain Haematoxylin 1 min 
15. "Blue" running tap water 5min 
16. Dehydrate l min 96% Ethanol, 2x3min 100% Ethanol, Xylene  
17.Coverslip sections with DPX 
